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 The United Kingdom Focal Point on Drugs 
 
The United Kingdom (UK) Focal Point on Drugs is based at the Department of Health 
and the North West Public Health Observatory at the Centre for Public Health, 
Liverpool John Moores University.  Along with equivalent organisations in other 
European Union (EU) Member States, the Focal Point provides detailed information 
to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) on the 
drug situation in England, Northern Ireland, Scotland and Wales.   
 
The Focal Point works closely with the Home Office, other Government Departments 
and the devolved administrations.  In addition to this annual report, it collates an 
extensive range of data in the form of standard tables and responses to structured 
questionnaires, which are submitted regularly to the EMCDDA.  It also contributes to 
other elements of the EMCDDA’s work such as the development of its five key 
epidemiological indicators, the Exchange on Drug Demand Reduction Action 
(EDDRA) and the implementation of the Council Decision on New Psychoactive 
Substances. 
 
The UK Focal Point website can be found at www.ukfocalpoint.org.uk and is currently 
under development. 
 
The EMCDDA's website is www.emcdda.eu.int.  
 
The Head of the UK Focal Point on Drugs is Alan Lodwick at the Department of 
Health (alan.lodwick@dh.gsi.gov.uk).  
 
 
The structure and content of this report 
 
The structure and content of this annual report are pre-determined by the EMCDDA 
to facilitate comparison with similar reports produced by the other European Focal 
Points.  Ten chapters cover the same subjects each year, and three further chapters, 
giving in-depth information on selected issues, change from year to year.  
 
Each of the first ten chapters begins with an overview.  This sets the context for the 
remainder of the chapter, describing the main features of the topic under 
consideration within the UK.  This may include information about the main legislative 
and organisational frameworks, sources of data, the broad situation and recent 
trends revealed by the data and definitions used. 
 
The remainder of each chapter is concerned with New Developments and Trends 
that have not already been reported in previous reports.  Generally, this includes 
developments that have occurred in the second half of 2004 or the first half of 2005. 
Relevant data that has become available during this period will also be discussed 
although this will often refer to earlier time periods. 
 
This report, and the reports from the other European countries, will be used in the 
compilation of the EMCDDA’s annual report of the drug situation in the European 
Union and Norway to be published in 2006. 
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SUMMARY 
Main Findings 
1. National policies and context 
The Drugs Act 2005 amends sections of the Misuse of Drugs Act 1971 and the 
Police and Criminal Evidence Act 1984 strengthening police powers in relation to 
drug use.  It allows for drug testing on arrest and makes it an offence to supply magic 
mushrooms (psilocin or psilocybin). 
 
A review of the Northern Ireland Drug and Alcohol Strategies began in January 2005. 
 
The Drug Strategy progress report Tackling Drugs. Changing Lives. Keeping 
Communities Safe from Drugs highlighted achievements since the launch of the 
Updated Drug Strategy in 2002. 
 
The Drug Harm Index, developed to capture the harms generated by the problematic 
use, combines national indicators into a single-figure time-series index.  It suggests 
that by the end of 2003, harms caused by drug use had fallen by nine per cent, since 
the launch of the Updated Drug Strategy in 2002.  
 
Direct expenditure for tackling drugs in 2004/051 was budgeted at €2,000 million2 
(£1,344 million) (DSD 2002a).   
2. Drug use in the population 
Prevalence of drug use amongst the adult population in the United Kingdom is 
estimated to be: 
• 34.1 per cent have one or more drugs in their lifetime; 
• 11.8 per cent have used one or more drugs in the last year; and 
• 7.1 per cent have used one or more drugs in the last month. 
Prevalence of drug use in England and Wales and in Northern Ireland has not 
changed significantly.  However, in Scotland the decline in prevalence seen in the 
previous survey (from 2000) has not been sustained. 
The highest prevalence level for lifetime use is now amongst 16 to 34 year olds, 
although young people aged 16 to 24 years old continue to show the highest levels of 
recent and current use.  Prevalence rates are: 
• 45.4 per cent of young people aged 16 to 24 years old had used one or more 
drugs in their lifetime, 46.9 per cent of those aged 16 to 34 years old had done 
so; 
• 27.2 per cent of young people aged 16 to 24 years old had used one or more 
drugs in the last year, 21.4 per cent of those aged 16 to 34 years old had done 
so; 
• 16.9 per cent of young people aged 16 to 24 years old had used one or more 
drugs in the last month, 13.1 per cent of those aged 16 to 34 years old had done 
so. 
                                                
1 UK Government financial years run from the start or April to the end of March.  So regarding 
the financial year 2005/06, the year starts on 1 April 2005 and ends on 31 March 2006.  Some 
data in this report relate to calendar year, whilst others relate to financial year.  Similar 
references are used to refer to financial year. 
2 All conversion rates used in this report will use the exchange rate of £1 equals €1.4881 
euros as of 30 June 2004 unless otherwise stated. (Please see 
http://www.bankofcanada.ca/en/rates/exchform.html for further details of exchange rates). 
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Cannabis continues to be the most commonly used drug, followed by ecstasy and 
cocaine; the latter, with magic mushrooms, showing an increase in use over recent 
years. 
 
Males remain significantly more likely to use drugs than females. 
 
Drug use amongst school age children has decreased. 
3. Prevention 
The needs of vulnerable young people have become a focus of policy attention.  The 
Children Act 2004 embodies legislation that seeks to ensure all children are able to 
reach their potential. This should provide for the needs of those at risk of drug misuse 
or affected by the drug use of others. 
 
In England, the Young People Substance Misuse Partnership Grant of €87.7 million 
(£58.9 million) will be used by Drug (and Alcohol) Action Teams (D(A)ATs), and 
Crime and Disorder Reduction Partnerships (CDRPs) to deliver the young people 
aim of the National Drug Strategy.  
 
More than 50,000 vulnerable young people have participated in the Positive Futures 
programme since its launch in 2000. 
4. Problem drug use 
The estimated number of problem drug use in Scotland has fallen from 55,800 in 
2000 to 51,582 in 2003.  
 
A study using capture-recapture methods and the multivariate indicator method is 
being carried out to provide local estimates for all 149 Drug Action Team areas of 
England and thus a national estimate. 
 
A capture-recapture study is also currently being undertaken in Northern Ireland. 
5. Treatment 
Expanding treatment remains a key priority of the UK Drug Strategy.   
 
Provisional figures for England published in July 2005 suggest that 125,500 clients 
were assessed for treatment, and that there were 160, 050 treatment episodes in 
2004/05.  
 
The Healthcare Commission has included drug treatment as one of the eight key 
targets used to assess the performance of Primary Care Trusts in England.  
 
A review of treatment and rehabilitation services was undertaken in Scotland and an 
Action Plan developed to improve access to, and effectiveness of treatment. 
 
The provision of treatment for young people, both those who are problem drug users 
and those who are vulnerable to becoming problem drug users, has been given 
priority and is a focus of UK Government’s strategy on drug prevention.  
 
In England, 30 per cent of treatments are drug free, offering either rehabilitation, 
structured counselling or structured day care; 3 per cent of known treatments 
involved inpatient detoxification.  Substitution treatment remains the main treatment 
(63% of treatments); methadone remains the drug of choice. 
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A change in regulations to enable the prescribing and dispensing of diazepam in 
instalments for treating drug addiction came into force in 2005. 
 
In December 2004 the Department of Health announced a shortage of injectable 
heroin; this is not expected to be resolved until early 2006. 
6. Health related correlates and consequences  
Latest information for drug-related deaths is for 2003.  The total number of deaths in 
the UK was 1,416, continuing the fall from 2000.  The male:female ratio continues to 
decline and in 2003 was 4.11:1.  The average age of death for females was 
considerably higher than that for men.  The overall average age at death rose to 35.3 
years old, having fallen in the previous two years.  Opiates accounted for the majority 
of deaths. 
 
There were 51 deaths associated with volatile substance abuse in 2003, the lowest 
figure since 1982. 
 
HIV prevalence amongst current injecting drug users (IDUs) in England and in Wales 
in 2004 was 1.5 per cent; the highest level since 1992.  In London, the incidence was 
3.4 per cent, higher amongst injecting crack-cocaine users, this groups being more 
likely to engage in risk behaviour.  There is evidence to suggest an increasing 
proportion of IDUs may be unaware of their HIV infection. 
 
Four in ten IDUs are infected with hepatitis C in the UK.  Evidence suggests that 
prevalence has increased, although there is marked variation within the UK: 59 per 
cent in the North West of England and 62 per cent in Greater Glasgow; crack-
cocaine injectors have higher prevalence.  
7. Responses to health related correlates and consequences  
In Scotland, a National Investigation into Drug Related Deaths in 2003 was published 
and in England a Volatile Substance Abuse Framework was adopted. 
 
In Scotland in 2005, prosecution policy was revised to allow test purchasing of age-
restricted goods by children and young people under the age of 18 years old. 
 
Ambulance technicians as well as paramedics can now administer naloxone to 
overdose victims. 
 
A UK wide audit of syringe exchange began in autumn 2004 to investigate in detail 
the nature of provision; to identify areas of innovative practice in this area; and to 
identify the barriers and difficulties in providing a needle exchange service. 
 
In July 2005 Government outlined plans for further reform of mental health 
legislation.   
 
The Advisory Council on the Misuse of Drugs (ACMD), which advises the 
Government, will make a formal study of the evidence, which has been published 
subsequent to reclassification, on cannabis and its association with mental health 
problems. 
 
The website, www.drugdrive.co.uk, was relaunched to raise awareness of the 
impairment effects of drugs when driving.   
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8. Social correlates and consequences 
A number of studies have been published which highlight the association between 
truancy, school exclusion and drug use.  There have also been a number of studies 
looking at the impact of drug use on the families of drug users. 
 
The number of offenders for drug offences brought before the courts continues to 
rise.  The number of people found guilty, cautioned or compounded for drug offences 
in England, Scotland and Wales increased by 14 per cent between 2000 and 2003 
(from 102,196 to 116,429).  The number arrested for cannabis possession has 
halved following the reclassification of cannabis. 
 
Amongst those tested through Mandatory Drug Tests in prisons in England and 
Wales, 11.6 per cent were positive; in Scotland, the proportion was 18 per cent. 
 
Approximately 66 per cent of prisoners in a survey in England reported using drugs 
prior to prison.  In Scotland, 50 per cent of prisoners reported having used drugs 
while in prison. 
 
The cost model of Class A drugs, developed in 2002, is to be updated.  
9 Responses to social correlates and consequences  
The third and final phase of Progress2Work (p2w), an employment initiative in 
England, Scotland and Wales for former drug users was, in place in 2004.  By March 
2005, 20,350 individuals had engaged with p2w.  Of these, 4,022 individuals (20%) 
had obtained jobs and of these 1.215 (30%) had remained in work.  
 
It is reported that acquisitive crime, to which drug-related crime makes a substantial 
contribution, fell by 12 per cent in the year to April 2005. 
 
More than 63,000 drug tests for heroin, crack and cocaine on offenders charged with 
a trigger offence were undertaken between April 2004 and March 2005 (an average 
of 5,312 per month).  On average, around 50 per cent tested positive for heroin or 
cocaine or both. 
 
Voluntary drug testing has been introduced in prisons in Northern Ireland. 
 
A further €148.8 million (£100 million) is being spent to provide housing related 
support to groups who are particularly at risk of homelessness, such as victims of 
domestic violence and people with drug and alcohol problems.  Guidance for 
commissioners on meeting the housing needs of drug users is now available. 
 
A new National Offender Management Service (NOMS), which joins the work of the 
Prison Service and the Probation Service, is to focus on the end-to-end management 
of the offender.  This should have a positive impact on problem drug users.
 
Counselling, assessment, referral, advice and throughcare services (CARATs) 
expected to engage with 47,000 drug users in custody in England and Wales in 
2004/05 but had already engaged with 53,396 between April 2004 and February 
2005. 
 
In 2003/04, 7,119 drug users began treatment programmes in prison in England and 
Wales, 65 per cent were completed (4,600).  
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The Drug Interventions Programme now covers all of England. There will be an 
investment of €245.5 million (£165 million) in the Drug Interventions Programme 
(DIP) 2005/06.  Over 14,000 people have entered treatment through this programme.  
Case management and aftercare for DIP was established throughout England and 
Wales during 2004/05.   
 
In Scotland Drug Testing and Treatment Orders are now available in nationally. 
 
Ten D(A)AT areas are currently piloting child and youth-centred models of arrest 
referral for 10 to 17 year olds. 
10. Drug Markets 
In general, the number and quantity of seizures are decreasing in the UK.  However, 
seizures of crack cocaine are increasing. 
 
Overall, in 2003, the average price of illegal drugs continued to fall. 
 
The mean purity of brown heroin fell (to 33%), the mean purity of cocaine was higher 
than previously (51%); crack stayed the same (70%).  The mean purity of 
amphetamines fell (to 10%). 
Operation Crackdown, a three month campaign targeting Class A drug dealers 
closed 70 crack houses, took drugs with a value of over €19.79 million (£13.3 million) 
off the streets, and arrested more than 3,400 suppliers.  
 
 
The summary for Part 2 is presented at the beginning of that section. 
 
 
Most relevant developments and trends 
The Drugs Act 2005, allowing drug testing on arrest, will strengthen the ability of the 
criminal justice system to identify problem users and get them into treatment, through 
programmes such as the Drug Interventions Programme in England and Wales. 
 
The Drugs Act, with its presumption that those caught in possession of more drugs 
than considered reasonable for personal use are intending to supply, will ensure a 
tougher approach to dealing.  In addition, with the Act, dealers targeting young 
people, may face harsher sentence as the law now enables the courts to take into 
account aggravating factors for those who deal near schools and those who use 
school children as drug couriers.  
  
The Drugs Act also clarifies the law on magic mushrooms, making raw 
psilocin/psilocybin mushrooms (in addition to prepared mushrooms) a Class A Drug. 
 
There is a new focus on vulnerable young people with The Young Peoples Drugs 
Delivery Plan being implemented in England and Wales to increase selected and 
indicated prevention programmes for young people and services to provide treatment 
for those with a drug problem.  
 
With access to treatment greatly improved over recent years, treatment services are 
now to focus on their effectiveness. 
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Drug use within the population is stablising, although use of cocaine (and magic 
mushrooms) continues to rise. 
 
There are indications, from Scotland, of a decrease in problem drug use. 
 
Drug-related deaths continue to fall. 
 
There have been increases in infectious disease amongst drug users, notably for 
those who use crack cocaine. 
 
Government is seeking to improve services for those with co-morbidity with changes 
in the Mental Health Act being proposed. 
 
Greater emphasis is being placed upon undermining the drugs market at the lower 
end of the supply chain as well as at the international level. 
 
 
Consistency between indicators 
Population surveys in the UK suggest that for the most part drug use is stabilising.  
However, Scotland shows an increase in drug use, and across the UK, cocaine and 
magic mushrooms are increasing in prevalence albeit from a very low base. 
 
While treatment presentations for problem drug use increased, this is more likely to 
be associated with increased capacity and cannot be seen to be attributed to an 
increase in problem use.  The results from the latest research undertaken to provide 
an estimate of problem drug use in Scotland, suggests a decrease in the latter, 
although as this is at the 93 per cent level, results should be treated with caution. 
 
Opiates continue to be the main drug for most treatment presentations in the UK, 
although there are variations between the different administrations.  Seizures of 
heroin fell slightly in 2003, which could relate to the activity by Police and Customs, 
but might also be associated with increased access to treatment, reducing the 
demand for opiates, and even a fall in problem drug use, as suggested by the latest 
estimates of problem prevalence in Scotland.  There has also been a reduction in the 
number of persons found guilty or cautioned for drug offences in the UK, and a 
reduction in the number of deaths. 
 
Use of cocaine has increased within the general population.  Without sufficient data 
over time with respect to the numbers of problem drug users presenting to treatment 
reporting cocaine as main drug, it is difficult to make assertions about its relative rise 
or fall amongst the treatment population.  However, the number of seizures of 
cocaine has clearly risen, as have the number of persons found guilty or cautioned 
for cocaine offences in the UK.  Deaths associated with cocaine have fallen.  
Seizures and offences involving crack have increased.   
 
With respect to injecting, there are insufficient data over time with respect to the 
numbers of those presenting to treatment who inject, to make assertions as to a rise 
or fall in injecting drug use.  However, there are indications of increased infections 
amongst injecting drug users.  HIV, while remaining very low amongst injecting drug 
users has increased slightly.  Prevalence amongst current IDUs in England in Wales 
(1.5%) is the highest level seen amongst current IDUs in this survey since 1992.  
Crack injectors report higher levels of risk behaviours that other IDUs.  There are 
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also indications that there has been an increase in the prevalence of IDUs exposed 
to hepatitis C infection. 
 
Recent and current prevalence of ecstasy is stable amongst the adult population.   
The number of persons found guilty or cautioned for ecstasy offences in the UK has 
remained stable.  Seizures have fallen and there has also been a fall in deaths 
associated with ecstasy. 
 
Lifetime prevalence of cannabis use is stable in the adult population and there is a 
slight decrease in use amongst school children in England and Wales.  However, the 
number of persons found guilty or cautioned for cannabis offences in the UK rose; 
this is based on 2003, too early to reflect changes in the classification of cannabis. 
 
Amphetamine use has fallen considerably over time amongst the general population; 
this is consistent with a continuing fall in seizures and offences.  Seizures remain low 
and there has only been a small increase in offences. 
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1. National policies and context  
1.1 Overview 
The Misuse of Drugs Act 1971 divides controlled drugs into three classes (A, B and 
C) depending on their potential for harm and there is a graded scale of penalties for 
possession and supply.  Some important changes came into force in 2004 including 
the reclassification of cannabis from Class B to Class C and an increase in penalties 
for drug trafficking.  Use of controlled drugs per se is not an offence in the UK; 
however, since 1995, drug use in prisons has been against prison rules (HM Prison 
Service 1995; HM Prison Service 2004a).  
 
The UK Drug Strategy was launched in 1998 (UKADCU 1998) with four principal 
aims: preventing drug use amongst young people, safeguarding communities, 
providing treatment and reducing availability.  These are to be achieved through 
education, prevention programmes, expanded treatment, legal sanctions and the 
expansion of legal opportunities.  The Strategy was updated in 2002 with an 
increased emphasis on reducing the use of Class A drugs (DSD 2002a).  Each of the 
devolved administrations (Northern Ireland, Scotland and Wales) has its own 
strategy, reflecting the aims of the UK Strategy, but tailored to their individual 
circumstances (NIO 1999; Scottish Office 1999; National Assembly for Wales 2000).   
 
Delivering the Strategy is a cross-government responsibility, with the Prime Minister 
chairing the Cabinet Ministerial Committee on Serious and Organised Crime and 
Drugs.  The Drugs Strategy Directorate of the Home Office is responsible for co-
ordinating the Drug Strategy and ensuring its delivery.  In England and Scotland, 
delivery is through local drug partnerships, Drug (and Alcohol) Action Teams 
(D(A)ATs)3.  In addition, Crime and Disorder Reduction Partnerships (CDRPs) in 
England and Community Safety Partnerships in Wales work with the police and 
communities to tackle local drug problems and associated crime.  In Wales, 
responsibility for tackling drug use has been transferred to the 22 Community Safety 
Partnerships. The Welsh Assembly has four Substance Misuse Action Teams to 
ensure the implementation of the Welsh Substance Misuse Strategy. In Northern 
Ireland, a Regional Drug and Alcohol Strategy Co-ordinator is responsible for driving 
forward delivery (DHSSPSNI 2003), and four Drug and Alcohol Co-ordination Teams 
bring together local agencies. 
1.2 Legal framework 
1.2.1. Drugs Act 2005 
The Drugs Act 20054 amends sections of the Misuse of Drugs Act 1971 and Police 
and Criminal Evidence Act 1984.  It will strengthen police and court powers in relation 
to drugs, and increase the effectiveness of the Drug Interventions Programme (DIP; 
see Section 9.3.3) by getting more offenders into treatment. Specifically it:  
• allows police to test drug offenders on arrest, instead of on charge; 
• requires those testing positive to undergo an assessment;  
                                                
3 A number of local teams tackle both drugs and alcohol, but some are also drug only. 
4 For more information, please seehttp://www.drugs.gov.uk/drugs-laws/drug-act-2005/. 
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• allows for an ‘intervention order’ to run alongside drug-related Anti-Social 
Behaviour Orders (ASBOs)5 , providing a requirement of drug counselling 
attendance; 
• enables courts to remand those in police custody who swallow drugs in secure 
packages for up to a further 192 hours6 (to increase the likelihood of recovering 
evidence);  
• allows a court or jury to consider occasions when a person refuses without a 
good reason an intimate body search, x-ray or ultrasound scan; 
• creates the presumption of intent to supply when a specified quantity7 of 
controlled drugs are found; 
• requires courts to account for aggravating factors (such as supplying drugs near 
a school8) when sentencing;  
• amends the Misuse of Drugs Act 1971, classifying those fungi containing psilocin 
or psilocybin (magic mushrooms) as Class A drugs except where they are 
growing wild or being picked for destruction;  
• amends the Anti-Social Behaviour Act 2003 so that the police can issue closure 
notices to buildings such as crack houses; and 
• repeals section 38 of the Criminal Justice and Police Act 2001, which criminalised 
occasions when an individual knowingly permits the use of illegal drugs on 
premises9. 
1.2.2 Laws implementation  
The Drugs Act 2005 will be implemented in stages (see Table 1). 
Table 1: The implementation stages of the Drugs Act 2005 
Provision of Act Implementation 
New civil order for adults Planned commencement: April 2006 
Enhancing Police and Court powers Planned commencement: 1 December 2005 
New presumption of intent to supply Planned commencement: 1 December 2005 
Legislation surrounding fungi 
containing psilocin or psilocybin Commenced 18 July 2005 
Repeal of section 38 of the Criminal 
Justice and Police Act 2001 Commenced 1 September 2005 
Source: Drugs Act 2005 
                                                
5 Anti-Social Behaviour Orders aim to protect the public from behaviour that causes or could 
cause harassment, alarm or distress.  They forbid the offender from specific acts or locations 
for a minimum of two years. For more information, please see  
http://www.crimereduction.gov.uk/asbos9.htm?fp.  
6 Under the Police and Criminal Evidence Act 1984, an individual can normally only be held 
for up to 24 hours without charge. Differences do exist in the devolved administrations; for 
more information, the Citizen’s Advice Bureau has established the following website: 
http://www.advice.org.uk.  
7 The particular amount is to be decided by the Secretary of State, following a consultation 
with the Advisory Council on the Misuse of Drugs.  It is possible that the level set will be 
different according to the type of drug, please see  
http://www.publications.parliament.uk/pa/ld199900/ldhansrd/pdvn/lds05/text/50404-
18.htm#50404-18_head0 for more details. 
8 The Home Office is drafting guidance on this. See 
http://www.drugs.gov.uk/NationalStrategy/DrugsAct2005/IntheVicinity for more information. 
9 This could have been problematic for drug workers. 
 19
UNITED KINGDOM FOCAL POINT REPORT 2005 
1.3 Institutional framework, strategies and policies 
1.3.1 Co-ordination arrangements 
The Audit Commission (2004) assessed the local impact of the Drug Strategy.  It 
suggested that while treatment has improved, organisations responsible for providing 
housing, social care and other support services need to ensure that their services are 
appropriate and help the individual become employed, housed and more self-
sufficient.  The report suggests that those locally responsible for such services must 
do more to deliver coherent and tailored services but that they face short-term 
funding and a disjointed regulatory framework.  Because health services, local 
authorities, the police and probation services are now preparing the drug component 
of their crime and disorder strategies for 2005 to 2008, this is an opportunity for 
developing strategies that will give drug users an effective pathway to recovery. 
1.3.2 National plan and/or strategies 
The UK Drug Strategy now aims to reduce the harm caused by illegal drugs (see 
Section 1.3.3). 
England 
In England, the Government White Paper Choosing Health sets out the key principles 
for supporting the public to make more informed and positive choices about their 
health (DH 2004a).  However, illegal drugs are not a focus within this policy 
document (see Section 12.3.4 for further discussion). 
Northern Ireland 
A review of and e-consultation on the Northern Ireland Drug and Alcohol Strategies, 
the Northern Ireland Drug and Alcohol Campaign and the structures established 
under the former Northern Ireland Executive began in January 2005 (DHSSPSNI 
2005).  
Wales 
The Welsh Assembly Government (2003a) has launched a strategic agenda to 
create a sustainable future for Wales. Officials are working with the Welsh Assembly 
Government Advisory Panel on Substance Misuse to review the objectives of the 
2000 strategy (Welsh Assembly Government, internal communication).  It has also 
launched an agenda for public services (Welsh Assembly Government 2004a), 
highlighting their intention to deliver, with partners, public services that reflect the 
nature, needs and values of Wales.  
1.3.3 Implementation of policies and strategies 
Public Service Agreements 
The Government’s 2004 Spending Review (HM Treasury 2004a) set out 
departmental spending plans for the financial years10 2005/06 to 2007/08.  
Associated with this are Public Service Agreements (PSAs), which commit 
Government Departments to particular objectives and targets.  These include targets 
that aim to reduce the harm caused by illegal drugs to individuals, their families and 
the community by (HM Treasury 2004b): 
• reducing drug use amongst young people and preventing problematic drug use, 
especially amongst the most vulnerable; 
                                                
10 UK Government financial years run from the start or April to the end of March.  So 
regarding the financial year 2005/06, the year starts on 1 April 2005 and ends on 31 March 
2006.  Some data in this report relate to calendar year, whilst others relate to financial year.  
Similar references are used to refer to financial year. 
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• having a long-term impact on the supply of Class A drugs; 
• using the Criminal Justice System to target drug-using offenders, engaging them 
in treatment and reducing drug-related crime; and 
• increasing the numbers in treatment by 100 per cent by 2008 (from a baseline of 
100,000 in 1998), and to yearly increase the proportion successfully being 
retained or completing treatment. 
Cannabis legislation 
After the reclassification of cannabis from Class B to C in 200411, to reinforce that 
cannabis remains illegal and explain any related health risks, the Cannabis Health 
Information Campaign was launched in July 200412.  It was later expanded with 
further information targeting young people, and then heavy cannabis users. 
Magic mushrooms legislation 
Ten thousand leaflets have been distributed to vendors and users to clarify the new 
legislation surrounding the classification of magic mushrooms13. It states that “The 
Government has made it clear it will not allow the sale of fresh magic mushrooms 
and we expect people to follow the spirit of the law’’14.  An individual would not be 
offending solely through a naturally occurring substance (the mushroom) growing in 
their garden if they can prove their lack of knowledge (under the section 28 of the 
Misuse of Drugs Act 1971). 
1.3.4 Impact of policies and strategies 
The reclassification of cannabis  
In 2004, the Metropolitan Police Authority (MPA 2004) published a report examining 
the impact of the change in legislation surrounding cannabis in London.  The report 
suggested that although the number of cannabis offenders dealt with has increased 
by 31 per cent (from 6,231 over the period April to August 2003 to 8,148 over the 
same period in 2004), the number of offenders who are arrested has decreased by 
53 per cent (from 6,231 to 3,307).  Since the change in legislation, offenders are 
increasingly managed through alternative means such as formal warnings.  A similar 
trend is emerging in the rest of England and Wales and it has been estimated that 
this change is saving approximately 199,000 hours of police time in a year (Home 
Office 2005a). 
 
However, Warburton et al. (2005) suggest that even before the reclassification, the 
police were using their own discretion in managing incidents of cannabis possession. 
Their interviews with 150 officers in England (before reclassification) showed that 69 
per cent had managed at least one such incident without arresting the individual 
during their career (through measures such as informal or formal warnings, or 
ignoring the incident).  Using such methods was seen as a way of saving police time. 
Warburton et al. predicted that in the future, either the police would dispose of 
informal methods to use on-the-spot warnings or that informal action would become 
more commonplace.  They suggest that the new system needs to be monitored 
closely, for example, to examine regional variations and to check for disparities in 
numbers of arrests amongst specific groups (for example, ethnic minorities). 
                                                
11 This occurred under the Misuse of Drugs Act 1971 (Modification) (No. 2) Order 2003 - see 
Focal Point Report 2004, Chapter 1.2.1. 
12 For further information, please see http://www.drugs.gov.uk/Campaign/Cannabis. 
13 Please see http://www.drugs.gov.uk/NationalStrategy/DrugsAct2005/MagicMushroomFAQ 
for further details. 
14 Please see http://www.drugs.gov.uk/NationalStrategy/DrugsAct2005/1116427341 for 
further details.  
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Tackling Drugs. Changing Lives. Keeping Communities Safe from Drugs 
The Drugs Strategy Directorate produced a progress report at the end of 2004 on the 
Drug Strategy, Tackling Drugs. Changing Lives: Keeping Communities Safe from 
Drugs (DSD 2004a).  Its launch was used to hold a series of regional events for 
practitioners working in the drugs field.  The report highlighted the achievements 
made since the launch of the Updated Drug Strategy in 200215:  
• Young People: Overall Class A drug use among young people has been stable 
since 1998 (see Section 2.3 for details of prevalence and Chapter 3 for 
information on drug prevention).  
• Drug-related crime: Acquisitive crime16 decreased by 12.9 per cent in England 
and Wales between April 2003 and June 2004 (see Section 9.3.3 for information 
on the Drug Interventions Programme or DIP).  
• Reducing supply: Between April 2002 and December 2003, UK enforcement 
agencies seized over 26,000 kilograms of cocaine and 11,000 kilograms of 
heroin, and disrupted over 330 “organised crime groups”. 
• Treatment: 54 per cent more drug users were in contact with drug treatment 
services in 2003/04 compared to 1998 and the proportion of individuals 
successfully completing treatment rose from 57 per cent in 2002/03 to 72 per 
cent in 2003/04 (NTA 2004a) (see Chapter 5 for details on the numbers in 
treatment). 
 
The report also stated the Directorate’s aims for the years leading up to 2008: 
• Further reduce the availability of drugs through disrupting traffickers, 
collaborating with other countries and inter-agency working. 
• Further, reduce the numbers using drugs through education, support and 
targeted interventions. 
• Rehabilitate existing users through prompt and effective treatment, aftercare and 
rehabilitation. 
• Encourage more people out of crime and into treatment by, for example, 
extending DIP. 
Measuring the impact of the Drug Strategy 
The Government’s success in delivering the aims of the Drug Strategy are measured 
in England firstly through the targets set in the PSAs (see Section 1.3.3).  The Drugs 
Strategy Directorate (DSD) is also seeking to improve the estimates of the number of 
problematic drug users. These indicators will be considered alongside the Drug Harm 
Index (DHI).   
The Drug Harm Index  
The DHI helps to measure the impact of the Drug Strategy in England and Wales by 
assessing the harms17 generated by problematic drug use of any illegal drug 
(MacDonald et al. 2005).  The relative importance of each harm indicator will be 
estimated by its generated economic and social costs.  Any change in the Index will 
be due to the level or volume of harms (e.g. the number of new HIV cases) and the 
change in their economic or social cost (e.g. the change in the expected cost per new 
HIV case).  However, caution will be required as different harm categories may 
evolve differently and no single index will capture this diversity.  Therefore, 
MacDonald et al. suggest that the DHI should be considered alongside other 
indicators.  
                                                
15 For details of the Updated Drug Strategy, see Drugs Strategy Directorate (DSD 2002a). 
16 To which drug-related crime particularly contributes (DSD 2004a). 
17 For example, drug-related crime, health consequences, community perceptions of drug 
problems and public nuisance issues.  
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The target is to lower the Index from its baseline in 2002 (DHI value of 113.2) by 
2007/08 (Home Office 2004a). By the end of 2003, the DHI’s value was 102.9, a nine 
per cent fall (MacDonald et al. 2005).  
1.4 Budget and public expenditure 
1.4.1 In law enforcement, social and health care, research, international actions, co-
ordination, national strategies. 
Direct expenditure for tackling drugs in 2004/05 was budgeted at €2,000 million18 
(£1,344 million) (DSD 2002a).  For specific areas of the Drug Strategy, the 2004/05 
budget was as follows:  
• Protecting young people  €230.7 million (£155 million); 
• Reducing supply   €565.5 million (£380 million); 
• Safeguarding communities €442.0 million (£297 million); and 
• Drug treatment   €761.9 million (£512 million). 
 
In Scotland, a recent review of drug treatment and rehabilitation (see Section 5.2.2) 
announced that the amount of funding invested into treatment would increase by €3.6 
million (£2.25 million) a year from 2004 on top of the €8.9 million (£6 million) 
additional investment planned for 2005/06, bringing the total to €48.4 million (£32.5 
million) a year (Scottish Executive 2004a). 
 
In Wales, from April 2003, specific funds for drug use (including alcohol) services 
were allocated as being 0.4 per cent of the Local Health Boards’ discretionary 
allocations (NHS Finance Division 2004).  This was raised by 5.04 per cent for 
2004/0519.  To enforce this spending, from 2004/05 onwards, Community Safety 
Partnerships will confirm that agreement has been reached locally on the planned 
expenditure and that it complements the delivery of the local drug use strategy 
(Welsh Assembly Government, internal communication).  
 
The Substance Misuse Action Fund in Wales will increase from €4.9 million (£3.3 
million) in 2002/03 to €27.4 million (£18.4 million) by 2007/08 (Welsh Assembly 
Government 2004b).  As such, €16.5 million (£11 million) will be available for the 3 
year period 2005/06 to 2007/08 to fund capital projects to improve substance misuse 
treatment facilities (Welsh Assembly Government, internal communication). 
 
Additionally in Wales, the Building Safer Communities funding is shared between the 
22 Community Safety Partnerships for projects which focus on youth crime and 
disorder or which link in with other partnerships’ and agencies’ community safety 
strategies and initiatives, with a particular emphasis on work in deprived 
communities; €12.1 million (£8.1 million) will be distributed to the Partnerships as 
follows: 
• €1.5 million (£1.2 million) in 2003/04; 
• €4.2 million (£2.8 million) in 2004/05; and 
• €6.4 million (£4.3 million) in 2005/06.  
                                                
18 All conversion rates used in this report will use the exchange rate of £1 equals €1.4881 
euros as of 30 June 2004 unless otherwise stated. (Please see 
http://www.bankofcanada.ca/en/rates/exchform.html for further details of exchange rates). 
19 In 2003/04 in Wales, Local Health Boards’ discretionary allocation was £1,857 million, in 
2004/05 this has been raised to £2,185 million (NHS Finance Division 2004). 
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1.4.2 Funding arrangements 
NO NEW INFORMATION  
 
Please see UK Focal Point Report 2004, Section 1.4.2. 
1.5 Social and cultural context 
1.5.1 Public opinion of drug issues 
The reaction to the decision to reclassify cannabis was mixed.  For example in 
January 2005 the Chief Executive of DrugScope said,  
“We supported and continue to support the reclassification of cannabis and it is 
encouraging that cannabis usage is stable.  The real win is for our communities 
as police have been able to divert an estimated 199,000 police hours to 
policing other crimes.  The reclassification of cannabis was in recognition that 
all drugs are not the same.  Young people respond well to accurate and 
balanced information but are sceptical of scare stories.  Most young people 
know that cannabis is illegal and can be harmful but we need a much greater 
focus on drug education and prevention.” (DrugScope 2005).  
 
However, the Headteachers Association of Scotland presented an opposing 
viewpoint, stating that, “The decision to reclassify cannabis was wrong because the 
message they seem to be sending to children is that the drug is safe” (Musson 2005).  
 
The British Crime Survey20 (BCS) asks respondents about their experiences of 
drugs.  The 2003/04 findings reported that the proportion of respondents who 
perceive drug users or suppliers to be a very or fairly big problem decreased from 32 
to 25 per cent since 2002/03 (Dodd et al. 2004).  This stabilised in 2004/05 at 26 per 
cent; however, levels vary regionally with London respondents reporting the highest 
proportion at 34% compared to a fifth of respondents in the East of England, the 
region with the lowest proportion (Nicholas et al. 2005). 
 
Findings from the 2003 Scottish Crime Survey suggest that 91 per cent of 
respondents21 felt drug abuse to be an ‘extremely’ or ‘quite’ serious issue (Scottish 
Executive 2005a). The Scottish Executive’s (2005b) attitude survey found similar 
results22. In addition, the latter survey also found that: 
• Eighty-three per cent of respondents were aware that cannabis remained illegal 
after the reclassification. 
• Sixty-seven per cent had seen or heard recent prevention materials on drug use 
(compared to 60% in 2002, and 75% for 16 to 25 year olds in 2004). 
• Forty-one per cent believed the Government to be doing enough to discourage 
drug use (compared to 53% in 2003). 
 
In addition, the university magazine ‘Student’ examined 500 questionnaires from 
Edinburgh students (Friedman 2005) (see Section 2.3.3). Students reporting illegal 
drug use were asked whether they considered drugs to be a positive force on their 
lives; the following responded that they were: 
• cannabis: 42 per cent; 
• ecstasy: 75 per cent; 
• magic mushrooms: 54 per cent; and  
                                                
20 The British Crime Survey interviewed 45,120 people aged 16 years old or over living in 
private households in England and Wales. 
21 In total, 5,041 respondents were involved aged 16 years old or over. 
22 For this evaluation, 1,001 participants aged 16 years old and over were interviewed. 
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• cocaine: 48 per cent. 
1.5.2 Attitudes to drugs and drug users  
See Section 1.5.1. 
1.5.3 Initiatives in parliament and civil society 
Together We Can, the UK Government’s action plan to get citizens and public bodies 
working together, was launched in June 2005 (HM Government 2005a).  
Programmes such as Positive Futures and Blueprint already enable community 
development to play an integral part in drug prevention but this action plan also 
reflects the UK Government’s commitment to ensuring that community involvement is 
part of the action against Class A drug-related crime.  For example, activity by local 
partners and community engagement underpinned the delivery of a crack house 
campaign, Operation Crackdown (Home Office 2005b; see Section 10.2.1).  
 
Improving and increasing regional communications are central to Tackling Drugs. 
Changing Lives (DSD 2004a; see Section 1.3.4).  The overall objective is to 
communicate more effectively that local action taken to tackle drugs is having a 
positive impact, and that a tangible difference is being felt in communities.  To this 
end, the DSD (2005a) has created guidance for regional D(A)ATs on how to run a 
local media campaign.  
 
A Ministerial event in September 2005 was attended by over 90 drug strategy 
stakeholders. These included representatives of state bodies, enforcement agencies, 
non-governmental organisations, community groups and the voluntary sector. The 
Home Office is also running a series of public-facing regional events designed to 
provide local communities (including tenants groups, faith groups, police authorities, 
and local councillors) with the opportunity to hear what the Government is doing to 
tackle drugs.  Delegates also have the chance to put questions to a Minister.  A 
critical success factor will be to secure enthusiasm among local communities for the 
work being done to tackle drugs.  
 
For many people, involvement in a community group or a voluntary organisation 
enables an opportunity to be included in community decisions (HM Government 
2005a).  These groups are key partners in the delivery of the UK Drug Strategy 
(delivering drug treatment services and drug services for young people, in particular) 
and the Home Office is committed to involving their expertise and networks more.  As 
such, the Drugs Strategy has created a Voluntary and Community Sector Forum to 
provide an ongoing opportunity to: 
• help shape priorities, by allowing early consultation on developments in drug 
policy; 
• support delivery by gaining feedback on the experience of local organisations in 
delivery of the strategy, and developing recommendations for strengthening the 
delivery framework; and 
• take full account of the interests, capacity and expertise of the voluntary and 
community sector: a particular focus of the forum will be ensuring that small 
community and user groups have a voice in the UK Drug Strategy. 
 
The first meeting of the Drug Strategy Diversity Forum will be held in October 2005.  
Chaired by the Director of the Home Office’s Drug Strategy Directorate, the Diversity 
Forum is being established to: 
• identify issues arising among minority communities that would have relevance to 
the implementation and development of the Drug Strategy; 
 25
UNITED KINGDOM FOCAL POINT REPORT 2005 
• ensure that policy developments do not have a disproportionate impact on 
members of minority communities; and 
• provide guidance on cross-cutting issues that will inform the ways in which the 
Drug Strategy is delivered with regard to minority communities. 
 
Membership will include representatives of black and minority ethnic groups; 
refugees and asylum seekers; gypsy and traveller communities; the lesbian, gay, 
bisexual and transgender community; and disabled people (including those with 
mental disabilities and mental illnesses). 
 
The UK’s cross-governmental drug website23 is a key resource in the drug sector.  
The website - which receives up to 45,000 hits every month (DSD, internal 
communication) – will be re-launched in October 2005.  It provides: 
• the latest government policy, research and legislation; 
• information on events and conferences; 
• details of good practice and guidance; and 
• a user forum aimed at those working in the drugs field. 
1.5.4 Media representations 
Representation of the Drug Strategy and its delivery has been generally positive in 
the media, with regional coverage more positive than national  (Home Office 2005c).  
The introduction of the Drugs Bill generated many headlines and coverage was 
positive.  Conversely, the potential effects of cannabis on users’ mental health (for 
example, regarding schizophrenia) have generated negative coverage of cannabis’ 
reclassification, and the Home Secretary’s recent decision to refer its classification to 
the Advisory Council on the Misuse of Drugs received wide coverage and was 
broadly welcomed.  Drugs therefore retain a high profile in the media and remain a 
controversial topic.  
 
Shortly after Sir Ian Blair assumed his new role as the Chief Commissioner for the 
Metropolitan Police in London in January 2005, he announced his intention to clamp 
down on ‘middle-class cocaine users’ (Leppard 2005), stating, 
“People seem to think the price of a wrap of cocaine is 50 quid [pounds], but 
the cost is misery on estates here and a trail of blood back to Colombia. 
Someone has died to bring it to a dinner party. People who wouldn’t dream of 
having a non-organic vegetable don’t seem to notice the blood on their fingers” 
(Leppard 2005). 
 
This intention sparked much debate in the media and in online forums for several 
weeks afterwards about the legitimacy of this claim and how easy it will be to tackle 
(BBC 2005a; Benedictus 2005; Douglass 2005; Pilger 2005; Steelem 2005). 
 
                                                
23 Please see http://www.drugs.gov.uk.  
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2. Drug use in the population 
2.1 Overview 
Prevalence of use of any drug amongst adults has fluctuated but has remained 
relatively stable over the last few years in much of the United Kingdom, although use 
of cocaine and ecstasy, both Class A drugs has increased24.  Prevalence is highest 
in England and Wales where around a third of those aged 16 to 59 years old have 
ever used illicit drugs.  In Northern Ireland, prevalence had been relatively low until 
the 1990s, but by 2002/03 one fifth of adults reported lifetime use.   
 
Young adults under 35 are significantly more likely to use drugs; in most of the UK, 
lifetime prevalence for this age group is 45 per cent (although it is less than a third in 
Northern Ireland).  Amongst those who are under 25 years old, prevalence rates are 
even higher.  However, throughout most of the UK, there has been a gradual but 
significant decline in the use of any drug amongst 16 to 24 year olds in the last five 
years; though Class A drug use has remained stable, except for cocaine and 
ecstasy.  Of note is that the age band with the highest prevalence is widening as 
young people continue to use into their thirties.  Amongst school children drug use 
increased markedly, doubling between 1998 and 2002 to around 20 per cent (based 
on lifetime prevalence), but appears to have stabilised over recent years25. 
 
Men are more likely to report drug use than women but the difference varies 
according to age group.  
 
Cannabis continues to be the most commonly used drug across all age groups in the 
UK; last year use in England and Wales being around 11 per cent although it is lower 
in Scotland and Northern Ireland at 7% and 6% respectively.  Prevalence of all other 
drugs is considerably lower; no more than three per cent for last year use.  There has 
been a steady increase in the use of cocaine, crack and magic mushrooms; this 
increase partly accounts for increased use of Class A drugs.  There has been a 
decrease in recent (last year) and current (last month) use of amphetamines and 
LSD. 
 
Prevalence is particularly high in certain groups, such as young offenders, children in 
need, care leavers, homeless young people (Lloyd 1998; Gilvarry 2001; DrugScope 
and DPAS 2002), and children of drug-using parents (ACMD 2003).  Not only are 
they more likely to use, but they are more likely to use a wider range of drugs, and to 
use them more often. 
                                                
24 In the UK, the primary sources of information about prevalence of drug use amongst the 
adult population are from crime and victimisation surveys.  Please see Chapter 2.2 for more 
details of these. 
25 Amongst the school age population, surveys of drug use prevalence are undertaken in 
schools.  In England, a survey of the prevalence of smoking, drinking and drug use amongst 
young people (11 to 15 year old school children), has been undertaken annually since 1998.  
The Young Person’s Behaviour and Attitudes Survey, which was undertaken in Northern 
Ireland in 2000 for the first time, and repeated in 2003.  It will run every three years thereafter.  
In Scotland, the Scottish Schools Adolescent Lifestyle and Substance Use Survey (SALSUS) 
is undertaken annually.  The Health Behaviour in School Age Children Survey (HBSC) 
provides Welsh data and is undertaken every four years with a two-year interim survey.  The 
most recent survey, the sixth in the series, was conducted in 2001/02. 
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2.2 Drug use in the general population 
The British Crime Survey (BCS)26 for 2003/04, covering England and Wales, the 
Northern Ireland Crime Survey (NICS)27 for 2003/04, and the Scottish Crime Survey 
(SCS)28 for 2003 have been published in the last year (Scottish Executive 2005a; 
Chivite-Matthews et al. 2005; McMullan and Ruddy 2005).  Surveys have been 
completed in England and Wales for 2004/05 and in Scotland for 2004; however, the 
final results are not due until late autumn 2005.  Revised data from the 2002/03 
Northern Ireland Drug Prevalence Survey (NACD and DAIRU 2005), which were 
described in last year’s Focal Point report, have recently been published. 
2.2.1 Prevalence estimates in the United Kingdom 
By combining the information from the BCS, SCS and Northern Ireland’s data from 
the All Ireland Drug Prevalence Survey, an estimate has been produced  for 15 to 64 
year olds in the UK (Hay 2005a; see Figure 1 and see table in Appendix 1)29.  This 
estimates that: 
• 34.1 per cent reported using one or more drug in their lifetime; 
• 11.8 per cent reported use of one or more drug in the last year; and 
• 7.1 per cent reported drug use in the last month. 
 
Prevalence in the UK is highest in England and Wales, and lowest in Scotland across 
various different drug types (see Figure 1 and table in Appendix 1). 
                                                
26 In England and Wales, the British Crime Survey (BCS) is a crime and victimisation survey.  
It questions respondents, aged 16 to 59, about a number of crime-related topics including 
their experience of illicit drugs.  In 2002, it became a continuous survey, reporting quarterly.  
The sample size for the drugs module was 24,422. 
27 The Northern Ireland Crime Survey (NICS) is a crime and victimisation survey.  It is 
undertaken every few years.  In addition, a Drug Prevalence Survey (using the EMCDDA 
model questionnaire and recommended methodology) was conducted for the first time in 
2002/03 in association with the Republic of Ireland.  This survey will be repeated in 2005/06 
subject to funding.  In total, 2,121 people completed the Drug Prevalence Survey and 3,104 
people completed the drugs component of the Northern Ireland Crime Survey. 
28 The Scottish Crime Survey (SCS) is a crime and victimisation survey.  It asks comparable 
questions to those in the BCS but surveys all adults aged 16 years and over.  The latest 
survey is for 2003.  Overall, 4,665 people completed the drugs section of the survey. 
29 This estimate has been derived by using data from EMCDDA Standard Tables, completed 
for UK Focal Point by the data analysts in the Home Office, Scottish Executive and Northern 
Ireland Office.  It must be noted that these Standard Tables have not been otherwise 
published and will not necessarily be consistent with published data. For Scotland the data 
provided for UK Focal Point is for 16 to 64 years. 
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Figure 1: Percentage prevalence of illicit drug use in the United Kingdom by country and by 
drug 
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Data for Scotland are for 2003, data for England and Wales for 2003/04, crime survey data for 
Northern Ireland are for 2003/04 and drug prevalence survey data for Northern Ireland are for 
2002/03.  Data for England and Wales, and from the Northern Ireland Crime Survey are for 16 
to 59 year olds; for Scotland for 16 to 64 year old; data from the Northern Ireland Drugs 
Prevalence Survey are for 15 to 64 year olds. 
Figures for the Northern Ireland Crime Survey for cocaine do not include data for crack. 
Source: Chivite Mathews et al. (2005); Hay (2005a); McMullan and Ruddy (2005); National 
Advisory Committee on Drugs and Drug and Alcohol Information Research Unit (NACD and 
DAIRU 2005); Northern Ireland Office (NIO 2005); Scottish Executive (2005a). 
Northern Ireland: the Drug Prevalence Survey and the Crime Survey 
It is of note that estimates resulting from the NICS are significantly higher than those 
obtained in the Drug Prevalence Survey reported for Northern Ireland in last years 
report and shown in Figure 2 and Appendix 1 to allow comparison.  The results from 
the latter suggesting prevalence as follows: 
• 20.0 per cent had used one or more drug in the their lifetime; 
• 6.4 per cent used one or more in the last year; and 
• 3.4 per cent in the last month (NACD and DAIRU 2005). 
 
This might suggest that prevalence results from victim surveys produce higher 
estimates than results obtained from the European Model Questionnaire.  The 
difference could be because of differences in sampling period, the age ranges used, 
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the surveys’ approaches, and the definitions of ‘any illegal drug’ compared to ‘any 
drug’30.   
Drugs used overall in the United Kingdom 
Cannabis continues to be the most commonly used drug, with a considerably higher 
prevalence than for any other drug (10.8% for last year prevalence in the UK), 
followed by ecstasy (2.0%) and cocaine (1.5%) (see Appendix 1).   
2.2.2 Trends in reported drug use prevalence 
As this is the first time that an estimate of prevalence for the UK as a whole has been 
produced it is necessary to look at the different surveys separately to get a picture of 
trends over time.  
England and Wales 
Trend data for England and Wales show that reported drug use prevalence in 
2003/04 has not changed significantly since 2000, although it has increased overall 
since 1996 (see Table 2). 
Table 2: Percentage prevalence of use illicit drug use in England and Wales from 1996 to 
2003/04 amongst 16 to 59 year olds  
Prevalence 1996 1998 2000 2001/ 02 
2002/ 
03 
2003/ 
04 
Lifetime 30.5 33.6 35.7 34.0 35.7 35.6 
Last year 11.1 12.1 11.9 11.9 12.2 12.3 
Last month 6.7 7.1 7.2 7.4 7.4 7.5 
Total sample size 10,940 9,984 13,018 20,146 23,586 24,222 
Source: Chivite-Matthews et al. (2005). 
 
LSD has seen a slight increase in reported lifetime use but has decreased notably in 
reported last year and last month use (see Table 3).  There has also been a large 
increase in the use of magic mushrooms; 5.3 per cent of people reported lifetime use 
of magic mushrooms in 1996 compared to 7.1 per cent in 2004/05 (an increase of 
33%).  However, the most significant increase is the use of cocaine in the previous 
year, a 295 per cent increase between 1996 and 2003/04.  
                                                
30 Tranquilisers, methadone and steroids are excluded from the definition of ‘any illegal drug’ 
in the Drug Prevalence Survey but included in the NICS definition of ‘any drug’.  Given the 
prevalence rates recorded for each of these in the NICS they could also account for higher 
overall rates recorded. 
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Table 3: Percentage prevalence of illegal drug use in the last year in England and Wales 
amongst 16 to 59 year olds by drug, from 1996 to 2003/04 
Illegal drug 1996 1998 2000 2001/02 2002/03 2003/04 
Percentage 
change 
from 1996 
to 2003/04 
Lifetime prevalence 
Amphetamine 9.3 10.8 12.3 11.6 12.3 12.3 31 
Cannabis 23.5 26.8 29.5 28.9 30.6 30.8 31 
Cocaine (not 
including crack) 3.0 3.7 5.5 5.1 6.1 6.7 123 
Ecstasy 3.8 4.2 5.3 5.9 6.6 6.9 79 
LSD 5.4 5.6 6.2 5.4 5.9 6.1 12 
Magic mushrooms 5.3 6.0 7.0 6.1 6.8 7.1 33 
Last year prevalence 
Amphetamine 3.2 3.0 2.1 1.6 1.6 1.5 -52 
Cannabis 9.5 10.3 10.5 10.6 10.9 10.8 14 
Cocaine (not 
including crack) 0.6 1.2 2.0 2.0 2.1 2.4 295 
Ecstasy 1.7 1.5 1.8 2.2 2.0 2.0 15 
LSD 1.0 0.8 0.7 0.3 0.3 0.2 -77 
Magic mushrooms 0.7 0.9 0.7 0.5 0.6 0.8 24 
Last month prevalence 
Amphetamine 1.6 1.4 0.9 0.7 0.6 0.6 -64 
Cannabis 5.5 6.1 6.4 6.6 6.7 6.5 18 
Cocaine (not 
including crack) 0.2 0.4 0.7 0.9 0.9 1.1 376 
Ecstasy 0.7 0.5 0.9 1.1 0.9 0.9 22 
LSD 0.3 0.1 0.1 0.1 0.1 0.1 -72 
Magic mushrooms 0.1 0.1 0.2 0.2 0.1 0.3 86 
Total sample size 10,940 9,984 13,018 20,146 23,586 24,222  
Source: Chivite-Matthews et al. (2005). 
Northern Ireland 
According to the Northern Ireland Crime Survey, levels of reported drug use 
prevalence have increased slightly since 1998 (see Table 4).  Whilst lifetime 
prevalence is considerably lower than in England and Wales (very low levels of drug 
use were reported in the 1990s; House of Commons Northern Ireland Committee 
2003), last year and last month prevalence is similar to that reported in England and 
Wales. 
Table 4: Percentage prevalence of illegal drugs in Northern Ireland amongst 16 to 59 year 
olds, from 1998 to 2003/04 
Prevalence 1998 2001 2003/ 04 
Lifetime  24.0 26.0 27.4 
Last year  9.0 11.0 9.7 
Last month  5.0 6.8 6.2 
Total sample size 2,277 2,037 3,516 
Source: Hague et al. (2000); McMullan and Kerr (2003); McMullan and Ruddy (2005). 
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Data for individual drugs in Northern Ireland shows a decrease in reported cannabis 
and ecstasy use in the last year (see Table 5). 
Table 5: Percentage prevalence of illegal drug use in the last year in Northern Ireland 
amongst 16 to 59 year olds by drug, in 2001 and 2003/04 
Illegal drug 2001 2003/04 
Amphetamine 1.2 0.9 
Cannabis 7.3 6.4 
Cocaine (not including crack) 0.5 1.1 
Ecstasy 3.0 1.9 
LSD 0.5 0.0 
Magic mushrooms 0.2 0.5 
Total sample size 2,037 3,516 
Source: McMullan and Kerr (2003); McMullan and Ruddy (2005). 
 
Scotland 
Prevalence levels for adults have increased since 1996, following a decrease in 2000 
(see Table 6)31.  
Table 6: Percentage prevalence of illegal drugs in Scotland amongst adults, from 1996 to 
2003/04 
1996 2000 2003 
Prevalence 
16-59 year olds 16-59 year olds 16-64 year olds 
Lifetime  22.5 19.2 23.4 
Last year  9.0 6.6 8.5 
Total sample size 3,175 2,886 4,665 
Source: Fraser (2002); Scottish Executive (2005a). 
 
For reports of individual drug use in Scotland, overall increases since 1996 can be 
seen in reported cocaine use for both lifetime and last year prevalence (see Table 7).  
In comparison, reported levels of LSD and magic mushroom use have decreased. 
                                                
31 Data for 1996 and 2000 are for those aged 16 to 59, for 2003 data are for those aged 16 to 
64 and are derived from the Standard Table. 
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Table 7: Percentage prevalence of illegal drug use in Scotland amongst 16 to 59 year olds by 
drug, from 1996 to 2003 
1996 2000 2003 
Illegal drug 
16-59 year olds 16-59 year olds 16 to 64 year olds  
Lifetime prevalence 
Amphetamine 7.3 6.3 8.9 
Cannabis 19.0 17.4 21.0 
Cocaine (not 
including crack) 2.6 2.5 4.6* 
Ecstasy 4.0 3.7 5.5 
LSD 5.5 4.1 4.3 
Magic mushrooms 5.1 3.6 4.3 
Last year prevalence 
Amphetamine 3.1 0.5 1.3 
Cannabis 8.2 5.5 7.4 
Cocaine (not 
including crack) 1.0 0.7 1.4* 
Ecstasy 2.1 1.0 1.5 
LSD 1.3 0.7 0.1 
Magic mushrooms 1.3 0.1 0.2 
Total sample size 3,175 2,886 4,665 
Data for 1996 and 2000 are for those aged 16 to 59 reported by Fraser (2005), for 2003 data 
are for those aged 16 to 64 and are derived from the Standard Table. 
*Cocaine data for 2003 include crack. 
Source: Fraser (2002); Scottish Executive (2005a). 
2.2.3 Further discussion of general prevalence rates 
• Overall, males are significantly more likely to report drug use than females: 
reported lifetime prevalence of any illicit drug being 39.9 per cent for males and 
28.2 per cent for females (Hay 2005a). (Please see Chapter 11 for a more 
detailed discussion of gender differences.) 
• The majority of those reporting use in the last month (75%) in the British Crime 
Survey have only used one type of drug (Chivite-Mathews et al. 2005). 
• Based on the British Crime Survey, the most common age at which respondents 
reported starting to use illicit drugs is 18 years old. 
Geographical variations 
The BCS considered geographical variations and found that overall, reported drug 
use was higher amongst those living in inner city areas and lowest in rural areas 
(Chivite-Mathews et al. 2005).  More specifically, those living in affluent areas of 
cities and towns had the highest levels of use (20.5% reported use of any drug in the 
last year), compared to those living in ‘Thriving areas’32 affluent suburban areas (who 
reported the lowest levels at 9.7% for use in the last year).  Overall, London had the 
highest prevalence of drug use (14.7% for use in the last year) compared to 12.3 per 
cent for the whole of England and Wales.  
                                                
32 This includes ‘wealthy achievers in suburban areas, affluent greys in rural communities and 
prosperous pensioners in retirement areas’ (Chivite-Mathews et al. 2005). 
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Socio-economic and lifestyle factors 
The BCS examined socio-economic and lifestyle factors (Chivite-Mathews et al. 
2005) and noted that: 
• single respondents (24.7%) and those who were cohabiting (18.4%) were more 
likely to report drug use in last year than other groups; 
• those who were privately renting reported high levels of drug use (23.9% for use 
in the last year) compared to those who were owner occupiers (9.4%);  
• those who were unemployed were more likely to report drug use in the last year 
(23.5%); and 
• there was a higher prevalence of drug use amongst those who had recently been 
to a club or a disco compared to those who had not (see Chapter 13 for more 
details on recreational settings). 
Risk factors for drug use  
In England and Wales, Chivite-Mathews et al. (2005) reported that those factors 
strongly associated with class A drug use were: being young, male, single (not 
including being a widow/er), divorced, cohabiting; visiting pubs or wine bars three 
times or more a week or visiting a nightclub; and living in a terrace or flat/maisonette, 
or in a household with no children or as single adult with child(ren). 
2.3 Drug use amongst young adults 
2.3.1 Estimates for the United Kingdom 
Estimates of prevalence of drug use in the UK amongst young people are as follows:  
• 45.4 per cent of young people aged 16 to 24 had used one or more drug in the 
their lifetime, 46.9 per cent of those aged 16 to 34; 
• 27.2 per cent of young people aged 16 to 24 had used one or more drug in the 
last year, 21.4 per cent of those aged 16 to 34; and  
• 16.9 per cent of young people aged 16 to 24 had used one or more drug in the 
last month, 13.1 per cent of those aged 16 to 34 (see Table 8 and 9) (Hay 
2005a). 
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Table 8: Percentage prevalence of illegal drugs in the United Kingdom by drug and country 
amongst 15 to 24 year olds 
 
British 
Crime 
Survey 
Northern 
Ireland 
Crime 
Survey 
Northern 
Ireland 
Drug 
Prevalence 
Survey 
Scottish 
Crime 
Survey 
United 
Kingdom 
estimate Illicit drug 
16-24 year 
olds 
16-24 year 
olds 
15-24 year 
olds 
16-24 year 
olds 
15-24 year 
olds 
Lifetime prevalence 
Any drug  46.6 40.1 28.5  39.8 45.4 
Amphetamine 12.4 14.1 6.5 13.0 12.3 
Cannabis  41.3 30.0 24.0  37.7  40.4 
Cocaine 
(including crack) 9.1 5.4* 2.6 10.8 9.0 
Ecstasy  10.7 15.0 10.2  14.3  11.0 
LSD 4.3 4.9 5.9 6.1 4.5 
Magic mushrooms 6.6 4.2 4.9 5.6 6.4 
Last year prevalence 
Any drug 27.8 24.0 14.5 25.9 27.2 
Amphetamine 4.0 1.7 2.0 3.0 3.8 
Cannabis  24.8 18.6 12.1 23.1 24.3 
Cocaine 
(including crack) 5.0 2.5* 1.4 5.1 4.9 
Ecstasy 5.3 7.1 4.8 5.2 5.3 
LSD 0.8 0.0 0.2 0.3 0.8 
Magic mushrooms 2.7 0.7 0.5 0.3 2.4 
Last month prevalence 
Any drug 17.3 16.2 9.0 15.6 16.9 
Amphetamine 1.6 1.0 0.4 0.7 1.5 
Cannabis 15.6 11.9 7.9 14.3 15.2 
Cocaine 
(including crack) 2.7 1.5* 0.2 1.3 2.5 
Ecstasy  2.5 4.2 2.0 2.5 2.5 
LSD 0.4 0.0 0.0 0.0 0.4 
Magic mushrooms 0.8 0.5 0.0 0.0 0.7 
Total sample 
size 5,429 286 768 619 Not known 
 
 
Data for Scotland are for 2003, data for England and Wales for 2003/04, crime survey data for 
Northern Ireland are for 2003/04 and drug prevalence survey data for Northern Ireland are for 
2002/03. 
 
* The cocaine figures for the Northern Ireland Crime Survey do not include data for crack. 
Source: Chivite Mathews et al. (2005); Hay (2005a); McMullan and Ruddy (2005); National 
Advisory Committee on Drugs and Drug and Alcohol Information Research Unit (NACD and 
DAIRU 2005); Northern Ireland Office (NIO 2005); Scottish Executive (2005a). 
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Table 9: Percentage prevalence of illegal drugs in the United Kingdom by drug, country and 
age group 
British 
Crime 
Survey 
Northern 
Ireland 
Crime 
Survey 
Northern 
Ireland 
Drug 
Prevalence 
Survey 
Scottish 
Crime 
Survey 
United 
Kingdom 
estimate Illicit drug 
16-34 year 
olds 
16-34 year 
olds 
15-34 year 
olds 
16-34 year 
olds 
15-34 year 
olds 
Lifetime prevalence 
Any drug  48.2 41.7 30.9  38.5 46.9 
Amphetamine 18.4 15.8 7.2 16.5 17.9 
Cannabis  43.4 33.1 25.1 35.9 42.3 
Cocaine 
(including crack) 11.6 5.9* 2.9 8.7 11.1 
Ecstasy  13.6 15.7 11.4 12.5 13.4  
LSD 4.3 9.4 5.9 7.8 9.0 
Magic mushrooms 9.7  6.3 6.4 7.0 9.4 
Last year prevalence 
Any drug 22.1 18.3 11.6 18.0 21.4 
Amphetamine 3.0 2.2 1.5 2.3 2.9 
Cannabis  19.5 13.8 9.8 16.5 19.0 
Cocaine 
(including crack) 4.9 2.5* 1.0 3.2 4.7 
Ecstasy 4.1 4.5 3.3 3.8 4.1 
LSD 0.5 0.1 0.1 0.2 0.5 
Magic mushrooms 1.8  0.4 0.5 0.4 1.6 
Last month prevalence 
Any drug 13.6 12.1 9.0 10.4 13.1 
Amphetamine 1.1 0.5 0.3 0.7 1.0 
Cannabis 12.0 8.8 5.4 14.3 11.6 
Cocaine 
(including crack) 2.4 1.5* 0.2 0.9 2.2 
Ecstasy  1.9 2.5 2.0  1.6 1.8 
LSD 0.2 0.0 0.0 0.0 0.2 
Magic mushrooms 0.5  0.2  0.0  0.0 0.5 
Total sample 
size 10,922 817 1,550 1,407 Not known 
Data for Scotland are for 2003, data for England and Wales for 2003/04, crime survey data for 
Northern Ireland are for 2003/04 and drug prevalence survey data for Northern Ireland are for 
2002/03. 
*The cocaine figures for the Northern Ireland Crime Survey do not include data for crack. 
Source: Hay (2005a); Home Office (2005d); National Advisory Committee on Drugs and Drug 
and Alcohol Information Research Unit (NACD and DAIRU 2005); Northern Ireland Office 
(NIO 2005); Scottish Executive (2005a). 
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2.3.2 Trends in drug use among young people 
Again, as this is the first time that an estimate of prevalence in the UK as a whole has 
been produced it is necessary to look at each of the three surveys in order to 
consider trends.  Evidence from England and Wales for 16 to 24 years olds shows 
that current use of any drug by young people has fluctuated slightly but on the whole 
remained stable since 1996 (see Table 10).  Lifetime and current prevalence levels 
amongst those aged 16 to 34 (where data is only available for the last two surveys) 
have been stable over the last two years, though recent use has increased. 
Table 10: Percentage prevalence of illegal drugs in England and Wales by age group, from 
1996 to 2003/04 
Age group 1996 1998 2000 2001/02 2002/03 2003/04
Lifetime prevalence 
16 to 24 48.6 53.7 52.0 48.8 47.3 46.6 
16 to 34 No 
data 
No 
data 
No 
data No data 48.3 48.2 
Last year prevalence 
16 to 24 29.7 31.8 29.9 29.6 28.1 27.8 
16 to 34 No 
data 
No 
data 
No 
data No data 22.2 22.1 
Last month prevalence 
16 to 24 19.2 20.8 19.0 18.8 17.6 17.3 
16 to 34 No 
data 
No 
data 
No 
data No data 12.2 13.6 
Source: Chivite-Matthews et al. (2005). 
 
Based on figure for 2003/04, prevalence levels of use of any drug amongst 16 to 34 
year olds is slightly higher than amongst 16 to 24 year olds but levels are relatively 
similar across lifetime, last year and last month prevalence levels (see Figure 2). 
 
Figure 2: Prevalence of drug use of any drug amongst young aged 16 to 24 and 16 to 34 
years old in 2003/04 in England and Wales 
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Source: Chivite-Mathews et al. (2005). 
 
 37
UNITED KINGDOM FOCAL POINT REPORT 2005 
In Scotland, the decrease in drug use, primarily amongst 20 to 24 year olds, reported 
in the 2000 Scottish Crime Survey (Fraser 2002; Scottish Executive 2005a) did not 
continue; last year prevalence amongst this age group returned to a similar level at 
28.4 per cent. 
2.3.3 Drugs used 
As with the total survey population, cannabis continues to be the most used drug 
(see Table 8 and 9).  Again, to understand trends, it is necessary to look at the 
different surveys.  Long-term trend data are most readily available for England and 
Wales.  Table 11 shows that amongst both age groups between 1996 and 2003/04 
there has been a notable increase in cocaine use.  Since 2002/03, there has been a 
significant decrease in the use of hallucinogens, particularly LSD, although the use of 
magic mushrooms has increased considerably. 
Table 11: Percentage prevalence drugs use by 16 to 24 year olds and 16 to 34 year olds in 
England and Wales 1996 to 2003 
1996 1998 2000 2001/02 2002/03 2003/4 
Drug 
16 – 24 16 – 24 16 – 24 16 – 24 16 - 24 16 - 34 16 - 24 16 – 34
Lifetime prevalence 
Amphetamine 18.8 21.5 21.2 15.9 14.3 18.6 12.4 18.4 
Cannabis 39.6 45.4 46.2 44.2 42.7 43.4 41.3 43.4 
Cocaine (not 
including crack) 4.3 6.8 10.4 8.4 8.5 10.0* 8.8 11.6* 
Ecstasy 11.7 10.8 11.7 12.0 11.6 13.0 10.7 13.6 
LSD 13.1 12.3 11.4 6.8 5.5 9.1 4.3 9.2 
Magic 
mushrooms 9.8 11.2 10.2 6.4 6.3 9.3 6.6 9.7 
Last year prevalence 
Amphetamine 11.8 9.9 6.2 5.0 3.7 3.1 4.0 3.0 
Cannabis 26.0 28.2 27.0 26.9 25.8 20.0 24.8 19.5 
Cocaine (not 
including crack) 1.3 3.1 5.2 4.9 4.7 4.3* 4.9 4.9* 
Ecstasy 6.6 5.1 5.6 6.8 5.4 4.3 5.3 4.1 
LSD 4.5 3.2 2.5 1.2 0.8 0.6 0.8 0.5 
Magic 
mushrooms 2.3 3.9 2.4 1.5 1.7 1.3 2.7 1.8 
Last month prevalence 
Amphetamine 5.7 5.3 2.9 2.0 1.7 1.2 1.6 1.1 
Cannabis 16.1 18.0 17.4 17.1 16.2 12.4 15.6 12.0 
Cocaine (not 
including crack) 0.5 0.9 1.8 2.1 1.9 1.9* 2.6 2.4* 
Ecstasy 2.9 2.2 3.2 3.6 2.6 1.8 2.5 1.9 
LSD 1.1 0.4 0.6 0.3 0.3 0.2 0.4 0.2 
Magic 
mushrooms 0.4 0.3 0.7 0.5 0.5 0.3 0.8 0.5 
Figures for 16 to 34 year olds are from Standard Tables 
*As data for 16 to 34 year olds are from the Standard Tables, figures for cocaine include 
crack and may therefore be higher than if they were for cocaine, not including crack. 
Source: Chivite-Matthews et al. (2005); Home Office (2005d). 
Gender differences  
As with the adult population as a whole, gender differences exist amongst younger 
people, although they are less wide (Chivite-Matthews et al. 2005; McMullan and 
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Ruddy 2005; Scottish Executive 2005a).  Gender differences in Scotland amongst 
these age groups are notable.  There are differences in lifetime prevalence for use of 
any drug (44% of males amongst the younger group compared with 36% of females, 
and 45 and 33 per cent respectively amongst the wider age group).  However, recent 
use differences are the most acute, with males more than twice as likely to use (22% 
and 10% amongst the younger group and 15% and 6% amongst the wider age 
range). 
 
Drug Use amongst university students  
Friedman (2005) published a survey of 500 students in Edinburgh.  It was reported 
that: 
• 59 per cent of students have smoked cannabis: 
• 28 per cent have taken magic mushrooms; 
• 36 per cent had taken ecstasy; and 
• 23 per cent cocaine.  
2.4 Drug use in the school and youth population 
Because of the methodological differences between the schools surveys in the UK 
and because only English and Scottish surveys have reported in the last year, it is 
not possible to provide an up-to-date UK prevalence estimate for the school and 
youth population. 
2.4.1 School survey for England 
Surveys of smoking, drinking and drug use prevalence have been undertaken in 
schools in England annually since 1998 amongst 11 to 15 year olds.  The latest was 
undertaken in 200433 (NatCen/NFER 2005).  This is the first survey since the 
reclassification of cannabis (see Section 1.1).  Key findings suggest:  
• in 2004, 10 per cent of pupils had taken illegal drugs in the last month (compared 
to 12%, as reported from 2001 to 2003 – Boreham and McManus 2003) and 18 
per cent in the last year (21% in 2003). 
• prevalence levels in the last year and last month were slightly higher among boys 
than girls (18% of boys had used drugs in the last year, 11% in the last month; 
corresponding figures for girls were 17% and 9%).  This pattern was evident in 
earlier surveys (DH 2000; Boreham and McManus 2003). 
• as in previous years (DH 2000; Boreham and McManus 2003), prevalence levels 
in the last year increased with age, from five per cent of 11 year olds to 32 per 
cent of 15 year olds. 
• one per cent of pupils reported using drugs most days, a further one per cent 
used them at least once a week, and another three per cent did so at least once 
a month. 
 
When addressing individual drugs, the survey suggested:  
• in 2004, as in previous years (DH 2000; Boreham and McManus 2003), cannabis 
was the most common drug reported: 11 per cent of 11 to 15 year olds had used 
cannabis in the last year (13% in 2001 to 2003); 
• prevalence of reported cannabis use in the last year was higher among boys 
(12%) than girls (10%), and increased according to age (1% of 11 year olds 
compared to 26% of 15 year olds); 
                                                
33 Just under 10,000 pupils in 313 schools across England completed questionnaires in the 
autumn term.   
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• six per cent reported volatile substance34 use in the last year in 2004 (8% in 
2003, 6% in 2002); 
• Three per cent reported sniffing “poppers” (amyl nitrates, butyl nitrates, isobutyl 
nitrates) in the last year in 2004 (which is similar to findings in 2002 and 2003). 
• Among 11 and 12 year olds, reported volatile substance use in the last year was 
more common than that of cannabis, following the trend of previous years (DH 
2000; Boreham and McManus 2003) (4% of 11 year olds had used volatile 
substances in the last year and 1% had used cannabis; corresponding figures for 
12 year olds were 5% and 2%). 
• The prevalence of Class A drug use in the last year (4%) has remained stable 
since 2001 (1% of 11 to 15 year olds had used heroin and 1% had used cocaine). 
2.4.2 Northern Ireland 
There is no new information for Northern Ireland.  The latest Young Person’s 
Behaviour and Attitudes Survey (undertaken in Northern Ireland in 2000 for the first 
time) in 2003 was discussed in the 2004 UK Focal Point Report.  It is due to run 
every three years.  However, Percy et al. (2005) examined the reliability of young 
people’s reports of drug use through a longitudinal study35 in Northern Ireland.  The 
study showed that of the 4,729 reports of lifetime drug use (across 13 drug 
categories), 789 (17%) were recanted the following year. Levels of recanting were 
lowest among alcohol, tobacco, cannabis and poppers. 
2.4.3 Scotland  
The Scottish Schools Adolescent Lifestyle and Substance Use Survey’s (SALSUS) 
report on drug use in 200436 was published in 2005 (Corbett et al. 2004). It showed 
that drug use prevalence was higher amongst 15 year olds than 13 year olds, and 
that some prevalence levels particularly amongst 15 year olds have decreased 
slightly since 2002 (see Table 12). 
Table 12: Percentage prevalence of illegal drugs in Scotland by age group in 2002 and 2004 
13 year olds 15 year olds Prevalence 2002 2004 2002 2004 
Lifetime 13 13 37 35 
Last year 11 11 33 31 
Last month 8 7 23 20 
Total sample size 10,853 3,599 9,761 3,453 
Source: Child and Adolescent Health Research Unit (CAHRU 2003); Corbett et al. (2005). 
 
In addition, prevalence of drug use in the last month among 15 year old boys 
declined from 24 per cent in 2002 to 21 per cent in 200437.  This is lower than 1998’s 
baseline figure of 26 per cent, but it is not clear yet if this is a short-term change or 
the start of a trend (Corbett et al. 2004). 
 
The most common drug reported was cannabis: 6 per cent of 13 year olds and 19 
per cent of 15 year olds reported having used it the last month (see Table 13). 
                                                
34 Including gas, glue, aerosols or solvents. 
35 Questionnaires were completed by 3,843 year 8 pupils. Of these, 3,336 (87%) completed a 
second questionnaire the following year. 
36 3,451 13 years olds and 3,315 15 years old were sampled; the survey was carried out in 
Spring 2004. 
37 Reported last month use for 25 year old girls was 21 per cent and 20 per cent for 2002 and 
2004 respectively. 
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Table 13: Percentage prevalence of illegal drugs in Scotland by age group and drug in 2004 
Illegal drug 13 year olds 15 year olds 
Lifetime prevalence 
Cannabis  12 34 
Cocaine (not including 
crack) 1 3 
Ecstasy 2 5 
Magic mushrooms  1 3 
Volatile substances 3 6 
Last year prevalence 
Cannabis  10 28 
Cocaine (not including 
crack) 1 2 
Ecstasy 1 3 
Magic mushrooms 1 2 
Volatile substances 2 4 
Last month prevalence 
Cannabis  6 19 
Cocaine (not including 
crack) 0 1 
Ecstasy 1 2 
Magic mushrooms 0 1 
Volatile substances 1 1 
Total sample size 3,599 3,463 
Source: Corbett et al. (2005). 
 
Most young people reported that they had never tried any illegal drug (86% of 13 
year olds and 65% of 15 year olds).  In comparison, one per cent of 13 year olds and 
four per cent of 15 year olds used drugs most days (see Table 14).  
Table 14: Frequency of illegal drug use in Scotland amongst 13 and 15 year olds in 2004 as a 
percentage 
Prevalence 13 year olds 15 year olds 
Never used 86 65 
Only used drugs once 6 10 
Used to take drugs 2 6 
A few times a year 2 6 
Used once or twice a month  2 6 
At least once a week  1 3 
Most days  1 4 
Source: Corbett et al. (2005). 
 
Since 2000, the number reporting that they had been offered drugs (the most 
common drug offered being cannabis) has decreased from 44 per cent to 33 per cent 
for 13 year olds and from 70 per cent to 63 per cent for 15 year olds.  
Socio-economic indicators  
• Lower family affluence was associated with drug use. 
• Eighteen per cent of 15 year olds who lived with both parents reported using 
drugs in the last month compared to 25 per cent of those in single parent families. 
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• Pupils reporting drug use in the last month were more likely to perceive low levels 
of parental monitoring38. Sixty-nine per cent of 15 year olds using drugs in the 
last month had a lower than median level of maternal monitoring.  
• Twenty-five per cent of 15 year olds who reported using drugs in the last month 
reported spending every evening with their friends.  
2.4.4 Wales  
There is no new information about illegal drug use amongst this population in Wales. 
Latest available information is for 15 year olds from the Health Behaviour in School 
Aged Children (HBSC) survey for 2001/02, which suggest that 26 per cent of boys 
and 24 per cent of girls had used cannabis in the last year (Clements et al. 2004). 
This was discussed in the 2004 UK Focal Point report. 
2.5 Primary School Children 
Research was undertaken in Northern Ireland to consider the feasibility of developing 
an appropriate survey to provide evidence of the prevalence of drug use (including 
solvents and alcohol) and related knowledge amongst primary school children 
(McCrystal and Thornton 2004).  It was recommended that a small-scale study of 
eight to 11 year old children should be undertaken using both quantitative and 
qualitative techniques.  
2.6 Drug use among specific groups 
2.6.1 Drug use among vulnerable groups of young people 
The Crime and Justice Survey39 has analysed patterns of drug use (especially Class 
A drugs) amongst young people identified as vulnerable (Becker and Roe 2005).  
Five groups were identified: those who have ever been in care, those who have ever 
been homeless, truants, school excludees and serious or frequent offenders. Key 
findings were that: 
• although those identified as vulnerable represented only 28 per cent of young 
people in the sample, they accounted for more than half (61%) of those using 
Class A drugs in the last year; 
• five per cent of those who were not identified as vulnerable used drugs frequently 
during the last year compared to 24 per cent for those identified as vulnerable; 
• those identified as being in more than one vulnerable group had higher levels of 
drug use than those in just one vulnerable group. So, frequent drug use in the 
last year for the former was 39 per cent, compared to 18 per cent for the latter; 
and 
• those who had been in care or had been homeless reported the lowest levels of 
drug use while serious or frequent offenders and truants showed the highest. 
Therefore, Class A drug use in the last year was five per cent for the former 
group, but 13 per cent for serious or frequent offenders and 16 per cent for 
truants. 
                                                
38 A parental monitoring score assessed the level of knowledge that the pupils perceived their 
parents to have regarding their friends and activities. 
39 The 2003 Crime and Justice Survey had a nationally representative sample of 10,079 
respondents in England and Wales aged 10 to 65 years old. This study focused on responses 
of the 4,574 10 to 25 year olds within the sample.
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Young refugees and asylum seekers 
Patel et al. (2004) examined the vulnerability of young refugees and asylum  seekers 
to drug use40. Approximately one third of their interviewees reported lifetime use of 
an illegal drug and only three were aware of the drug services available. The 
researchers also highlighted that this population are at risk of problematic drug use 
because of the risk factors often present in their situation (for example, barriers in 
accessing education and employment, poor accommodation, lack of family support 
and difficulties in establishing social networks). 
2.6.2 Predictive and risk factors amongst vulnerable young people 
Beckett et al. (2004)41 suggested a relative hierarchy of such factors, which predict 
increased levels of problematic drug use among young people:  
1. perceived lack of parental discipline; 
2. whether the respondent’s peers are using drugs; 
3. their age during the interview; 
4. whether they have a history of running away from home; 
5. if there is a parental lack of concern about smoking or alcohol issues; 
6. if there are problems in the area (such as assault or burglary); 
7. perceived lack of local amenities; 
8. the age at which substance use began; 
9. if they have a poor school attendance (or left school before they were 16 years 
old); and 
10. if they are not living in a household with adults. 
2.6.3 Drug use among workers 
Smith et al. (2004) surveyed 4,620 workers in Wales and highlighted that 13 per cent 
reported drug use in the last year.  Drug use was associated with factors such as 
heavy drinking, smoking, being male, being under 25 years old, and living in a more 
affluent area.  
                                                
40 Patel et al. (2005) interviewed 67 young people (aged between 16 and 25 year olds) who 
were born in countries such as Nepal, Iraq or Zimbabwe and who had been in the UK for 
between six months and 13 years.  
41 103 young drug users (response rate 95%) completed a structured questionnaire in two 
study centres in England.  Forty-six parents (response rate 70%) were also interviewed.   
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3. Prevention 
3.1 Overview of the situation before 2004 
Drug prevention among young people, especially those who are vulnerable, is a key 
element of the Drug Strategy (DSD 2002a; 2004a).  
 
Drug education in schools is a key component of prevention.  It aims to develop 
young peoples’ knowledge, skills, attitudes and understanding about drugs to build 
their resistance.  In England and Northern Ireland it is a statutory part of the national 
curriculum and in Scotland, where there is no statutory curriculum, the majority of 
schools provide drug education programmes using the 5-14 guidelines42 (Scottish 
Executive 2003a).  Information campaigns such as those focused on the young and 
their parents also form part of the prevention strategy43. 
 
Vulnerable young people are seen as being at risk of using drugs and of problematic 
drug use (Cusick et al. 2003; Hammersley et al. 2003; Ward et al. 2003; Wincup et 
al. 2003), and drug prevention in areas of social disadvantage is seen as being part 
of the wider need to address social deprivation (DSD 2002a).  Because these groups 
cannot always be reached through the school setting (for example, in the case of 
truants or school excludees), initiatives such as Positive Futures are based in the 
community.  
 
In England, Wales and Northern Ireland, the Building Safer Communities (BSC) 
programme44 supports local action (Home Office 2004b).  In Scotland, the Scottish 
Drugs Forum (SDF)45 works to develop communities’ capacity and Scotland Against 
Drugs (SAD)46 provides support to community-based initiatives aimed at drug 
prevention 
3.2. Universal prevention  
Universal prevention targets the general population regardless of individual levels of 
risk47, for example through the classroom setting.  
 
As discussed in Section 1.3.3, the 2004 Spending Review Public Service Agreement 
(PSA) states that by 2008 there should be a reduction of Class A drug use and the 
frequency of use of any illicit drugs among all those under 25 years old, especially 
among the most vulnerable.  Universal prevention will play a key part in this (DSD 
2004a).  
 
The Home Secretary has overall responsibility for the Drug Strategy, with 
involvement from organisations.  The Secretary of State for Education and Skills 
leads on policy for preventing young people from becoming problematic drug users 
and shares responsibility with the Home Secretary for the delivery of this PSA’s 
component.   
                                                
42 Please see www.ltscotland.org.uk/5to14/guidelines for more details. 
43 See http://www.talktofrank.com and http://www.knowthescore.info for more details. 
44 In England and Wales, Communities Against Drugs (CAD) has now been subsumed under 
the Building Safer Communities programme (BSC). 
45 For more information, please see http://www.sdf.org.uk  
46 For more information, please see http://www.sad.org.uk  
47 See http://www.publichealth.nice.org.uk/page.aspx?o=504111 for more information. 
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Every Child Matters 
In December 2003, the Government published the Green Paper Every Child 
Matters48 (HM Government 2003).  The Paper sets out the need to ensure that every 
child is properly protected from risk and is supported in reaching their full potential.  
The Children Act 2004 will help to embed its principles in legislation.  Although the 
Paper and the legislation go beyond drug prevention, the Paper’s five key 
outcomes49 are also important in preventing drug use (DSD 2004a; DfES 2005).  The 
Paper is part of the Every Child Matters: Change for Children Programme, which is 
the responsibility of DfES.  
 
Following the Paper’s publication, the programme entered a consultation process.  It 
highlighted that the aims of the Green Paper were strongly supported across the 
different sectors (DfES 2004a).  
 
The Department for Education and Skills et al. (DfES et al. 2005) have outlined the 
Government’s strategy of linking the delivery of Every Child Matters to the National 
Drug Strategy by developing universal, targeted and specialist services to prevent 
drug harm and to ensure that children and young people are able to reach their 
potential.  The approach has three main objectives: 
• Reforming delivery and strengthening accountability.  
• Ensuring provision is built around the needs of vulnerable children and young 
people through a greater focus on prevention and early intervention by all 
agencies providing services for children. 
• Building service and workforce capacity. 
 
This is a joint approach between the DfES, the Home Office and the Department of 
Health, which is to be implemented nationally.  Locally, Local Authorities are 
expected to progress towards meeting the required objectives.  It also requires Drug 
(and Alcohol) Action Teams (D(A)ATs) and Directors of Children’s Services to agree 
priorities and set targets with respect to young people.  These will be included in the 
Children and Young People’s Plan to be produced in 2006.  Following the 
establishment of this joint approach, the Young People’s Substance Misuse Grant 
was agreed in 2004.  It will be used to develop drug intervention programmes for 
young people. 
 
Joint teams50 based in Government Offices (GO) will help local areas implement this 
approach (DfES et al. 2005).  They will identify local problems and challenges, 
provide performance management and interventions, and negotiate local targets.  
Youth Matters 
Following on from Every Child Matters, the Government has now published a Youth 
Green Paper called Youth Matters (HM Government 2005b).  The Paper seeks to 
improve outcomes for all young people (13 to 19 year olds), especially those who are 
vulnerable.  It aims to restructure young people’s services so that they have more 
choice and influence, encourage young people to participate in voluntary and 
community work, provide better information to them on the subjects that interest them 
and in a way that suits them, and to provide better support to those who need it. 
                                                
48 For more information, please see http://www.everychildmatters.gov.uk. 
49 Being healthy, staying safe, enjoying and achieving, making a positive contribution to the 
community and society, and economic well-being (HM Treasury 2003). 
50 With staff from Government Office drug and crime teams, the DfES, the Youth Justice 
Board, the National Treatment Agency for Substance Misuse, Public Health and various 
regional bodies. 
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3.2.1 School  
The Office for Standards in Education (Ofsted 2005) believes that standards in drug 
education have notably improved since 1997 regarding drug education planning, 
achievement, teaching quality and the number of schools with what are seen as 
effective procedures for managing drug-related incidents.  However, there are also 
several issues which need addressing: in a number of schools, drug education 
continues to be taught through teachers without subject knowledge; poor assessment 
of drug education; and the need to develop a better understanding of pupil needs.  
 
Guidance on drug education for schools in England (DfES 2004b) and in Northern 
Ireland (DENI 2004) was published in 2004 (see UK Focal Point Report 2004).  
 
Her Majesty’s Inspection of Education in Scotland (HMIE 2004) published their 
inspection report on Scottish schools’ progress towards providing all pupils with 
appropriate drug education in November 2004.  The report concluded that there has 
been a considerable increase in the provision of drug education, however there were 
areas which still need to be addressed, such as: partnership with other agencies; 
staff development; self- evaluation to improve learning; identifying pupils’ needs; and 
building on prior learning. 
All Wales Schools Programme 
The Police-led All Wales Schools Programme encourages Police School Liaison 
Officers to work together with schools and Personal Social Education teachers to 
educate young people in an interactive and imaginative way about lifestyle risks 
(Wales at Heart 2005).  It covers drug use, social behaviour and community safety.  
Those leading the project work alongside Community Safety Partnerships.  Just 
under €3.0 million (£2 million) has been set aside for this project to run for three 
years from September 2003. 
Blueprint 
Launched in 2003, Blueprint is continuing to examine the effectiveness of a multi-
component approach to drug education (see UK Focal Point Report 2004).  In 2004, 
the project researchers interviewed teachers and assessed the impact of Blueprint on 
Year seven pupils (those aged 11 to 12 years old)51.  The first research findings are 
due to be published in 2007.  However, the National Children’s Bureau will be 
publishing the Blueprint magazine and a booklet on Blueprint called Pupil Voice from 
the summer of 200552.  These will enable the participating children to share their 
experiences. 
Drug testing in schools 
The overwhelming majority of England’s 25,000 schools are not planning to use 
methods such as drug tests or drug dogs (Ofsted 2005).  As such, only one state 
school has introduced drug testing (BBC 2005b; Press Association 2005).  The 
scheme randomly selects 20 pupils to be tested each week.  Those with positive 
results will not necessarily be expelled unless they are supplying drugs.  However, 
there has been little evaluative research on the impact of such schemes and the 
existing evidence lacks methodological rigour (McKeganey 2005).  As such, Ofsted 
(2005) states that the use of these methods needs to be subject to an independent 
evaluation. 
                                                
51 For more information, please see  
http://www.drugs.gov.uk/NationalStrategy/YoungPeople/Blueprint. 
52 See http://www.ncb.org.uk/projects/project_detail.asp?ProjectNo=305 for more information. 
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Education sector initiative 
The Education Sector Initiative (ESI) in Scotland was designed to systematically 
address the needs of secondary school teachers providing drug education (Lowden 
and Quinn 2004).  Lowden and Quinn (2004) identified that 87 per cent of teachers53 
believed that the programme would help their school to promote more effective drug 
education and that 78 per cent thought that the training would help them to develop 
useful links between their school and such relevant services. 
National Healthy Schools Standard 
In England, all schools in the most disadvantaged areas are to become ‘Healthy 
Schools’ by 2006 with all schools working towards Healthy School status by 2009/10 
(see UK Focal Point Report 2004).  The percentage of schools achieving the National 
Healthy Schools Standard (NHSS)54 is one of the Key Performance Indicators of 
Every Child Matters (DfES et al. 2005).  
 
Blenkinsop et al.’s (2004) evaluation of NHSS identified several key findings: 
• Schools value their involvement in NHSS. 
• Participation improved health-related work in schools. 
• Active participation by children and young people is essential. 
 
The Department of Health (DH) issued €6.1 million (£4.12 million) in 2003/04 to local 
education and health partnerships to develop drug education in NHSS primary 
schools.  One hundred and thirty projects were funded in primary schools that 
encourage primary care teams to be involved in developing drug education work as 
part of the wider Personal Social and Health Education programme.  
 
Northern Ireland runs a similar initiative through its Health Promoting Schools55.  An 
evaluation of this is due in 2005. 
 
The Welsh Network of Healthy School Schemes (WNHSS)56 was launched in 1999 
to encourage local healthy school schemes to develop within a national framework.  
All 22 local schemes have been accredited by the Welsh Assembly Government.  
The Welsh Assembly Government (2005) aims to have three quarters of schools 
involved by March 2008 and all schools to be involved by March 2010.  At present 
1,076 schools are involved, over half of the schools in Wales (Welsh Assembly 
Government, internal communication). 
Online information 
Launched in May 2003, the FRANK campaign in England and Wales provides 
information about drugs to young people and their families.  In its first year, 407,457 
calls were made to its helpline, it distributed 22,590,000 campaign materials57 and 
there were 1.5 million visits to its website58 (Home Office et al. 2004a).  FRANK is 
                                                
53 Questionnaires were completed by 1,007 teachers and 106 probation teachers. 
54 The NHSS aims to support schools in creating an enjoyable, safe and productive learning 
environment. It covers eight areas: Personal, Social and Health Education (PSHE); 
citizenship; drug education (including tobacco and alcohol); emotional health and well being 
(including bullying); healthy eating; physical activity; safety; sex and relationship education; 
and local healthy school programmes. Health partnerships support schools in enabling them 
to become healthier places. Please see http://www.standards.dfes.gov.uk for further details. 
55 For more information, please see http://www.investingforhealthni.gov.uk/schools.asp. 
56 For more information, please see  
http://www.cmo.wales.gov.uk/content/work/schools/wnhss-e.htm.  
57 Such as leaflets, toolkits and Action Updates. 
58 See http://www.talktofrank.com. 
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planning to continue to build awareness of its brand, ensuring that the population 
knows about FRANK, knows what it offers and are able to access its resources. 
 
Action packs are also issued through FRANK, which provide updates on local 
actions, information and advice, ideas for local action and activities, and press 
release templates (Home Office et al. 2004b, 2004c, 2004d).  These cover specific 
issues such as the summer, crack cocaine and the family and are issued to 
prevention practitioners such as teachers and D(A)ATs.  Although FRANK focuses 
on England, those in the devolved administrations can access the website or help 
line.  Some publicity campaigns and publications also penetrate parts of the UK 
outside England. 
 
The Scottish Executive runs a similar campaign through Know the Score59 60. In 
2004, an evaluation was published assessing its success and showed that (Scottish 
Executive 2005b): 
• awareness levels have declined slightly over the last two years (see Table 15);  
• levels of awareness are noticeably higher amongst those in the campaign’s target 
population of young people (89% of 16 to 25 year olds recognised a slogan or 
catchphrase compared to 60% of those aged over 16 years61); and 
• 90 per cent of 16 to 25 year olds had seen at least one of the television adverts, 
and 80 per cent agreed that the adverts ‘make you think about the consequences 
of drugs’. 
Table 15: Evaluating the Know the Score campaign amongst those aged over 16 years old in 
Scotland by year 
Level of awareness 2003 2004 
Aware of a recent slogan or 
catchphrase – spontaneous 
awareness 
10% 7% 
Recognised a recent slogan or 
catchphrase – prompted 
awareness 
67% 60% 
Number completing the 
questionnaire 1,007 1,001 
Source: Scottish Executive (2005b). 
Young People Substance Misuse Partnership Grant 
Various funding streams in England from DfES, DH, Home Office, the Youth Justice 
Board and the Spending Review were pooled in 2004 to form the Young People 
Substance Misuse Partnership Grant (YPSMG)62.  In total for 2004/05, €87.6 million 
(£58.9 million) has been made available.  The money is to be used by D(A)ATs and 
Crime and Disorder Reduction Partnerships (CDRPs) to deliver the young people 
aim of the National Drug Strategy63, for example through providing universal drug 
education, treatment, Young Person’s Arrest Referral (within some areas) (see 
Chapter 9), training, and early prevention for vulnerable groups.  
                                                
59 The Know the Score website can be accessed through www.knowthescore.info.  
60 Northern Ireland’s equivalent is the National Drugs helpline (please see UK Focal Point 
Report 2004). 
61 Researchers surveyed 1001 people aged 16 and over, and within that population 317 were 
aged between 16 and 25 years old. 
62 For more information, please go to 
http://www.drugs.gov.uk/WorkPages/CoreDocuments/PartnershipGrantGuidance/YPSMPGgu
idance.dp.V2.21-05-04.doc.  
63 To prevent young people from becoming problem drug users (DSD 2002a). 
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In Wales, the Building Safer Communities Funding of €12.1 million (£8.1 million) over 
3 years, focuses on youth crime and disorder or which link in with other partnerships’ 
and agencies’ community safety strategies and initiatives, with a particular emphasis 
on work in deprived communities. (See Section 1.5.3 for more details on this.) 
3.2.2 Family 
Parental involvement in drug education can be very important (DfES 2004a, 2005).  
The FRANK campaign has developed an action pack for D(A)ATs and prevention 
practitioners on how to reach the family (Home Office et al. 2004d).  However, Ofsted 
(2005) noted that despite the efforts of many schools to involve parents in their 
children’s drug education, advice evenings have often been poorly attended.  Those 
parents who live in rural areas, fathers, those who use drugs themselves, those from 
ethnic minorities and those with special needs have been especially difficult to reach.  
Such events are important because parents may lack drug knowledge, which will 
hamper effective drug-related communication with their children (DrugScope 2004). 
 
DrugScope (2004) examined five different parent-orientated projects in England and 
Scotland. Their research suggests that: 
• a needs assessment is essential for any project targeting parents to establish 
their needs and level of knowledge; 
• involving local organisations can help to increase interest; 
• working with volunteers can help to create levels of sustainability (although 
training and support will be needed); 
• it can be advantageous to employ workers from the same community to improve 
credibility and understanding; 
• outreach work may be required; and 
• using a more holistic programme can lead to increased levels of interest from 
parents, as DrugScope believes that the parents are less likely to feel intimidated. 
3.2.3 Community  
Shiner et al. (2004) examined the processes by which local communities are involved 
in drug and alcohol-related fields64.  They concluded that the community element of 
the Drug Strategy should be re-examined.  The notion of community is often tied to 
the criminal justice system and, where wider community engagement exists, it is 
often limited to supporting the former.  However, in practice formal community 
involvement is more likely to focus on education, support for users and carers, and 
campaigning.  Further, any approach treating communities as ‘free-standing entities’ 
will only provide a limited solution. Instead, ‘community engagement’ should be 
located within a broader perspective addressing the wider social forces that affect 
communities (such as employment policies, the impact of relative disadvantage or 
the effects of geographic isolation).  
Volatile Substance Abuse campaign 
In March 2005, the Scottish Executive (2005c) launched a campaign on Volatile 
Substance Abuse (VSA).  Leaflets, posters and window stickers will aim to raise 
awareness among shop workers that it is an offence to sell butane gas lighter refills 
to those who are under 18 years old.  
                                                
64 Preliminary interviews were conducted with seven key informants to identify the key issues. 
The survey then covered a representative sample of 37 Drug (and Alcohol) Action Teams 
(D(A)AT) areas in England and Community Safety Partnership areas in Wales. The case 
studies focused on specific projects for a more detailed examination of the issues identified. 
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3.3 Selective/indicative prevention  
Selective or indicative prevention initiatives target those groups identified as being 
high risk such as truants or young offenders65. 
3.3.1 Recreational settings  
Please see Chapter 13: Developments in drug use within recreational settings. 
3.3.2 At risk groups 
The Drugs Strategy Directorate (DSD 2004a) emphasises that support and early 
interventions are needed for the key risk groups – the children of drug users, school 
excludees and truants, and young offenders.  In addition, the Health Development 
Agency (now part of the National Institution for Clinical and Health Excellence, NICE) 
review of drug use prevention among young people identified looked-after children, 
young homeless and sex workers as vulnerable (Canning et al. 2004).  
 
The National Collaborating Centre for Drug Prevention (NCCDP) published a review 
of the literature surrounding vulnerable young people in 2005 pulling together the 
evidence from these groups (Edmonds et al. 2005). This review revealed from the 
literature that: 
• school is seen as an important setting for both protective reasons against drug 
use and for a setting in which to deliver drug education; 
• training is needed for non-drug specialists (such as teachers or youth workers); 
• young people should be assessed for drug-related needs as a matter of routine 
when they are in contact with non-drug agencies. 
 
The following sections detail new information, where it is available, for most of the 
identified groups. 
Children of drug users 
In 2003, the Advisory Council on the Misuse of Drugs (ACMD) published a report on 
the needs of children of drug users.  It estimated that there are between 250,000 and 
300,000 children of problem drug users in the UK (that is one for every problem drug 
user) and suggested that reducing the harm caused to these children should be a 
priority in policy and practice. 
 
The Government accepts the vast majority of the recommendations suggested by the 
ACMD, and intends to respond to them (see Section 7.6). 
Looked after children 
DfES et al. (2005) are developing a Key Performance Indicator (KPI) on drug use in 
this population. Data collection for this will begin in late 2005. 
School excludees and truants 
DfES et al. (2005) will explore the feasibility of developing a drug use KPI for 
excludees and truants. This will be implemented in 2005/06. 
 
In addition, DfES (2004b) guidance for schools directs teachers to focus on the drug 
education needs of this group, and recommends that they: 
• focus on harm reduction; 
• involve a range of external contributors so additional approaches are offered; 
• link with tier two and three services (such as young people's drugs services) for 
education, advice and support; 
                                                
65 Please see http://www.publichealth.nice.org.uk/page.aspx?o=504111 for further details. 
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• provide a variety of engaging activities focusing on life skills (such as through 
media or music); 
• organise access to diversionary activities that focus on life skills and develop 
pupils' self-esteem and basic skills such as numeracy; and  
• help pupils access further information and support. 
Young offenders 
Early drug interventions are seen as being a priority for Youth Offending Teams 
(YOTs) (DSD 2004a).  As part of the KPIs for Every Child Matters, all young 
offenders are to be screened for drugs so that their needs can be identified and 
appropriate interventions provided (DfES et al. 2005).  
 
In addition to the vulnerable groups described above, work is also being done to stop 
drug use becoming problematic amongst heavy cannabis users.  DSD (2004b) has 
developed guidance aimed at 16 to 24 year old heavy cannabis users to encourage 
them to re-assess their use.  It also provides tools to control their dependence.  
General strategies targeting at-risk groups 
DH (2004b) is funding the alliance of five children’s charities66 to work together on 
drug prevention.  The project’s three aims are to: 
• develop the capacity of such charities to deliver support in drug prevention to 
those working with vulnerable children and young people; 
• increase the levels of multi-agency working between such charities, D(A)ATs and 
children and young people’s drug use services; and  
• increase the levels of communication between charities and mainstream 
children’s services for children and young people who have drug-related needs. 
Every Child Matters 
Every Child Matters notes that services should be built around the needs of children 
and young people, especially around those who are vulnerable to drugs. As such, it 
has identified several key targets. 
• All young people are to be able to access core services such as health and 
education services. 
• Early assessment of all vulnerable children and young people to identify any 
drug-related issues so that the appropriate intervention can be involved. 
• Agencies should have integrated information systems. 
• Protocols are to be established that enable prompt access to services if required. 
 
In Scotland, guidance was published on assessing the needs of both young drug 
and/or alcohol users, or those at risk of becoming so (EIU 2004a): 
• Effective engagement with young people is key. Workers must be sensitive to 
their needs and must be aware that first impressions can determine whether the 
young person engages effectively. 
• Continual assessment will help provide evidence to support need identification, 
and to inform the design of future interventions and approaches.  
Positive Futures update67
More than 50,000 vulnerable young people have participated in Positive Futures 
since its launch in 2000 (DSD 2004a). 
                                                
66 Barnado’s, the National Society for the Prevention of Cruelty to Children (NSPCC), the 
National Children’s Bureau (NCB), the Children’s Society and the National Children’s Home 
(NCH). 
67 The closest equivalent in Scotland to Positive Futures is Sportscotland. However, it is not 
directly linked to drug prevention, aiming instead to involve all young people in sport. 
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Positive Futures staff will include more drug use interventions within the programme 
(DSD 2005b).  Interventions are usually delivered jointly by both specialist agencies 
and the lead Positive Futures agency.  However, interventions are increasingly being 
delivered in-house because confidence has increased through training and increased 
involvement of the D(A)ATs. 
 
The programme has reported success in educational reintegration: between 
February and October 2004, 493 young people who were participating regularly 
returned to full-time education, 2,423 were doing better at school and 515 had 
achieved other educational improvements (DSD 2005b). 
3.3.3 At-risk families 
Because of the impact of drug use on the family, the Effective Interventions Unit (EIU 
2004b) published a review on supporting the families and carers of drug users. It 
provided several recommendations for family support services: 
• They should focus on the needs of the family and the carer. 
• They should be open, accessible and non-judgemental. 
• They should participate in needs assessment and in designing services. 
 
Please also see Section 3.2.2 for details on providing information to hard to reach 
parents, and Section 3.2.2 for information on the children on drug using parents. 
3.4 Future actions 
DSD (2004a) aims to: 
• Improve identification and assessment of children and young people’s drug use 
needs, especially for those in known risk groups. 
• Increase services to vulnerable young people through programmes such as 
Positive Futures (see Section 3.3.2). 
• Support those schools in the most disadvantaged areas to become a Healthy 
School (see Section 3.2.1) by 2006 and all schools by 2009/10. 
• Continue to provide information about drugs to young people and parents through 
FRANK (see Section 3.2.2) and through schools.  
• Ensure those working with children and young people have the appropriate skills 
to identify risk factors and drug use as early as possible. 
• Provide further support to those areas with the highest need. 
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4. Problem drug use 
4.1 Overview 
Population-based surveys68, because of the often hidden nature of problem drug 
use, are considered to be of limited use in estimating the full extent of problem drug 
use.  More reliable estimates can be derived from alternative methods, with the 
multivariate indicator method being one such approach (Frischer et al. 2004).  This 
combines local prevalence estimates69 with routinely available indicator data.  Based 
on these, and reported in the UK Focal Point report for 2004, the estimate for 
problematic drug users was 9.35 per thousand (with a Confidence Interval or CI of 
8.99 to 9.79 per thousand), with a total problem drug use population estimated at 
360,811.  For injecting drug use, the estimate was 3.2 per thousand (123,498 with a 
CI of 3.07 to 3.34 per thousand population aged 15 to 64 years).  These rates varied 
across the UK (see Table 16). 
Table 16: National prevalence estimates for problem drug use in the United Kingdom 
Problem drug use Injecting drug use 
Country  Year 
Number 
Rate per 
thousand 
population 
Number 
Rate per 
thousand 
population 
England 2000/01 287,670 
8.91 
95% CI= 
8.53 to 9.29 
93,185 
2.89 
95% CI= 
2.87 to 2.91 
Northern Ireland 2000 828 
0.76 
95% CI= 
0.63 to 0.93 
No 
estimate No estimate 
Scotland 2000 55,800 
16.65 
95% CI= 
16.45 to 
17.53 
24,696 
7.737 
95% CI= 
5.87 to 8.58 
United Kingdom 2000/01 360,811 
9.35 
95% CI= 
8.99 to 9.79 
123,498 
3.2 
95% CI= 
3.07 to 3.34 
Source: Information Services Division (ISD 2002)70; McElrath (2002)71; Frischer et al. 
(2004)72; Hay (2005b). 
 
At the local level, estimates of problem drug use in Scotland range from 2.9 in the 
Orkney Isles to 30.8 per thousand (CI = 26.6-36.7) in Glasgow (ISD 2002).  In 
Greater Manchester, estimates of local prevalence of problem drug use are 13.9 per 
                                                
68 Such as the British Crime Survey, Northern Ireland Crime Survey or Scottish Crime Survey. 
69 Local estimates are usually derived from specific research studies that employ slightly 
different definitions of what constitutes problem drug use. The capture-recapture method is 
the most widely used to provide local prevalence estimates. 
70 ISD (2002) derived their national estimate through using the sum of the 32 local prevalence 
estimates. Here, problem drug use is defined as opiate and/or benzodiazepine use. 
71 McElrath (2002) used the capture-recapture method for Northern Ireland. Here, problem 
prevalence is defined as heroin use. 
72 Frischer et al. (2004) used  the multivariate indicator method to provide data for England, 
as as such multiple indicators were used. 
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thousand of the population aged 16 to 54 years old (19,255, 95% CI of 18,731-
21,853; Millar et al. 2004). 
 
There have been variations between countries regarding the characteristics of clients 
presenting to treatment.  On the whole, heroin is the main drug used although there 
has been a rise in cocaine-based drugs.  In Scotland, however, while heroin has 
been the most common main drug of use, diazepam (rarely reported elsewhere in the 
UK) has been the second most commonly used drug.  In Northern Ireland, just over a 
quarter reported the use of opiates as their primary drug, and nearly half reported 
cannabis (cannabis as the primary drug used by those presenting to services is 
rarely reported elsewhere in the UK).  Injecting as main route of administration also 
varies between countries; with just over a quarter of clients reporting having ever 
injected in Northern Ireland and Scotland, but a much higher level of 59 per cent in 
England and Wales. 
 
For all new presentations (presentations where the individual has not previously been 
in treatment during the reporting period), approximately a third are under 24 years of 
age and a quarter of clients are aged between 25 and 29 years old; approximately 
three quarters are male (see UK Focal Point report for 2004 and for 2003).  
4.2 Prevalence and incidence estimates 
4.2.1 National estimates 
Following on from previous research in 2000, a study in Scotland examined national 
and local estimates of the prevalence of problem drug use and drug injecting in 2003 
using the capture-recapture method (Hay et al. 2004).  Overall, the estimated 
prevalence of problem drug use dropped from 55,800 in 2000 to 51,582 in 2003 (this 
was approaching significance at the 95% level, at 93%). 
 
Currently a research study using capture-recapture and the multivariate indicator 
method is being used to provide a national estimate and local estimates for each of 
the 149 Drug (and Alcohol) Action Team (D(A)ATs) areas of England.  The 
researchers will provide estimates by age group (covering the overall age range of 15 
to 64 years old, which is compatible with the EMCDDA guidelines), and the estimates 
will be for the three successive years starting from 2004/05.  A capture-recapture 
study is also currently being undertaken in Northern Ireland. 
4.2.2 Local estimates 
There have been a few local prevalence studies, using capture-recapture methods, 
carried out in parts of England and Wales in the last year.  In Sandwell73, the 
prevalence of opiate and/or cocaine use was estimated to be 21.12 per thousand of 
the population aged 15 to 64 (3,773 with a 95% CI 15.93 to 28.84) (Quigley 2005).   
4.3 Profile of clients in treatment 
Information on clients in treatment is for the financial year 2003/0474.  Data from 
across the UK have been combined to provide a national picture of clients75.  
Number of presentations for each country is shown in Table 17. 
                                                
73 A metropolitan borough in the West Midlands in England. 
74 From 1 April 2003 to 31 March 2004. 
75 Data are provided by the National Drugs Evidence Centre, Information and Statistics 
Division in Scotland, Department for Health Social Services and Public Safety Northern 
Ireland, and Health Solutions Wales.  
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Table 17: Number of presentations for treatment in the United Kingdom in 2003/04 by country 
Presentation status England Northern Ireland Scotland Wales 
United 
Kingdom 
Outpatients  
First presentations 19,921 984 5,635 1,357 27,897 
Previous presentations  26,836 425 5,468 818 33,547 
Not known 28,270 N/A N/A 1,945 30,215 
Total 75,027 1,409 11,103 4,120 91,659 
Inpatients  
First presentations 748 No data available 109 
No data 
available 857 
Previous presentations 1,121 No data available 228 
No data 
available 1,349 
Not known 1,832 No data available N/A 
No data 
available 1,832 
Total 3,701 N/A 337 N/A 4,038 
General Practitioners 
First presentations 499 
No GP 
treatment 
provided 
620 No data available 1,119 
Previous presentations 1,414 
No GP 
treatment 
provided 
527 No data available 1,941 
Not known 906 
No GP 
treatment 
provided 
N/A No data available 906 
Total 2,819 N/A 1,147 N/A 3,966 
Total presentations 
First presentations 21,168 984 6,364 1,357 29,873 
Previous presentations 29,371 425 6,223 818 36,837 
Not known 31,008 N/A N/A 1,945 32,953 
Total 81,547 1,409 12,587 4,120 99,663 
Percentage of clients 
who are outpatients 92.0% N/A 88.2% N/A 92.0% 
Percentage of clients 
who are inpatients 4.5% N/A 2.7% N/A 4.1% 
Percentage of clients 
who see General 
Practitioners 
3.5% N/A 9.1% N/A 4.0% 
Definitions of first and previous presentations vary according to country.   
For England and Wales, new presentations refer to those presentations that were started in 
2003/04 and previous presentations refer to those who began their treatment episode before 
2003/04.  For Northern Ireland and Scotland, new presentations refer to those who have 
never been in treatment before or for whom it has been at least six months since their last 
attendance and previous presentations apply to those who are continuing their treatment 
episode or whose last treatment episode was within the previous six months.  
Source: National Drugs Evidence Centre, Department for Health Social Services and Public 
Safety Northern Ireland, Health Solutions Wales, Information Services Division.  
 55
UNITED KINGDOM FOCAL POINT REPORT 2005 
4.3.1 By substance used 
Two thirds of clients (66.2%) presenting to treatment in the UK use opiates as their 
main drug (see Figure 3 and Table 18).  However, variations are apparent across the 
individual countries, for example: 
• in Northern Ireland only 20.3 per cent report opiate use, instead the most 
commonly reported drug is cannabis (51.7%);   
• in Wales, amphetamines are much more commonly reported as a primary 
drug of use than elsewhere in the UK (14.8%); 
• England shows the highest levels of reported use of crack cocaine as a 
primary drug (6.0%). 
Table 18: Number and percentage of drug treatment presentations in 2003/04 in the United 
Kingdom by primary drug of use and by country 
Primary drug of 
use 
England 
(%) 
Northern 
Ireland 
(%) 
Scotland 
(%) 
Wales 
(%) 
United 
Kingdom 
(%) 
2,643 19 203 609 3,474 Amphetamines  (3.2%) (1.4%) (1.6%) (14.8%) (3.5%) 
1,015 97 698 119 1,929 Benzodiazepines (1.2%) (6.9%) (5.5%) (2.9%) (1.9%) 
7,165 727 1,262 695 9,849 Cannabis  (8.8%) (51.7%) (10.0%) (16.9%) (9.9%) 
3,342 Cocaine (4.1%) 
68 
(4.8%) 
249 
(1.9%) 
80 
(1.9%) 
3,739 
(3.8%) 
Crack cocaine 4,859 (6.0%) 
3 
(0.2%) 
35 
(0.3%) 
83 
(2.0%) 
4,980 
(5.0%) 
Opiates 55,531 (68.1%) 
286 
(20.3%) 
7,836 
(62.3%) 
2,359 
(57.3%) 
66,012 
(66.2%) 
Other / unknown 6,989 (8.6%) 
209 
(14.9%) 
2,304 
(18.3%) 
175 
(4.2%) 
9,680 
(9.7%) 
Total 81,547 1,409 12,587 4,120 99,663 
Source: National Drugs Evidence Centre, Information Services Division, Scotland; 
Department for Health Social Services and Public Safety Northern Ireland, Health Solutions 
Wales. 
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Figure 3: Percentage of drug treatment presentations by country and by drug in the United 
Kingdom in 2003/04 
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Source: National Drugs Evidence Centre, Information Services Division, Scotland; 
Department for Health Social Services and Public Safety Northern Ireland, Health Solutions 
Wales. 
Cocaine and crack users reporting for treatment 
Neale and Robertson (2004)76 examined 585 new treatment clients in Scotland and 
found that those who had recently used cocaine and/or crack had distinct 
characteristics as they were more likely to: 
• have used non-prescribed benzodiazepines in the previous 90 days; 
• be seeking residential treatment; 
• have recently committed an acquisitive crime; 
• have been robbed, attacked or assaulted in the last six months; 
• have a spouse or partner; and  
• have a longer history of problematic drug use. 
4.3.2 Centre type 
The majority of treatments (93%) are undertaken through community based specialist 
drug services (outpatient treatment). 
4.3.3 Gender 
Across the UK, 71.3 per cent of treatment clients are male and 28.5 per cent are 
female (see Table 19).  This difference has been the same for a number of years.  
However, in Scotland, the proportion is very different with only 65.6 per cent of clients 
being male. 
76 This research has been carried out as part of the Drug Outcome Research in Scotland 
(DORIS) (please see Chapter 5.2.6 for more details on DORIS).  For this study, 1,007 drug 
users starting a new episode of drug treatment were recruited from services across Scotland, 
including the Scottish Prison Service (SPS) and the primary care sector.  
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Table 19: Percentage of male and female clients presenting to treatment in the United 
Kingdom in 2003/04 by country 
Gender  England Northern Ireland Scotland Wales UK 
Female 27.8 24.5 34.4 26.6 28.5 
Male 72.0 75.5 65.6 73.3 71.3 
Source: National Drugs Evidence Centre, Information Services Division; Department for 
Health Social Services and Public Safety Northern Ireland, Department of Health. 
Gender differences in clients entering treatment  
Neale (2004a)77 examined the characteristics between men and women beginning a 
new treatment episode in Scotland.  For example, women were more likely to: be 
younger than men (24 years old compared to 28); have been involved with social 
services; have been dependent on state benefit; sell sex; be in arrears with rent; live 
in a poorly maintained building; have at least one child living with them; or have been 
physically or sexually abused by a partner, a relative or family friend. 
 
Men displayed other characteristics such as being more likely to: have considered 
their cannabis use to be problematic; to have used injecting equipment after 
someone else; have undertaken education or training in the six months before 
interview; have earned money from informal or cash-in-hand employment and to 
have had legal employment in the six months prior to interview; have begged or sold 
the Big Issue78; have reported illegal debts; have sold or supplied drugs; have stolen 
from a person, house or home or vehicle; have caused criminal damage; have 
committed assault; or have stayed with relatives or had slept rough. 
 
(See Chapter 11 for a full report on gender differences.) 
4.3.4 Physical and sexual abuse amongst clients 
McKeganey et al. (2005)79 noted that a considerable proportion of those in treatment 
have been physically or sexually abused, and that women are more likely to have 
been abused than men (see Figure 4). Past abuse was associated with younger age 
at onset of drug problems, suicide or self-harm attempts, overdose and involvement 
in prostitution in the last 12 months. 
                                                
77 This research was part of DORIS, where 1,033 treatment clients were interviewed in 
Scotland. (Please see Chapter 5.2.6 for more details on DORIS.) 
78 The Big Issue is a street newspaper published on behalf of and sold by homeless people. 
79 This research was part of DORIS, where 1,033 treatment clients were interviewed in 
Scotland. (Please see Chapter 5.2.6 for more details on DORIS.) 
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Figure 4: The percentage of those in drug treatment in Scotland who have been physically or 
sexually abused by gender 
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Source: McKeganey et al. (2005). 
4.4 Main characteristics and patterns of use from non-treatment sources 
Shewan and Dalgarno (2005) suggest that heroin can be taken in a controlled, non-
intrusive fashion for an extended period – without the negative health and social 
outcomes normally associated with use80.  Key points from the research included: 
• 74 per cent were employed and well represented at the higher end of the 
employment sector – 27 per cent were placed in occupational class I or II; 
• 81 (64%) had progressed to educational levels beyond secondary school, with 
only 6 (5%) reporting no educational qualifications;  
• full-time higher education students made up 11 per cent of the group; and 
• 15 per cent were unemployed.  
                                                
80 The longitudinal study focused on 126 long-term heroin users, who had never received 
specialist treatment for any drug use (including alcohol) or served a custodial sentence.  All 
participants had illicitly used opiates at least ten times in each of the last two years.  
Participants had been using heroin for an average of seven years.  
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5. Drug-related treatment 
5.1 Overview  
UK drug strategies identify treatment as being effective in tackling problem drug use 
and, therefore, indicate a need to increase its availability and quality (NIO 1999; 
Scottish Office 1999; National Assembly for Wales 2000; DSD 2002a).  In seeking to 
ensure quality treatment in 2000, the Effective Intervention Unit (EIU) was 
established to identify and disseminate effective practice in Scotland.  In 2001, the 
National Treatment Agency for Substance Misuse (NTA) was established in England 
to increase the availability, capacity and effectiveness of drug treatment.  The 
Department of Health, Social Services and Public Safety, Northern Ireland 
(DHSSPSNI), and the Welsh Assembly Government are responsible for similar 
arrangements. 
 
While the ultimate goal of treatment has been abstinence, the Updated Drug Strategy 
in 2002 emphasised the need to reduce the harms associated with problem drug use 
(DSD 2002a).  Treatment providers are to offer advice and information, needle 
exchange, care planned counselling, structured day care programmes, community 
prescribing, inpatient drug treatment and residential rehabilitation.  In addition, drug 
users are to be offered relapse prevention and aftercare programmes, hepatitis B 
vaccinations, and testing and counselling for hepatitis B and C, and HIV (DH 2002a).  
With regards to prescribed treatment, oral methadone maintenance is the most 
common method used in treating heroin addiction, although recently buprenorphine 
has been introduced (injectable heroin and methadone are also available).  Pilots for 
specialist crack treatment have been introduced as part of the National Crack Plan 
(DSD 2002b). 
 
In the UK, the majority of treatment for problem drug users has been through 
specialist community-based treatment services with open referral, and increasingly 
through General Practitioners (GPs).  Treatment is provided free of charge.  GPs 
have been encouraged (DH 2002a) to provide treatment, and this is usually 
undertaken through shared care arrangements with specialist community-based 
services.  Inpatient care is reserved for those drug users with particularly acute 
problems, for rehabilitation or for detoxification (although the latter is now more 
commonly undertaken in the community). 
 
Referral into treatment through the criminal justice system and whilst in prison, is a 
further component of UK Drug Strategy (see Chapter 9). 
5.2 Treatment system 
5.2.1 Treatment effectiveness in England 
Treatment expansion 
Expanding treatment remains a key priority in the UK.  The Healthcare Commission 
has included drug treatment as one of the eight key indicators used to assess the 
performance of Primary Care Trusts in England81.  In addition, latest directives from 
the Drug Strategy Directorate state (DSD) that: 
                                                
81 Please see http://www.nhs.uk/england/aboutTheNHS/starRatings/pctPI.cmsx or 
http://ratings2005.healthcarecommission.org.uk/Trust/Overview/pct_overview.asp for further 
details. 
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Effective treatment helps individual drug misusers escape from addiction and 
crime, and improves their health and their lives.  Effective treatment helps 
communities as the link between drug misuse and offending is broken and 
fewer crimes are committed.  Effective treatment helps society as the costs of 
drug misuse are reduced (DSD 2004a). 
 
As such, treatment has been expanded, and in England:  
• since 1998, the number of drug users in treatment had increased by 54 per cent 
in 2003 (from a baseline of 100,000) (DSD 2004a); and provisional figures for 
2004/05 suggest that 160,050 clients were in contact with treatment services in 
England (NTA 2005a), a 27 per cent increase on 2003/0482; 
• waiting times have been reduced by 72 per cent compared to 2001 (so that 
average waiting times are now two to four weeks or less in the highest crime 
areas, compared to six to 12 weeks) (DSD 2004a); and 
• over half of all clients entering treatment (52%) in 2003/04 were retained in 
treatment for twelve weeks or more83. 
Improving treatment effectiveness 
In June 2005 in England, the NTA (2005b) launched a strategy to improve treatment 
effectiveness.  It aims to: 
• provide quick access to structured treatment (that is within three weeks84) - with 
faster access for some such as pregnant women or offenders; and 
• retain clients for at least 12 weeks so they receive the maximum benefits. 
 
Guidance has been published for managers and commissioners of services on 
retaining clients in treatment (NTA 2005c). This provides information, advice, 
research, evaluated best practice and guidance on performance management 
concerning retention.  It suggests that a number of factors can help in retaining 
clients, including:
• reminders to encourage clients to keep coming to appointments; 
• motivational interventions; 
• quicker entry into treatment; 
• client induction, so that the client understands what to expect of drug treatment. 
 
The NTA (2005d) has also published guidance relating to nurse prescribing.  
5.2.2 Treatment effectiveness in Scotland 
The document A Partnership for a Better Scotland committed the Scottish Executive 
to reviewing and investing further resources into drug treatment and rehabilitation 
services (Scottish Executive 2003b).  The review reflected concerns regarding the 
rise in drug-related deaths (DRDs) in Scotland and long waiting times for services 
(Scottish Executive 2004a).  It recognised that a number of issues needed to be 
addressed, including:  
• waiting times remaining high in some parts of Scotland; 
• the need for more crisis/respite beds; 
• the need for further and faster progress in the delivery of integrated care; 
• the need to ensure care offered reflects appropriate, evidence based practice; 
• although DRDs fell in 2003, more needs to be done to reduce loss of life; and  
                                                
82 This is due both to increases in the number of clients in contact with treatment services but 
also to improvements in the National Drug Treatment monitoring system. 
83 For more details, please see  
http://www.nta.nhs.uk/frameset.asp?u=http://www.nta.nhs.uk/home/main.htm.  
84 If this does not happen, the NTA have stated that there should be a local investigation. 
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• the need to ensure that investments reach frontline services and produce results, 
noting that the lines of accountability between the Executive, Drug (and Alcohol) 
Action Teams (D(A)ATs) and local service providers has become blurred and 
information systems need to be fit for purpose. 
 
As such, an Action Plan to improve services called for (Scottish Executive 2004a): 
• improving access and increasing options through: reducing waiting times; 
improved service integration and information sharing; ensuring D(A)ATs have 
realistic timetables for individuals accessing treatment; widening and improving 
the range of services available; funding the roll-out of Drug Treatment and 
Testing Orders (DTTOs) so that they are in place across Scotland by June 2005; 
and improving the links between the community and prisons; 
• improving service quality and consistency through: developing National Care 
Standards; performing an external service audit; providing improved training; 
supporting D(A)ATs to monitor services and emphasise best practice guidance; 
• integrating service delivery through: improving links between treatment and 
services offering aid, for example, regarding housing or employment; promoting 
interventions which help drug users into employment; and supporting drug 
services in identifying children of drug-using parents; 
• reducing DRDs through: supporting the national investigation into drug-related 
deaths and its recommendations; developing a targeted campaign emphasising 
the risks of injecting; monitoring progress made abroad; approaching the Scottish 
Advisory Committee on Drug Misuse regarding the possibility of widening 
Naloxone availability; and supporting the Scottish Drugs Forum’s First Aid 
training; and 
• increasing funding and improve accountability through: increased investment in 
treatment (see Section 1.4); linking treatment funding to capacity and quality; re-
examine existing treatment and rehabilitation targets to focus on capacity, access 
and outcomes; and review the work of the Scottish D(A)ATs. 
5.2.3 The Welsh treatment system  
A Welsh standardised data collection and reporting system has been developed to 
underpin a performance management framework for drug use treatment services85.  
Once the database has been established, stage two will involve producing key 
performance indicators.  Stage three will deliver a research and evaluation 
programme. 
 
In September 2003, development began of the Substance Misuse Treatment 
Framework for Wales (Welsh Assembly 2003b).  It will imitate the professional 
consensus on what works best for drug users (including alcohol misusers).  Its 
development has been informed by Models of Care (DH 2002a) and will be 
completed by March 2009. 
5.2.4 The provision of treatment for young people 
England 
Providing drug services for young people is a priority in the UK Drug Strategy (DSD 
2002a).  As such, the Home Office, Department for Education and Skills (DfES), 
Department of Health (DH) and the Office of the Deputy Prime Minister (ODPM) have 
developed the Young People's National Delivery Plan for 2004 to 2008.  It aims to 
ensure that drug use issues are identified among vulnerable young people as early 
                                                
85 For more information, please see http://www.hsw.wales.nhs.uk and  
http://www.wales.gov.uk/subicsu/content/substance/pmframework/pid-e.htm.  
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as possible and that individuals have access to the appropriate services and 
interventions86 (see Chapter 3 for more details on prevention). 
 
In April 2005, the NTA (2005e) published guidance establishing the types and 
standards of services that should be available in young people’s treatment services. 
This document highlights the Key Performance Indicator, which has been set: 
increase the participation of young problem drug users (under 18 years of 
age) in treatment programmes by 50 per cent between 2004 and 2008. 
(NTA 2005e). 
 
In addition (NTA 2005e): 
• the DSD is producing an online commissioning toolkit87; 
• the DSD is developing guidance on the Young People’s Substance Misuse 
Partnership Grant (YPSMG; see Section 3.2.1), and commissioning in children’s 
services and in relation to performance management framework; and 
• the NTA is developing models of integrated care pathways to aid referral into 
young people’s treatment services.   
Scotland 
During 2004, the EIU (2004a) produced guidance for commissioners and providers 
on identifying young people’s drug-related needs in designing their effective 
assessment. A consultation was subsequently held with a range of stakeholders 
including young people and their families (EIU 2004c). 
Wales 
As part of the Substance Misuse Treatment Framework for Wales (Welsh Assembly 
2003b), work has commenced on the production of a Children and Young People’s 
module.  This will contain guidance on education, prevention and treatment services.  
Publication of the consultation document is anticipated in March 2006. 
5.2.5 Referral into treatment through the criminal justice system 
The Drug Interventions Programme (DIP) was referred to in the 2004 UK Focal Point 
Report (see Section 9.3.3).  In September 2004, it was reported that €266.4 million 
(£179 million) extra funding would be made available for the treatment of problematic 
drug users and will be targeted at the most seriously affected drug users (that is, 
those with the most complex problems who are the most likely to drop out of 
treatment88) (DH 2004c).  These extra funds should allow for an extra 40,000 drug 
users to be treated by 2008 and an expansion in treatment for those under 18 years 
of age.  
5.2.6 Research  
A number of pieces of research, commissioned to help in improving treatment 
outcomes were completed during 2004/05. 
 
Drug Outcome Research in Scotland: The Drug Outcome Research in Scotland 
(DORIS) study is based at the University of Glasgow’s Centre for Drug Misuse. It is 
examining the effectiveness of Scotland’s drug treatment services and how evidence 
of what works can be incorporated into treatment. The researchers have recruited 
1,007 drug users who are starting a new drug treatment episode from across 
                                                
86 For more information, please see  
http://www.dfes.gov.uk/datastats1/guidelines/children/pdf/2005%2006%20OC2%20letter.pdf.  
87 This will be available on www.drugs.gov.uk.  
88 This includes persistent offenders and drug offenders with associated alcohol and mental 
health problems. 
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Scotland89.  As part of DORIS, McKeganey et al. (2004) noted that 56.6 per cent of 
their sample of 1,007 drug users in treatment identified abstinence as the only goal 
they sought to achieve (others sought reduced or stabilised drug use, and 1% sought 
safer use).  
 
Drug Treatment Outcomes Research Study: The National Drug Evidence Centre 
(NDEC) was commissioned by the Home Office in June 2005 to investigate treatment 
outcomes (University of Manchester 2005).  This research, the Drug Treatment 
Outcomes Research Study (DTORS), will follow 3,000 drug users from across 
England for an initial 12 months, examining how treatment influences factors such as 
levels of drug and alcohol use, offending behaviour, health issues and other social 
outcomes.  A cost-benefit analysis will also be undertaken. 
Treatment retention 
NDEC (2004)90 has found that the strongest predictor of treatment retention or 
completion is not a characteristics of the clients, but rather is related to the nature of 
agency that they attend. Those clients who received both counselling and prescribing 
were the most successful (regarding retention or completion), implying that services 
providing a package of prescribing and psychosocial support are more likely to be 
effective.  
Treatment outcomes 
Gossop (2005a) reviewed four major national drug treatment outcome studies: the 
National Treatment Outcome Research Study (NTORS) in the UK and three 
American studies91.  These studies showed that treatment clients displayed 
considerable reductions in illegal drug use and improvements in injecting risk 
behaviours.  Length of time in treatment was associated with better treatment 
outcomes.  However, overdose remained a serious problem and many clients 
continued to drink heavily. 
 
In addition, Gossop’s (2005b) review examined the relationship between treatment 
and crime. He noted that effective drug treatment can facilitate crime reduction, so 
benefiting society by reducing the costs of crime. 
 
The effectiveness of psychological therapies: Wanigaratne et al. (2005) suggested 
that there is a substantial evidence base for the effectiveness of psychological 
interventions with drug users.  Programmes such as family interventions, motivational 
interviewing and relapse prevention appear to be effective across a range of 
substances.  They noted that community reinforcement and contingency 
management are rarely used in the UK and could be developed further.  
 
Substance use nurses: Matheson et al. (2004)92 highlighted consistency of practice 
between substance use nurses across Scotland with high levels of consultation with 
other colleagues.  Nurses felt a substantial part of their role to rest in counselling, yet 
there are questions about their individual level of competency.  The report 
                                                
89 For more information, please see http://www.gla.ac.uk/centres/drugmisuse/DORIS.html. 
90 This was based on information collected from treatment services in the North West of 
England from April to September in 2001 and 2,616 clients from community-based services. 
91 The American studies involved were the Drug Abuse Reporting Programme (DARP), 
Treatment Outcome Prospective Study (TOPS) and Drug Abuse Treatment Outcome Study 
(DATOS). 
92 Matheson et al. interviewed 29 nurses, received 192 questionnaires from nurses working in 
substance use and performed observational fieldwork. 
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recommended further exploration of which counselling models could be used to 
assess whether current training procedures are adequate. 
Research from the Drug Misuse Research Initiative  
The Drug Misuse Research Initiative (DMRI) is a €3.6 million (£2.4 million) 
programme of research running from 2000 to 200593.  It comprised 14 studies in the 
areas of drug treatment and prevention, some of which were reported by the 2004 
UK Focal Point report.  Those not previously reported, are detailed below.  
 
The effects of time on a waiting list on clinical outcomes in opiate addicts: Research 
found that while reduced waiting times was associated with more successful 
treatment entry, it did not improve treatment retention (Ridge et al. 2004)94.  
 
The needs and views of drug service users: Moring et al. (2004)95 looked at 
treatment pathways for new clients. Their findings reiterated those of previous 
studies, which have shown that service culture and staff attitude can affect retention. 
 
The effectiveness and cost effectiveness of cognitive behaviour therapy: Drummond 
et al. (2005)96 examined the differences between cognitive behaviour therapy (CBT) 
and methadone maintenance treatment (MMT). They found that there was no 
significant difference in treatment outcome and both were identified as being cost 
effective. 
 
Dexamphetamine substitution: Merrill et al. (2004)97 undertook a two-centre 
randomised controlled trial of dexamphetamine substitution for amphetamine 
dependence.  The study observed that dexamphetamine prescribing did not 
significantly reduce illicit amphetamine use or reduce injecting behaviour compared 
to drug-free methods. In addition, some evidence suggested poly drug use in the 
prescribed group. However, those prescribed dexamphetamine showed significant 
improvements in physical health.  The researchers suggested that dexamphetamine 
may be suitable for treating cocaine dependence. 
5.3 Drug free treatment 
The NTA estimates that about 30 per cent of treatments in England could be 
identified as drug free in that they offer either rehabilitation, structured counselling or 
structured day care (although medication may still be involved as part of the 
treatment).  Figures for 2004/05 suggest that of 163,985 treatment episodes in 
England, 4,148 (2.5%) were in residential rehabilitation, 13,161 (8.0%) were in 
structured day care and 39,348 (24.0%) were in structured counselling (Best and 
Abdulrahim 2005).  
                                                
93 Please see http://www.mdx.ac.uk/www/drugsmisuse/index.html for further details. 
94 The study recruited drug users attending a drop-in assessment service for methadone 
prescribing.  Patients were randomly allocated into either ‘fast-track’ structured drug treatment 
(around two weeks after first contact) or a ‘standard’ wait (lasting approximately 8 weeks on 
average but this changed substantially). 
95 The researchers performed semi-structured interviews with 46 service users and 51 drug 
service providers across the North of England.  
96 The study was based on a randomised, parallel group design comparing cognitive 
behavioural therapy with methadone maintenance against methadone maintenance alone. 
Outcome assessments were performed twice a year with 60 clients in 10 community based 
clinics in three English regions. 
97 Fifty-nine participants fulfilling DSM IV criteria for amphetamine dependence were recruited 
from two centres in England and Wales.  Participants were randomly assigned to 
dexamphetamine or drug-free treatment.  
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5.3.1 Inpatient treatments 
Inpatient provision in England 
In a needs assessment of current inpatient provision, Best et al. (2005) suggest that 
at least 24,500 inpatient and residential places are needed in England to meet 
demand (comprising approximately 16,390 in inpatient detoxification services and 
8,190 in residential rehabilitation - an increase of 90% and 34% respectively). 
Improvements are also required in the management of existing services to ensure 
flexibility and sufficient support after inpatient treatment has ended. 
Client retention in residential rehabilitation services 
A survey of client retention in residential rehabilitation services in England found that 
48 per cent of those admitted in 2004 completed treatment, 32 per cent quit and 19 
per cent were discharged for disciplinary reasons (Meier 2005)98.  Increased levels of 
client retention were associated with fewer beds, less housekeeping duties, higher 
service fees and providing between one and two hours of individual counselling per 
week.  
Detoxification and rehabilitation services in Scotland 
The EIU (2004d) reviewed residential services in Scotland. Key findings included:  
• Twenty-one residential detoxification and rehabilitation units were identified in 
Scotland, with 329 beds for adult drug users99. However, there is no 
comprehensive directory of residential services in Scotland. 
• Approximately 1,294 Scottish drug users were admitted to residential treatment 
between April 2003 and March 2004 (905 in 2002/03), although these figures are 
likely to be an underestimate.  
• Completion rates for residential detoxification programmes were around 75 to 80 
per cent.  However, relapse was also common. In comparison, residential 
rehabilitation programmes have low levels of client retention, with 25 per cent 
leaving after two weeks, and 40 per cent leaving within three months. 
• Detoxification programmes have better long-term outcomes if they are followed 
up by structured aftercare.   
• Four main factors influencing the effectiveness of residential rehabilitation 
programmes are: time in treatment (those programmes lasting at least 3 months 
are more likely to be effective), retention, client characteristics and aftercare 
provision.   
• On average, a week in residential rehabilitation programme costs between 
€461.3 (£310) and €632.5 (£425), although some cost much more.  The cost of 
residential detoxification may be at least double this because of the clinical input 
required. 
5.3.2 Outpatient treatments 
Treatment for crack users 
Following the pilot services for crack users in 2003, guidance for those working with 
crack in primary care was issued by the Royal College of General Practitioners and 
Substance Misuse Management in General Practice (Shapiro 2004)100. 
 
An impact evaluation of pilot service specification and treatment delivery models has 
been completed (NTA 2005f)101.  It aimed to improve the availability and quality of 
                                                
98 Fifty-seven of 87 (65%) residential services identified in England responded to a postal 
questionnaire replied to the survey. 
99 This does not include residential crisis services or supported accommodation services. 
100  See www.rcgp.org.uk/drug/index.asp for more details. 
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drug treatment for crack/cocaine users.  The research covered 13 drug services 
across 11 cities in England.  The study concludes that those exposed to the 
intervention tools were positive about their utility and impact, with associated gains in 
health and social engagement.  However there was little evidence of service re-
design or efforts to embed changed practices among the participating services.  
5.4 Medically assisted treatment 
5.4.1 Withdrawal Treatment  
Inpatient detoxification  
Of 163,985 treatment episodes in England in 2003/04, 3,466 (2.1%) involved 
inpatient detoxification (Best and Abdulrahim 2005). 
 
In a review of opiate detoxification, Day (2005) suggested rates of successful 
completion are higher in inpatient settings.  
Community based drug detoxification  
The EIU (2004e) published guidance to inform evidence-based practice in planning 
and delivering community-based drug detoxification. It suggests that various key 
issues need to be addressed when developing a person-centred integrated-care 
pathway including assessment of the individual’s needs and aims, sharing 
information between partner agencies and continually monitoring the service. 
5.4.2 Substitution treatment  
Substitution treatment remains the main treatment in the UK102.  Of 163,985 
treatment episodes in England in 2004/05, 20,686 (12.6%) involved GP prescribing 
and 60,292 involved specialist prescribing (36.8%) (Best and Abdulrahim 2005).   
 
The National Institute for Health and Clinical Excellence (NICE) is producing 
appraisals for substitute prescribing.  These will cover the effectiveness and cost 
effectiveness of methadone and buprenorphine (Welsh Assembly Government 
2004c; House of Commons 2005).   
Prescribing of diazepam 
A change in regulations to enable the prescribing and dispensing of diazepam in 
instalments for treating drug addiction came into force in April 2005; guidance is to be 
to be issued103.  
Prescribing of injectable diamorphine 
In December 2004 the Department of Health announced a shortage of injectable 
diamorphine (DH 2004d). Although the numbers requiring injectable diamorphine are 
low104, it is suggested that those for whom it is prescribed are among the most 
vulnerable, and for whom other interventions have not been successful (Cook et al. 
2005). As such, the NTA have prepared a briefing for service users to explain the 
problem and provide advice (NTA 2005g). 
                                                                                                                                         
101 Over a hundred crack users, predominantly white were recruited into the study, of whom a 
large proportion was successfully followed up.  
102 However, as reported in last year’s report, substitute prescribing was only initiated in April 
2004 for the first time in Northern Ireland (DHSSPSNI 2004). 
103 Please see http://www.psnc.org.uk/index.php?type=more_news&id=1590&k=9 for more 
details. 
104 The NTA (2003) estimates the number to be around 450. 
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The costs of methadone 
A Scottish report suggested that the average cost per patient per year of methadone 
hydrochloride, in 2003, was €906.3 (£609); this includes only the cost of the 
medication and dispensing (ISD 2005a). 
5.4.3 Other medically assisted treatment 
Only prescribed treatments are offered with medical assistance. 
 68
UNITED KINGDOM FOCAL POINT REPORT 2005 
6. Health correlates and consequences 
6.1 Overview  
6.1.1 Drug related deaths 
• Drug-related deaths (DRDs)105 106 in the UK rose steadily from 1996 until 2001, 
but have since fallen.  In Scotland, according to the ONS definition, deaths 
continued to rise until 2002. 
• Males are more likely to suffer DRDs than females, by over 4:1 (which is not 
dissimilar to the gender ration for problematic drug users), with the difference 
closing over the last decade.   
• The overall average age at death (which rose from 33.7 years in 1996 to 35.2 
years in 2000) fell in 2001 and 2002 to 34.0 years.  The age at death for females 
has been considerably higher than that for men, ranging from an excess of 4 to 9 
years in different years. 
• Males are more likely to die at a younger age of drug dependence through non-
dependent abuse of drugs, and females at an older age by means of 
intentional/undetermined poisoning. 
• Most deaths are associated with opiates (chiefly heroin/morphine and 
methadone), often in combination with other drugs and/or alcohol.  Large 
numbers of deaths also involve benzodiazepines such as temazepam and 
diazepam.  However, the non-opioid drugs most often mentioned are 
antidepressants and paracetamol - either alone or in compound preparations. 
• The number of cases implicating methadone peaked in 1993, having fallen since 
then.   
• In Scotland, diazepam is more likely to be involved than elsewhere in the UK (for 
example in 2001, it was involved in 47% of the 332 DRDs recorded by the 
General Register Office for Scotland; GROS 2002). 
                                                
105 There are two main types of source in the UK for information on 'acute' deaths: three 
General Mortality Registers (GMRs - the General Register Offices for England and Wales 
(GRO), Scotland (GROS), and Northern Ireland (GRONI)) and one Special Mortality Register 
(SMR - the National Programme on Substance Abuse Deaths or np-SAD) based at St 
George’s Hospital Medical School, University of London.  The General Mortality (GMR) data 
are derived from medical death certificates.  Whilst the GMRs for England and Wales, and 
Scotland have established special databases to monitor DRDs, this has not yet happened in 
Northern Ireland.  The UK-wide use of ICD-10 in coding DRDs provides consistency in 
approach.  There are three different definitions that are used in the UK when discussing drug-
related deaths: that of the Office for National Statistics (ONS), that of the UK Drug Strategy 
and that of the European Monitoring Centre for Drugs and Drug Addiction. However, the 
adoption of a common definition for the Drug Strategy baseline figure means that valid 
comparisons are now possible between different parts of the UK.   
106 Because of differences in the information published by ONS (who publish GRO data), 
GRONI and GROS, it is impossible to derive UK statistics from published sources.  However, 
statistics from all three GMRs have been collated by the UK Focal Point Expert on DRDs 
since 2000.  This means that UK figures using all three definitions are available on the 
EMCDDA Standard Tables 5 and 6. 
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6.1.2 Blood borne infectious diseases 
HIV107 prevalence among injecting drug users (IDUs) in the UK has remained at less 
than or around one per cent since the mid-1990s, although in London it has been 
higher, at or near, four per cent.  At the end of 2002, there were an estimated 1,400 
people living with HIV infection acquired through injecting drug use, of whom 300 
were thought to be undiagnosed.  Prevalence of hepatitis C (HCV) has been much 
higher at around 40 per cent of IDUs, and there is evidence of increased incidence 
(Health Protection Agency 2004a).  Prevalence of antibodies for hepatitis B (anti-
HBc) has declined, levelling off at 20 per cent.  Outbreaks of hepatitis A and other 
infections among IDUs have been increasingly reported108, following reported 
increases in injecting risk behaviour (Hope et al. 2002). 
6.1.3 Dual diagnosis 
Prevalence and attribution of dual diagnosis remain difficult to estimate.  Depression, 
anxiety disorders, personality and psychotic disorders are commonly reported, 
although prevalence varies with setting and specific sub-populations. It has been 
suggested that that from 1993 to 1998 there were at least 195,000 comorbid patients 
and 3.5 million general practitioner (GP) consultations involving such patients in 
England and Wales (Frischer et al. 2003). Eighty to 90 per cent of patients consulting 
for both drug abuse and mental illness do so for the first time. The level of 
comorbidity is increasing at a higher rate among younger patients, which indicates 
that comorbidity may increase in future years. Approximately one-third of psychiatric 
discharges involve a supplementary rather than a main diagnosis of drug use. In 
these cases, the most common diagnoses were: schizophrenia, mood (affective) 
disorders, and alcohol misuse.  
 
There is also increasing information regarding the association of mental health issues 
with cannabis (Patton et al. 2002) and ecstasy use (MacInnes et al. 2001), although 
this needs further investigation. 
                                                
107 Data on the prevalence of blood borne infectious diseases amongst injecting drug users 
(IDUs) are provided by a number of sources.  The Unlinked Anonymous Prevalence 
Monitoring Programme’s (UAPMP) surveys of IDUs in contact with drug services in England, 
Wales and Northern Ireland (Hope et al. 2001; Unlinked Anonymous Steering Group 2002); 
the Centre for Research on Drugs and Health Behaviour’s surveys of IDUs recruited from 
community settings in England (Hunter et al. 2000); and the Scottish Centre for Infection and 
Environmental Health's (SCIEH) surveys of IDUs attending community and drug agency 
settings in Glasgow (Taylor et al. 2000).  SCIEH also holds anonymous epidemiological data 
on all those who have had a named HIV antibody test in Scotland since 1989 (on the HIV 
Denominator Database).  All collect behavioural data and oral fluid for testing for antibodies to 
hepatitis C (anti-HCV).  The main sources of information on newly diagnosed HIV/AIDS 
infections are from voluntary cases reporting from laboratory reports of newly diagnosed 
infections by microbiologists and clinicians.  For England, Wales and Northern Ireland, reports 
are made to the Health Protection Agency’s Communicable Disease Surveillance Centre 
(CDSC) whilst new diagnoses in Scotland are reported to Health Protection Scotland.  
Laboratory report data for England and Wales, Scotland, and Northern Ireland are available 
from the following websites: http://www.hpa.org.uk for England and Wales, 
http://www.hps.scot.nhs.uk/ for Scotland and http://www.cdscni.org.uk for Northern Ireland.  
108 Methicillin resistant Staphylococcus aureus (MRSA) as a cause of IDU-related sepsis 
(CDR Weekly 2003) and other serious Clostridial infections acquired through contaminated 
drugs have been reported (Jones et al. 2002; McGuigan et al. 2002). 
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6.1.4 Other health correlates and consequences 
While a number of other physical health problems are associated with problem drug 
use109, evidence of the extent of problems is not readily available. 
 
Maternal drug use can have a significant impact on unborn children (through, for 
example, early pregnancy loss, placental disruptions and low birth weight babies).  
However, withdrawal from maternal drug use can also be problematic for babies, 
particularly due to benzodiazepines (DH et al. 1999).  Benzodiazepines are linked to 
“floppy infant syndrome”, major malformations such as cleft palate, and deviation in 
neurological development during their first 18 months (which can result in 
behavioural problems, dyslexia and attention-deficit disorder - problems may not 
come to light until puberty) (Bibby 2000).  Cleft palate is also associated with 
amphetamine use (Bibby 2000) and evidence has emerged that children whose 
mothers used cocaine during pregnancy are at risk of haemorrhaging as they grow 
older (DH et al. 1999).  There is also concern about birth defects linked to ecstasy 
use (Ho et al. 2001).  However there is little information about the nature and extent 
of these problems.   
 
In the UK, there is little evidence of HIV transmission to babies through maternal 
infection specifically associated with drugs, but there is a risk of hepatitis 
transmission, particularly HCV, where the risk of transmission amongst babies whose 
mothers test positive is six per cent (DH 2002b; Siney 2001).  
6.2 Drug-related deaths and mortality of drug users 
6.2.1 Direct overdoses (differentiated) indirect drug-related deaths 
Latest available data for DRDs are from 2003.  The total number of deaths in the UK 
was 1,416 (Figure 5 and Appendix 2); a fall of 27.2 per cent since the peak in 2000.   
Figure 5: Number of deaths in the United Kingdom using the European Monitoring Centre for 
Drugs and Drug Addiction’s drug-related deaths definition from 1996 to 2003, by country 
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Source: Corkery (2005). 
                                                
109 This includes thrombosis, blood clots and gangrene (ACMD 2000) as well as health 
problems that are associated with problem drug users’ lifestyles including poor diet. 
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The number of deaths per 100,000 of the population shows that differences exist 
between the different countries in the UK: in 2003 the rate in Scotland was 6.79 
compared to 2.02 in England and Wales and 0.23 in Northern Ireland.  The UK 
average was 2.38. 
 
Gender differences also exist (see Chapter 11 for a full discussion on gender in the 
UK). Of the DRDs in the UK in 2003, 80.4 per cent (1,139) were male and 19.6 per 
cent (277) were female (a male:female ratio of 4.11:1, continuing the decline from 
previous years).  The highest proportion of males was 80.7 per cent in England and 
Wales and the lowest in Northern Ireland at 75.0 per cent (Figure 2). 
 
The average age of those dying was 35.3 years (Standard Deviation or SD is 12.6), a 
rise from the previous two years, with males (34.2 years, SD 11.1) tending to be 
about 5 years younger than females (39.4 years, SD 17.6).  Age at death tended to 
be higher in Northern Ireland than in the rest of the UK.  Overall, most deaths 
occurred in the 30 to 34 year old age group (for both males and females). 
Drug-related deaths by definition  
To obtain a comprehensive understanding of DRDs in the UK, it is necessary to look 
at data derived from other definitions (see Figure 6 and Appendix 2).  The definition 
used by the Office for National Statistics (ONS) is much broader than the other two 
and so the totals produced are different, although the trend followed is reasonably 
similar. 
Figure 6: The number of drug-related deaths in the United Kingdom from 1996 to 2003 
according to the definition 
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Source: Corkery (2005). 
Drug-related deaths by drug implicated 
In England and Wales using the ONS definition from 1993 to 2003, more than one 
drug was mentioned on the death certificate in 23.7 per cent (7,022 out 29,659 over 
the 11 year period) of DRDs, and alcohol in 22.9 per cent (6,792) of drug poisoning 
deaths in England and Wales.  In England and Wales most deaths were associated 
with opiates: heroin and/or morphine were implicated in 55 per cent (591) of reports 
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and methadone in 20 per cent (216) in England and Wales in 2003.  After a 
substantial rise in cocaine deaths to 171 mentions on death certificates in 2002, 
these fell to 113 (mentioned in 11 per cent of death certificates).  Deaths involving 
ecstasy, accounting for only 0.8 per cent of drug-related deaths, also fell from 55 in 
both 2001 and 2002 to 33 in 2003. 
 
In Scotland diazepam was involved in 31 per cent and methadone in 18 per cent of 
cases.  The number of DRDs involving heroin and/or morphine trebled from 1996 to 
2002, but fell by 27 per cent in 2003 (being implicated in 35%).  As in England and 
Wales the mention of ecstasy on death certificates fell. 
 
The number of DRDs in Northern Ireland is very low and has been without any 
discernible trend from year to year.  The DRDs involve mostly opiates and related 
narcotics. The first death in the Province involving oxycodone was recorded in 2003. 
 
In the UK, the number of deaths attributed to volatile substance abuse continued to 
decline in 2003 to 51 (65 in both 2002 and 2001).  This is the lowest figure since 
1982 and compares with the peak of 152 in 1990 (Field-Smith et al. 2005). 
6.2.2 Mortality and causes of deaths among drug users 
In 2003 in England and Wales, the largest proportion of deaths related to drug 
poisoning (using the ONS definition) was described as intentional/undetermined 
poisoning (1,159 out of 2,445 or 47.4%), followed by mental & behavioural disorders 
(655 or 26.8%) and then accidental poisonings (626 or 25.6%) (Griffiths 2005).   
AIDS deaths 
Deaths of IDUs from AIDS accounted for 7.6 per cent of the total number of AIDS 
deaths in England and Wales up to the end of December 2004110.  In Northern 
Ireland, the figure was 5.1 per cent, but in Scotland it was 51.0 per cent.  The decline 
in the number of deaths of IDUs from AIDS seen in recent years has continued: in 
2003, 65 IDUs died from AIDS compared to 80 in 2002, and 212 in 1995.   
A case-control study of illness and death amongst IDUs in Glasgow 
Taylor et al. (2005a) highlighted that Clostridium novyi and other bacteria were 
important agents in 60 deaths and illnesses amongst injecting drug users in 
Scotland. They also noted that muscle-injecting cases were significantly more likely 
to inject larger amounts of heroin per average injection than controls.  
Drug related suicides 
Nicoll et al. (2003) found that of the suicides and undetermined deaths in the 
Grampian region of Scotland, a greater proportion of those with previous psychiatric 
contact were drug users between 1991 and 1999 than between 1974 and 1990 (odds 
ratio (OR)  = 3.75, 95% Confidence Interval or CI [2.7, 5.2]).  
Fatal poisoning 
A study of fatal poisonings between 1983 and 1999 in England, Scotland and Wales 
found that chloral hydrate, clomethiazole, barbiturates and related sedatives had 
much higher fatal toxicity indices than anxiolytics such as benzodiazepines, 
buspirone, zolpidem and zopiclone (Buckley and McManus 2004). There was also a 
substantial reduction in the annual number of deaths from sedative drug poisoning 
due to a sustained reduction in prescriptions for high toxicity drugs. 
                                                
110 Data were provide to John Corkery from the Health Protection Agency via a personal 
communication. 
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The role of methadone in fatalities 
Corkery et al. (2004) reviewed the effects of methadone (such as renal failure, 
respiratory depression and cardiac problems) and their role in related fatalities. They 
suggested that methadone-related deaths can be averted if individuals’ tolerance 
levels are considered and polydrug use is avoided. 
6.2.3 Research into drug-related deaths 
National Programme for Substance Abuse Deaths 
Data from the National Programme for Substance Abuse Deaths (np-SAD)111 
database are broadly consistent with those from ONS. Reports show that (Ghodse et 
al. 2004): 
• seventy to seventy-five per cent of cases are male and about 75 per cent are 
under 45 years of age; 
• from 1997 to 2003, two-thirds of cases had a history of drug abuse or 
dependence, and on average death was 10 years or more earlier than for this 
group than for those without such a history; 
• deaths involving methadone were more likely to be the result of possibly illicit 
(60% or more) rather than prescribed drugs; 
• in 2003, 46 per cent of those who died were unemployed (40% lived alone and 5 
to 6% were of no fixed abode); and 
• In 2003, about two-thirds of cases died in a defined residential address, a quarter 
in hospital, and seven to eight per cent elsewhere (e.g. a public place).  
• GHB was implicated in two cases in 2003. 
The effect of legislation limiting the size of analgesic packs 
Two studies examined the effect of legislation change in September 1998 to limit the 
size of analgesic packs sold over the counter.  Hawton et al. (2004) found that 
suicidal deaths from paracetamol and salicylates decreased by 22 per cent in the 
year in England and Wales following the change, and that the numbers continued to 
fall in the next two years112.   
 
In Scotland, deaths from paracetamol poisoning fell by 45 per cent in the year 
following the legislative changes, but rose in the following three years to reach the 
same levels as before the legislative change (Inglis 2004). These results suggest 
further limitations and public education are needed to sustain the benefits achieved. 
Populations at risk 
Data from the Special Mortality Register show that most male accidental poisoning 
deaths occur amongst young age groups who consume illicit drugs, whereas most 
female deaths involve deliberate overdoses on antidepressants and (opioid) 
analgesics.  It also shows geographical differences (both locally and between 
administrations) in the types of drug and mode of administration.  Therefore, local 
interventions should be based on local patterns of consumption and knowledge of the 
phenomena specific to the locale. 
                                                
111 The np-SAD coroners' database provides a useful crosscheck on ONS data.  It acts as a 
complementary source of information since it collects data on a wider range of variables and 
continues to expand its coverage across the UK.  
112 In 1996-98, there were 364 deaths related to any paracetamol or salicylate in England and 
Wales, compared to 284 in 1998-99 and 274 in 1999-2001. 
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Cohort mortality studies 
The Drug Treatment Outcome Research Study (DTORS) will be monitoring mortality 
amongst its 3,000 subjects across England during the last 3 months of 2005 (see 
Section 5.2.6).  
 
A cohort study of 667 IDU patients in a large Edinburgh family General Practitioner 
(GP) practice found that there had been changes in the cause of deaths between 
1980 and 2001 (Copeland et al. 2004).  Death rates peaked in the early to mid-
1990s, reflecting the development of advanced HIV from the early 1982-4 epidemic 
(the onset of antiviral chemotherapy in the late 1990s helped to lower the number of 
deaths).  The principal cause of death was overdose in the early years, HIV/AIDS in 
later years, and towards the end of the study period HCV emerged as a cause of 
death.  Drug deaths and suicides tended to occur in younger subjects. 
6.2.4 Methodological issues in the monitoring of DRDs  
A number of inquiries and reviews investigating DRDs were completed in 2003 to 
2005 (GRO 2003; Home Office 2003a; NIO 2003a, 3003b; Shipman Inquiry 2003; 
TSO 2003; Home Office 2004c; NICS 2005).  These could impact significantly not 
only on how DRDs are investigated but also on what information is recorded and by 
whom.  If the principal recommendations are acted upon, it is anticipated that there 
will be: 
• a more consistent approach toward death certification, investigation and 
registration will be in place, with guidelines and codes of good practice.   
• an increase in use of toxicology in the future (potentially increasing the number of 
DRDs identified).   
• changes to the roles of coroners and their organisation so that jurisdictions align 
to the suggested new geographic units.   
 
Full details are expected to be included in a White Paper on a new death certification 
and investigation service for England and Wales. A draft Bill was included in the 
background papers to the Queen’s Speech 17 May 2005, but little detail was given. 
6.3 Drug-related infectious diseases 
Infectious disease continues to be a cause of considerable levels of morbidity and 
mortality among IDUs in the UK.  
 
Initial results from the Unlinked Anonymous Prevalence Monitoring Programme 
(UAPMP) enhancement pilot study are now available, this study recruited IDUs in 
community settings at five locations in England and collected dried blood spot 
samples (n=952).  They are presented alongside those from the UAPMP agency 
survey 2004 (n=2,686 of which 1,625 were current IDUs, i.e. had injected in the 
preceding month) and other data on infections among IDUs in the current Shooting 
Up report (Health Protection Agency 2005a).  A summary of key trends and new data 
is discussed in Section 6.3.1 and 6.3.2. 
6.3.1 HIV 
Various reports were published in 2005, which provided an estimate of HIV 
prevalence amongst IDUs. 
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• A recent analysis113 permitted a closer examination of trends in HIV infection 
among current IDUs in England in Wales between 1990 and 2003.  It showed 
that HIV prevalence declined in the early 1990s from 5.6 per cent in 1990 to 0.6 
per cent in 1996 and then increased in recent years to 1.4 per cent in 2003 (Hope 
et al. 2005).  
• The prevalence amongst current IDUs participating in the UAPMP agency survey 
in England in Wales in 2004 was 1.5 per cent (Health Protection Agency 2005a).  
This is the highest level of prevalence amongst current IDUs in this survey since 
1992 when it was 2.0 per cent. 
• A cohort study of IDUs was recently undertaken in London and, to a lesser 
extent, Brighton to estimate the rate of HIV infection among new IDUs (Judd et al. 
2005).  The study found an incidence of 3.4 per cent among the 428114 HIV 
negative IDUs in this study; levels were higher amongst those reporting (during 
the follow-up interview) that they injected crack-cocaine.  The UAPMP 
enhancement pilot study supports this, as those participants who had injected 
crack-cocaine also had a higher prevalence of HIV than those who had not (1.3% 
and 0.4% respectively) (Health Protection Agency 2005a). 
 
These higher prevalence levels amongst those reporting crack cocaine injecting may 
be linked to evidence showing that this population demonstrate have higher levels of 
risk behaviours.  Those participants in the UAPMP enhancement pilot reporting 
injecting crack-cocaine (two-fifths had) were more likely to have engaged in sharing 
needles and syringes in the last month (42% compared to 29% of those not injecting 
crack cocaine).  They were also more likely to have used their last needle at least 
five times (15% compared to 8% for those not injecting crack-cocaine) (Health 
Protection Agency 2005a). 
 
The UAPMP agency survey suggests that an increasing proportion of IDUs may be 
unaware of their HIV infection (Health Protection Agency 2005a).  In 2004, 37 per 
cent of those participating in this survey reported never having had a voluntary 
confidential test for HIV, and only 50 per cent of those who had antibodies to HIV 
were aware of their infection.  This is the lowest level of awareness seen in this 
survey since the question was first asked in 1995. 
 
Although the rate of HIV infection in the UK remains low, it is considerably higher in 
London, among all the participants in the UAPMP agency survey HIV prevalence was 
3.9 per cent in London compared with 0.6 per cent elsewhere; whilst combining data 
for 2003 and 2004 the prevalence in Northern Ireland was 2 per cent (n=153)  
(Health Protection Agency 2005a).  However, a high proportion of IDUs are also 
accessing needle exchange services – 88 per cent (2,326 of 2,644) of IDUs in the 
UAPMP agency survey report lifetime use of a needle exchange service. 
6.3.2 Viral hepatitis 
In 2004, 45 per cent of the current IDUs115 in the UAPMP agency survey have been 
infected with HCV (Health Protection Agency 2005a), increasing from 40 per cent of 
current IDUs in 1998 (Hope et al. 2001).  However, there are marked regional 
variations in HCV prevalence that have been sustained over time.  For example, 
                                                
113 This analysis combined data from IDUs participating in the UAPMP agency survey with 
data from IDUs recruited through surveys undertaken by the Centre for Drugs and Health 
Behaviour. 
114 The participants were under 30 years old and an injecting history of six years or less – all 
had injected in four weeks before the study. 
115 Current injecting drug users are defined as those who had injected drugs in the four weeks 
prior to participating in the survey. 
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combined data from the IDUs who participated in the UAPMP agency surveys of 
2003 and 2004 show that HCV prevalence was 18 per cent in Wales, and 25 per cent 
in Northern Ireland (Health Protection Agency 2005a).  In England, prevalence levels 
ranged from 20 per cent in the North East to 55 per cent in London and 59 per cent in 
the North West116.  In Scotland, the prevalence of HCV among those IDUs who had 
undergone a voluntary confidential HIV test in 1999/2000 varied from 23 per cent in 
Forth Valley to 62 per cent in Greater Glasgow (Hay et al. 2001).] 
 
Initial results from the UAPMP enhancement pilot study found that 54 per cent had 
antibodies to HCV (anti-HCV)117 (Health Protection Agency 2005a).  Those who had 
injected crack-cocaine were found to have a higher prevalence than those who had 
not (67% and 45% respectively). 
 
The cohort study of IDUs in London, and to a lesser extent Brighton, estimated the 
annual incidence of HCV to be 41.8 per cent (Judd et al. 2005; see Section 6.3.1).  
This incidence is similar to prevalence levels, suggesting that transmission may have 
recently increased.  
 
During 2004, a community-wide survey of 531 current IDUs in Glasgow found the 
prevalence of HCV was as high as 77 per cent (Taylor, internal communication).  
Among the 55 IDUs who had commenced injecting in the previous two years, the 
prevalence of HCV was 51 per cent; this prevalence was higher than that detected 
among equivalent IDUs surveyed in 1999 (24%) and 2001 (43%). 
 
Recent work has estimated that approximately 50,000 persons were infected with 
HCV in Scotland (representing 1% of the population) in 2004 (Scottish Executive 
2005d).  Of these it was estimated that 37,500 (75%) were chronically infected 
(comprising 33,000 individuals who have ever injected drugs) and 30 to 40 per cent 
had been diagnosed with their infection.  Of the 33,000 ever IDUs living in Scotland 
with chronic HCV in 2004, it was estimated that 22,800, 8,400 and 1,800 had mild, 
moderate and severe (cirrhosis) HCV respectively. 
6.3.3 Sexually Transmitted Infections 
NO NEW INFORMATION 
6.3.4 Tuberculosis 
NO NEW INFORMATION  
6.3.5 Other infectious morbidity  
There is a continuing problem with bacterial infections among IDUs, including 
ongoing problems with group A streptococcal infections.  The UAPMP enhancement 
pilot found that 58 per cent of the participating IDUs reported having a possible 
symptom of an injecting site infection or reaction118 in the last year, and 36 per cent 
reported having an abscess, sore or open wound at an injecting site in the last year 
(Health Protection Agency 2005a).  Of these, 53 per cent sought medical attention.  
Those who had injected crack-cocaine were more likely to have had an abscess, 
sore, or open wound at an injecting site (45% of those injecting crack cocaine 
reported this in the last year compared to 30% of those not injecting crack cocaine).  
                                                
116 See http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/hiv/epidemiology/ua.htm.  
117 This is comparable to the UAPMP agency survey, after allowing for the differences in test 
sensitivity and recruitment areas. 
118 Symptoms include redness, swelling or tenderness. 
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These findings could reflect poor general hygiene, as only 33 per cent of participants 
reported always swabbing injection sites. 
 
There has also been a continuing occurrence of wound botulism cases among IDUs 
(Akbulut et al. 2005).  Between 2000, when the first reported cases occurred, and the 
end of 2004, 85 cases had been reported in the UK.  Overall, 70 of the cases 
occurred in England, 12 in Scotland, and two in Wales.  In 2004, there were 40 
cases, the largest annual number of cases so far. 
6.3.6 Research  
There are number of new and ongoing research projects:   
• A cohort study of IDUs in Wales will estimate the incidence of HCV (it is led by 
National Public Health Service Wales (NPHSW), the Centre for Research on 
Drugs and Health Behaviour (CRDHB) and the Health Protection Agency. 
• DORIS (see Section 5.2.6) looking at prevalence and incidence of HCV among 
IDUs attending drug services in Scotland.   
• The CRDHB and Health Protection Agency are examining whether the collection 
of dried blood samples rather than full blood will increase the uptake of HCV 
testing among IDUs in England. 
• The CRDHB and Health Protection Agency are collecting dried blood spot (DBS) 
samples from IDUs in prisons and low threshold services in England. This will 
explore combining named voluntary counselling and testing for HCV, HBV and 
HIV with an unlinked anonymous survey.   
• Two studies are being completed by the University of Paisley and CRDHB, which 
video taped injecting events.   
• A pilot companion UAPMP survey is currently being developed in Scotland by 
Health Protection Scotland (HPS) with the University of Paisley and the Health 
Promotion Agency, which will focus on those using needle exchanges. 
6.4 Psychiatric comorbidity (dual diagnosis) 
In the last year, several articles have been published addressing co-morbidity: 
• Best et al. (2004) examined 43 deaths involving drug use that had occurred in 
police custody between 1998 and 2002, in England and Wales119.  In 18 of these 
cases (42%), there was evidence of mental illness (psychosis, self-harm or 
suicide attempts, or anxiety or depression). 
• The COSMIC120 study was performed in four urban areas: Brent, Hammersmith 
and Fulham, and the inner city areas of Nottingham and Sheffield (Weaver et al. 
2004). The study found that 44 per cent of the 400 individuals surveyed who were 
in contact with Community Mental Health Teams reported problem drug use 
and/or alcohol use in the last year, and that 74.5 per cent of the 353 clients 
surveyed who were in contact with drug services had experienced a psychiatric 
disorder in the last year. 
• Keene (2005) studied the comorbid population of a health authority area in 
England.  She found that the proportion of clients from mental health services 
who are in contact with drug agencies (1.7%) is notably higher than the 
proportion of the general population who are in contact with drug agencies 
(0.2%). A similar pattern was found for drug agency clients in contact with mental 
health services (see Table 22). 
                                                
119 All deaths assessed had been supervised by the Police Complaints Authority. 
120 This refers to the Comorbidity of Substance Misuse and Mental Illness Collaborative 
Study. 
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Table 20: The number and percentage of clients of drug services or mental health services 
being treated by mental health services or drug services respectively compared to the general 
population in a county in England  
 Mental health 
services clients 
Drug agency 
clients Total population 
Number in contact 
with a drug agency 331 N/A 1,206 
Percentage in 
contact with a drug 
agency  
1.7% N/A 0.2% 
Number in contact 
with mental health 
services 
N/A 331 19,029 
Percentage in 
contact with mental 
health services 
N/A 27% 3% 
Total population 19,029 1,206 646,239 
Source: Keene (2005). 
6.5 Other drug-related health correlates and consequences 
6.5.1 Somatic comorbidity (as abscesses, sepses, endocarditis, dental health etc.) 
See 6.3.5 for information on injecting site infections or reactions. 
 
Research by Neale (2004b)121 in Scotland suggested that, based on self report, drug 
users health was consistently worse than the general population on entry into 
treatment (based on perceptions of, for example, physical and social functioning, role 
limitation due to physical and emotional problems, mental health, energy and general 
health). 
6.5.2 Non-fatal drug emergencies 
Neale and Robertson (2005)122 noted that of the 793 primary heroin users entering 
treatment in 2000/01 in Scotland, 11.5% (91) reported taking at least one overdose. 
6.5.3 Driving and other accidents 
Neale (2004c) considered the prevalence of drug driving among drug users entering 
treatment.  Ninety-five (16.2%) of the 585 new drug treatment clients in Scotland who 
completed the questionnaire had driven whilst under the influence of drugs in the 
previous 90 days.   
6.5.4 Pregnancies and children born to drug users  
Data on maternities involving maternal drug use are an underestimate of the actual 
situation; however, figures are available for England and Scotland. In England, 
hospital episode statistics show that in 2003/04, there were 495 foetus and newborn 
affected by maternal drug use or drug addiction and 3,148 neonatal withdrawal 
symptoms from maternal use of drug addiction (DH 2005a).  
                                                
121 This is part of DORIS.  The research used the results from the Health Status 
Questionnaire completed by a sample of the UK general population (see Jenkinson et al. 
1993) to compare perceptions of health with 990 individuals who were starting a new 
treatment episode.  
122 This study was part of DORIS. 
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In Scotland, the latest information is for 2002/03 and suggests that there were 334 
maternities involving maternal drug use (6.7 per thousand maternities), compared to 
241 in 2001/02 (4.8 per thousand) (ISD 2005b).  Just under 140 drug using mothers 
were aged between 20 and 29 years old (see Table 21).  Opioids were the most 
common drug recorded (see Table 22). 
Table 21: Number of maternities recording drug use in Scotland in 2002/03 by age (the 
mothers’ age at the point of delivery) 
Age Number 
Under 20 years 26 
20-24 years 120 
25-29 years 119 
30-34 years 49 
35-39 years 18 
40-44 years <5 
45 years and over 0 
Source: Information Services Division (2005b). 
Table 22: Number of maternities recording drug use in Scotland in 2001/02 and 2002/03 by 
drug 
Drug 2001/02 2002/03 
Opioids 148 187 
Cannabinoids 8 13 
Sedatives/hypnotics 17 22 
Cocaine 0 <5 
Other stimulants (including caffeine) <5 0 
Hallucinogens <5 <5 
Volatile solvents <5 <5 
Multiple/others 82 116 
Total 241 334 
Source: Information Services Division (2005b). 
 
 
 
 
 
 
 80
UNITED KINGDOM FOCAL POINT REPORT 2005 
7. Responses to health correlates and consequences 
7.1 Overview 
Drug-related deaths (DRDs), infectious diseases, comorbidity and other health 
consequences are key policy issues within the UK Drug Strategy (DSD 2002a). 
7.1.1 Drug related death  
A Government target to reduce DRDs by 20 per cent by 2004 from an English 
baseline of 1,568 deaths was set in 1999.  A strategy for England and Wales was 
published in 2001.  This was accompanied by guidance for both generic and 
specialist services, and a range of materials and training for drug users123 (DH 
2001a).
7.1.2 Drug related infectious disease 
In the 1980s, UK drug policy was led by a public health approach aimed at containing 
HIV transmission (this was led by the Department of Health).  The subsequent action 
is regarded as having been successful in containing HIV amongst injecting drug 
users (IDUs) by harm reduction approaches such as providing free needles and 
syringes, and promoting the safe disposal of used equipment (Stimson 1995; 
McVeigh et al. 2003).  Other actions to reduce infection include: information 
campaigns on safer sex and safer injecting; and HIV/AIDS, hepatitis B (HBV) and C 
(HCV) counselling, support and testing.  The Hepatitis C Action Plan for England was 
developed in 2004, prioritising prevention of infection and disease progression (DH 
2004f). Treatment for infectious diseases is provided as part of the National Health 
Service (NHS), including the provision of anti-retroviral treatment for HIV and HCV (in 
2004, NICE developed guidelines for this).  Treatment for wound infections is 
available through primary care, Accident and Emergency (A&E) departments, and in 
some areas, through needle exchange schemes and specialist drug services.  Those 
in prison have access to HIV and hepatitis testing, and vaccination against HBV. 
7.1.3 Psychiatric comorbidity (dual diagnosis) 
Because of the need to provide services for problem drug users with mental health 
problems, standards for their care were agreed in 2001 (HAS 2001), and guidance 
on good practice (DH 2002c) and the provision of services (DH 2002a) were 
developed in England.  The Department of Health (DH 2002a) highlighted the need 
for generic mental health services to work in partnership with other agencies, such as 
drug services.  Local Implementation Teams (LITs) implement the policy 
requirements described in the guidance, and work in partnership with Drug (and 
Alcohol) Action Teams (D(A)ATs). 
7.1.4 Other health correlates and consequences 
Maternity services are expected to provide appropriate facilities for the needs of 
pregnant women drug users and their babies, although the approach is inconsistent 
across the country.  The Advisory Council on Misuse of Drugs (ACMD 2003) has 
highlighted concerns, and guidance has been issued locally (for example, NHS 
Borders 2004).  
                                                
123 See http://www.nta.nhs.uk/programme/drd3.htm.  
 81
UNITED KINGDOM FOCAL POINT REPORT 2005 
7.2 Prevention of drug-related deaths 
7.2.1 Overdose prevention  
In late 2004, further guidance on preventing DRDs was provided for A&E staff in 
hospitals (NTA 2004b) and for telephone helplines (NTA 2004c).  
National Programme on Substance Abuse Deaths  
In April 2004, the Department of Health (DH) provided funding for three years to the 
National Programme on Substance Abuse Deaths (np-SAD) so that it can supply 
accurate and timely information on DRDs in England and Wales.  Data suppliers in 
the Isle of Man, Guernsey and Jersey also contribute.   
National Investigation into Drug-Related Deaths  
An action plan for Scotland based on the Scottish Advisory Committee on Drug 
Misuse (SACDM 2005) recommendations will be published in 2005. Until then, the 
Scottish Executive (2005e) is aiming to reduce the number of DRDs by:  
• funding a First Aid project to train drug users, their families/friends and service 
providers; 
• raising awareness through the First Aid project, a DVD and a Know the Score 
campaign; and  
• funding the Royal College of General Practitioners to train General Practitioners, 
nurses and pharmacists on drug use management. 
7.2.2 Safer use training  
See above. 
7.2.3 First aid training  
See above. 
7.2.4 Consumption rooms 
There are no plans to provide consumption rooms in the UK.  
7.2.5 Antagonists 
A consultation by the Medicines and Health Care Products Regulation Agency 
(MHRA 2004) on the proposal to add Naloxone to the range of prescription only 
medicines that can be administered in an emergency (enabling ambulance 
technicians as well as paramedics to administer it) showed that it was widely 
supported (MHRA 2005).   
7.2.6 Volatile substances  
The DH (2005b), with the Home Office and the Department for Education and Skills 
(DfES), has published a framework for Volatile Substance Abuse (VSA) outlining the 
key priorities: 
• Providing effective VSA education to all children and young people. 
• Providing effective targeted interventions for all those abusing or at risk of abusing 
volatile substances. 
• Reducing the availability and accessibility of volatile substances. 
• Strengthening the ability of parents, carers and practitioners to identify and work 
effectively with those who are abusing or at risk of abusing volatile substances. 
• Increasing the evidence base with regard to what works in the prevention of VSA. 
 
In Scotland in 2005, policy was revised to allow test purchasing of age-restricted 
goods by those under 18 years old (Scottish Executive 2005f).  A campaign to raise 
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awareness among shop workers of the law around the sale of butane gas lighter 
refills and other solvents to children was rolled out in March 2005 (Scottish Executive 
2005c).  The Scottish Executive is currently looking at the scope for action on VSA 
under their Know the Score Communication Strategy.   
7.3 Prevention and treatment of drug-related infectious diseases  
7.3.1 Prevention 
The publication of the Hepatitis C Action Plan for England (DH 2004f) was referred to 
in last year’s report, as was Department of Health’s funding of €1.5 million (£1 
million) in 2003/2004 to the National Treatment Agency for Substance Misuse (NTA) 
for local projects connected with increasing HCV testing of IDUs.  Further funding 
has since been made available, €74,400 (£50,000) in 2004/2005 and €119,000 
(£80,000) in 2005/2006, for work in this area and a national audit of needle exchange 
schemes. 
 
Northern Ireland has launched an Action Plan for reducing HCV (DHSSPSNI 2004).  
This Action Plan specifically targets IDUs through: 
• an information campaign aimed at IDUs on blood borne viruses; 
• training for drug workers to enable them to raise awareness of such viruses; 
• development of guidelines for drug workers; 
• publication of a leaflet to inform drug workers 
 
The Scottish Executive (2005d) launched a consultation on a proposed HCV Action 
Plan for Scotland in 2004.  It will aim to reduce incidence among IDUs through 
actions such as: 
• revising the current guidelines (see DH et al. 1999); 
• providing improved training for GPs and health professionals; 
• raising awareness of hepatitis among IDUs and potential IDUs; 
• reducing the sharing of injecting equipment through targeted interventions; and 
• developing interventions to target potential IDUs to resist injecting. 
 
In autumn 2004, a publicity campaign was instigated to raise awareness by 
addressing how to avoid the risk of infection, together with testing and treatment.  In 
addition, national standards for commissioning, delivery and monitoring of the syringe 
exchange services are being established (NTA, internal communication).  
National syringe exchange audit 
A UK wide audit of syringe exchange began in autumn 2004 to investigate in detail 
the nature of service provision. The overall aims of the audit are:  
• to investigate the extent and nature of provision of needle exchange and wider 
harm reduction facilities; 
• to assess data reporting systems; and  
• to investigate issues relating to the delivery, commissioning and planning of 
needle exchange and harm reduction and blood borne virus prevention services. 
 
The programme incorporated research and consultation with commissioners, service 
managers, syringe exchange co-ordinators, practitioners and service users, utilising 
questionnaires, qualitative interviews and focus groups. 
 
Interim findings suggest that: 
• there is needle exchange provision in all English D(A)ATs (pharmacy and non-
pharmacy outlets). Usually both pharmacy and non-pharmacy services are 
available; 
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• the majority of non-pharmacy needle exchange services are located within wider 
drug treatment services, with a minority of services 'dedicated' to needle 
exchange only;  
• more than half of non-pharmacy facilities exchange syringes in more than one 
way/setting (e.g. from the agency and through outreach); 
• despite notable exceptions the commissioning of needle exchange services by 
D(A)AT commissioning groups has to be strengthened; 
• data collection by services is much stronger than data management by D(A)ATs; 
• there are wide variations between services, D(A)ATs and Regions. This includes 
variations in:  
number of clients and level of contact with clients;  
paraphernalia distribution;  
blood borne virus prevention measures available on site in the agency 
(including HCV and HBV antibody testing and hepatitis B immunisation); and 
policies on needle distribution and return.  
 
Provision of syringes in Police stations – Scotland  
Prisoners are to be given free needles upon their release from custody by the Police 
in the Lothian and Borders region in Scotland (Edwards 2005). It is hoped that by 
doing this, prisoners will be more willing to surrender any used needles, so protecting 
Police Officers from injury by hidden needles during searches.  
Research  
The uptake of hepatitis B vaccination 
Whilst the prevalence of oral fluid antibodies to hepatitis B core antigen (a marker of 
current or past infection) remains stable among IDUs in England, Wales and 
Northern Ireland, the Unlinked Anonymous Prevalence Monitoring Programme 
(UAPMP) agency survey’s (see Section 6.3.1) participants showed that the 
proportion reporting uptake of the HBV vaccine more than doubled from 25 per cent 
in 1998 to 56 per cent in 2004 (Health Protection Agency 2005a).  Of those reporting 
vaccination, 55 per cent reported receiving three or more doses.  A similar trend can 
be seen in Scotland, where a survey of community-recruited IDUs who had injected 
for 5 years or less in Glasgow showed an increase in reported HBV vaccinations 
from 16 per cent (of 166) in 1993 to 52 per cent (of 387) in 2001/02 (Hutchinson et al. 
2004).  During 2004, a further increase in HBV vaccine uptake was detected among 
this group to 65 per cent.  These results, together with the decreasing number of 
laboratory reports of HBV diagnoses among IDUs, indicate that the prison and 
targeted community vaccination programmes have had a major impact on 
vaccination uptake among IDUs. 
Distribution of needles and syringes 
Taylor et al. (2005b) have evaluated the Lord Advocate’s124' guidance on the 
distribution of sterile needles and syringes to IDUs in Scotland (Taylor et al. 2005b).  
This guidance, published in 2002, increased the number that could be distributed125. 
However, the study found that over a year later and after a targeted campaign, only 
                                                
124 The Lord Advocate is the main Law Officer of the Crown in Scotland, and is the legal and 
constitutional adviser to the Government. For more details, please see 
http://www.scotland.gov.uk/deleted/library/documents/lord-adv.htm.  
125 The number of needles and syringes that could be distributed was increased to a 
maximum of 20 sets for new clients (previously 5), 60 for any following visits (previously 15) 
and 120 in exceptional circumstances (previously 30).  For details of the guidance, please see 
http://www.show.scot.nhs.uk/sehd/mels/hdl2002_90.pdf.  
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27 per cent of the 296 IDUs surveyed in Glasgow were aware of the change (this 
figure remained constant both before and after an awareness campaign).   
Foresight 
The Department of Trade and Industry (DTI) is managing a series of projects under 
the umbrella of Foresight126.  One of these projects is addressing infectious disease 
and aims to develop a long-term vision for the detection and identification of such 
diseases. A second project is addressing addiction and drugs, and how scientific 
developments may influence our understanding of these in the future. 
7.3.2 Counselling and testing 
Data on the uptake of HIV testing can be found in Section 6.3.1.   
 
The Hepatitis C Action Plan for England aims to increase the proportion of IDUs that 
are aware of their infection through improved uptake of voluntary confidential testing 
(DH 2004f).  It sets a national standard of good practice that all those attending drug 
treatment services should be offered hepatitis C testing routinely.  In 2004, although 
most of the IDUs who participated in the UAPMP agency survey127 reported having 
taken an HCV test, 33 per cent of IDUs (n=2,351) reported that they had never had 
one (compared to 51% of 2,998 participating IDUs in 2000) (Health Protection 
Agency 2005a).  Of the 945 who were infected, 49 per cent were unaware of their 
infection, compared to 60 per cent in 2000 (n=2,998).  In 2003/04 in Wales, 54 per 
cent of the 91 UAPMP participants reported not having taken a test, and in Northern 
Ireland, 23 per cent had not done so (n=37). 
7.3.3 Infectious disease treatment  
In 2004, in England, Northern Ireland and Wales, 40,265 patients were seen for 
statutory medical HIV care (Health Protection Agency 2005b). Of these, 2.4 per cent 
(974) were infected through injecting drug use. This can be compared to 969 (2.7% 
of 35,428) in 2003 (Health Protection Agency 2004c). 
7.4 Interventions related to psychiatric comorbidity 
In July 2005, the Government outlined plans for the Mental Health Bill, which will 
reform mental health legislation (DH 2004g). It will prohibit clinicians from 
compulsorily treating individuals whose sole mental disorder is alcohol or drugs 
dependency.  
Cannabis and mental health 
The ACMD will examine the evidence on cannabis and its association with mental 
health published since the reclassification (see Section 1.1).  The review will be 
completed in November 2005. 
Research  
The Centre for Addiction Research and Education will assess existing service 
provision in Scotland for those with co-existing mental health problems and drug 
use128.  This will be completed in late summer 2005. 
                                                
126 For more details, please see http://www.foresight.gov.uk. Foresight has been developed 
through several phases or rounds, whereby each round (lasting approximately four or five 
years) concentrates on a number of topics.  The latest round (commencing in 2002) is 
addressing public health topics such as obesity and infectious diseases. 
127 See Chapters 6.3.1 and 6.3.2 for more details on this. 
128 Please see http://www.dundee.ac.uk/psychiatry/res_addictions/_CurRes_000.htm for more 
information. 
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7.5. Interventions related to other health correlates and consequences 
7.5.1 Somatic co-morbidity 
NO NEW INFORMATION  
7.5.2 Non-fatal emergencies and general health-related treatment  
NO NEW INFORMATION 
7.5.3 Prevention and reduction of driving accidents related to drug use 
The Drug Drive website129 was relaunched to raise awareness of the effects of drugs 
and how they can affect driving.  It is aimed at 17 to 30 year olds. 
 
In Scotland, leaflets providing information about Police powers with regard to drug 
driving and the penalties faced by offenders are distributed by Police forces to 
licensed premises and local drug action groups. 
7.5.4 Other health consequences reduction activities  
Care of drug users in acute hospitals 
In Scotland, the Effective Interventions Unit (EIU 2005a) has produced guidance on 
the care of people with drug problems in acute hospital settings.  It aims to assist 
practitioners, managers and commissioners in reviewing how they design, record and 
deliver screening and assessment services to people with drug problems. 
7.6 Interventions concerning pregnancies and children born to drug users 
Following the ACMD’s (2003) report examining the situation faced by children of drug 
using parents, the Government published its response to the recommendations given 
in the report (DfES 2005; see Table 23). 
Table 23: The Government’s response to the Hidden Harm report 
Advisory Council on the Misuse 
of Drugs’ recommendation 
Responding 
body 
Response 
Problem drug/alcohol use by 
pregnant women should be 
recorded by antenatal clinic. These 
data should be linked to those on 
stillbirths, congenital abnormalities 
in the newborn, and subsequent 
developmental abnormalities in the 
child. Epidemiological studies 
would then be able to examine the 
links between the two. 
Department 
of Health  
The pregnant woman often holds the primary 
antenatal record during her care (DfES 2005). 
This will be established as the preferred way of 
record keeping and so that there is a single 
dataset. The preferred content is shown by the 
Perinatal Institute’s Antenatal Record, whose 
data items would meet the recommendation.  
                                                
129 Please see http://www.drugdrive.co.uk. 
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Advisory Council on the Misuse 
of Drugs’ recommendation 
Responding 
body 
Response 
The Department of Health and the 
devolved administrations should 
ensure that all maternity units and 
social service teams record 
problem drug/alcohol use by 
parents or a pregnant mother 
(whilst respecting confidentiality 
but enabling assessment of the 
family and evaluation of the 
services). 
Department 
of Health 
The National Service Framework notes the 
importance of adequate service provision for 
pregnant drug users and their partners (DH and 
DfES 2004). An integrated multidisciplinary and 
multi-agency team should provide their care 
(this should include a midwife and/or 
obstetrician with specialist drug knowledge).  
Collecting data enables effective planning and 
evaluation of all maternity services, including 
drug use services. Assimilating the antenatal 
record into the health record at birth enables 
this data to be analysed whilst respecting 
confidentiality. This will be supported by the 
National Health Service Care Records Service. 
Every maternity unit must provide 
an accessible and non-
judgemental service, offering high 
quality care to minimise the effects 
of maternal drug use.  Evidence-
based protocols should address 
the clinical management of drug 
use during pregnancy and 
neonatal withdrawals. 
Department 
of Health 
The National Service Framework establishes 
standards of care for antenatal, delivery and 
postnatal services (DH and DfES 2004). It 
assesses how maternity services can improve 
their flexibility, accessibility and 
appropriateness.   
Pregnant drug users should be 
routinely tested (with informed 
consent) for HIV, hepatitis B and 
hepatitis C, and appropriate 
clinical management should be 
provided for all babies. 
Department 
of Health 
Guidance in the Hepatitis C Action Plan for 
England discusses antenatal services as a 
chance to test pregnant women at increased 
risk of hepatitis C (DH 2004f).  National Health 
Service policy offers HIV and hepatitis B 
antenatal screening so appropriate measures 
can be taken.  The UK National Screening 
Committee advises not to have routine 
antenatal hepatitis C screening as current 
evidence does not support its use.  
Primary care teams offering 
services for drug users should 
ensure that their chlidren’s well-
being is being met, in partnership 
with the school health service, 
children and family teams and 
other services. Primary Care 
Trusts or the equivalent in the 
administrations must have clear 
arrangements for ensuring that 
these children benefit fully from the 
appropriate services. 
Department 
for Education 
and Skills, 
and 
Department 
of Health 
Primary Care Trusts assess and commission 
services to meet their population’s health 
needs.  Children of drug/alcohol users should 
be identified within their needs assessments 
and appropriate services should then be 
commissioned. The National Service 
Framework (DH and DfES 2004) establishes 
standards for health and social care services 
for children, young people and pregnant 
women.  
Training on problem drug use 
management by primary care staff 
should include information about 
the importance of identifying and 
meeting the health needs of the 
children of problem drug users. 
Department 
of Health 
The Royal College of General Practitioners 
delivers training through the Management of 
Drug Misuse in Primary Care programme, 
which includes the needs of children whose 
parents are problem drug users. They have 
also run special interest classes on pregnancy 
and drug use, and on young people and drugs. 
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Advisory Council on the Misuse 
of Drugs’ recommendation 
Responding 
body 
Response 
All education services and schools 
should have plans for liaison with 
social services teams and child 
protection committees if there are 
concerns about the impact of 
parental problem drug/alcohol use 
on the child(ren). 
Department 
for Education 
and Skills 
The Education Act 2002 strengthens 
arrangements for safeguarding children. New 
guidance was published in 2004 (DfES 2004c). 
It clarified specific roles of those in Local 
Education Authorities and schools.  Those 
providing day care for children aged under 
eight years old must comply with national 
standards under the Children Act 1989, which 
include requirements relating to child 
protection. Guidance has also been published 
on discovering that a child is being abused (DH 
et al. 2003). 
All women’s prisons be able to 
allow pregnant drug users to 
receive antenatal care and 
treatment of drug dependence of 
an equal standard to that in the 
community 
Home Office Further improvements are needed cfES 
2005b). This will occur as part of the 
partnership with the National Health Service. 
Until then, the Prison Service aims to keep 
pregnant drug users in remand prisons which 
have medical links with the National Health 
Service.. 
Source: Advisory Council for the Misuse of Drugs (ACMD 2003); Department for Education 
and Skills (DfES 2004c); Department for Education and Skills (DfES 2005); Department of 
Health (DH 2004f); Department of Health and Department for Education and Skills (DH and 
DfES 2004); Department of Health et al. (DH et al. 2003). 
Hidden Harms – the response from Northern Ireland 
In Northern Ireland, a draft strategy for children and young people completed its 
consultation period in February 2005 (DfES 2005). This strategy will aim to co-
ordinate, monitor and promote children’s services and rights within Government, 
including those children whose parents are drug users. 
Hidden Harms – the Scottish Executive’s response 
Prior to the UK response, the Scottish Executive (2004b) had published its own full 
and separate response document in October 2004. This document demonstrated that 
there was a good deal of action underway to develop services and to apply good 
practice in response to the needs of this client group.  The report acknowledged, 
however, that there was still much more to be done.  This has been followed up with 
a Scotland-wide consultation process to agree priorities for taking the agenda 
forward.  An Action Plan is to be published in spring 2006. 
 
In Scotland the Effective Interventions Unit published guidance on problem drug use 
in pregnancy and reproductive health (EIU 2005b).  
Hidden Harms – the Welsh Assembly Government’s response 
The Welsh Assembly Government Advisory Panel on Substance Misuse presented a 
framework for action for progressing work on the recommendations to the Cabinet of 
the Welsh Assembly Government (2005).  The Cabinet has approved the paper and 
agreed that the Cabinet Sub Committee for Children and Young People should 
consider the cost of its implementation before referring the matter back to Cabinet.  
This is now underway. 
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8. Social Correlates and Consequences 
8.1 Overview 
8.1.1 Social exclusion 
The social correlates and consequences associated with problem drug use include 
street homelessness (Randall and DrugScope 2002); begging (Jowett et al. 2001); 
selling sex on the street (Hester and Westmarland 2004); unemployment (Klee at al. 
2002); and the lack of educational achievement, truancy and school exclusion 
(Goulden and Sondhi 2001; Boreham and McManus 2003).  Drug problems can be 
the most serious where social exclusion is acute, and where people do not have the 
resources to manage drug problems (DSD 2002a).  
8.1.2 Drug-related crime  
Drug use per se is not a crime in the UK; possession, dealing and trafficking are 
under the Misuse Act of Drugs Act 1971.  The number found guilty of drug offences 
has continued to rise (the number of known drug offenders has risen from 82,890 in 
1994 to 110,400 in 2002), although the number of heroin offenders appears to have 
stabilised (remaining at approximately 10,000 to 11,000 since 1998) (Mwenda and 
Kumari 2005). Changes in the classification of cannabis to Class C (see Section 
1.1.1) and the anticipated increased Police concentration on offences for Class A 
drugs may influence these figures (Home Affairs Committee 2001).  
8.1.3 Drug use in prison 
Between one half and two thirds of those in custody are reported to be problematic 
drug users (HM Prison Service 2004b; ISD 2005b), the proportion is lower in 
Northern Ireland (House of Commons Northern Ireland Affairs Committee 2003). 
8.1.4 Other social correlates and consequences 
Drug use can give rise to dangers associated with safety in the workplace and 
productivity (DSD 2004c).  However, the full nature and extent of the problem is 
unknown in the UK.  In addition, inappropriate disposal of certain items of used drug 
paraphernalia (such as needles or syringes) can cause distress to communities 
(Burgess 2004). 
8.1.5 Social costs 
Latest cost estimates are based on the study by Godfrey et al. (2002) and are for 
2000.  They estimated that drugs cost UK society between €16.5 and €29.8 billion 
(£11.1 and £20 billion) a year. 
8.2 Social Exclusion  
8.2.1 Homelessness 
In 2004/05, various data were published showing the association between 
homelessness and drug use: 
• Fountain et al. (2004) surveyed 389 rough sleepers in London.  Eighty-three per 
cent of them had used a drug in the last month and 80 per cent were dependent 
on their main drug of use (including alcohol).  
• The Scottish Drug Misuse Database indicates that of those entering treatment in 
2003/04, 12 per cent (of the 11,757 for whom information is available) were in 
temporary or unstable accommodation and two per cent were roofless (ISD 
2005b).   
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• In Northern Ireland, Deloitte MCS Ltd (2004) showed that 54 per cent of the 154 
homeless people interviewed were current drug users.   
 
In 2004, the Office for the Deputy Prime Minister (ODPM 2004) published a policy 
briefing on addressing the needs of the homeless.  It emphasised the need for joint 
working and highlights examples of good practice in local projects (for example, the 
Clock Tower Surgery in Exeter or the Handel Street Centre in Nottingham – see 
ODPM 2004). 
8.2.2 Unemployment  
Eighty-five per cent of those accessing treatment services (of the 11,627 for whom 
information is available) in Scotland reported being unemployed in 2003/04, and 73 
per cent had been unemployed for one year or longer, or had never been employed 
(ISD 2005b) 
 
As part of DORIS (see Section 5.2.6), Kemp and Neale (2005) found that just four 
per cent of their sample of individuals in treatment were in legal paid employment at 
the time of their research (13% in the previous 6 months)130.  This low level of 
employment could be because drug users face barriers in finding employment 
including poor health, inebriation, withdrawal symptoms, lack of concentration and 
punctuality, and homelessness (20% of those in the study were homeless).  
8.2.3 School Drop out  
In the last year, several studies were published that highlight the association between 
truancy or exclusion and drug use in young people: 
• Market and Opinion Research International (MORI 2004)131 found that of 19 per 
cent of excluded young people in a sample in England and Wales reported 
lifetime use of a Class A drug (compared to 4% of young people in school).  
Fifteen per cent reported lifetime ecstasy use and 10 per cent cocaine use 
(compared to 3% and 2% respectively for school children).   
• Twenty per cent of 15 year olds participating in the school survey in Scotland 
reported lifetime use of any illegal drug (n=3,453) (Corbett et al. 2005).  Of these, 
78 per cent had truanted in the current school year (compared to 34% of those 
who had never used drugs).  Also, it noted that 30 per cent of 15 year olds who 
had reported drug use in the last month had been excluded (compared to 7% of 
those who had never used drugs).  
• The Edinburgh Study of Youth Transitions and Crime132 found that in the third 
year of secondary school, 52 per cent of the 1,729 pupils reporting truancy133 
also reported lifetime drug use, compared to 16 per cent of non-truants (McAra 
2004).  They were also more likely to be involved in the sale of drugs (14% 
compared to 2%).  While the prevalence of exclusion was relatively low (7% or 
247) for third year pupils, such pupils did report a significantly higher prevalence 
of drug use (57% compared to 31% for non-excluded pupils).  They were also 
more likely to have sold drugs (although the numbers are very small).  
                                                
130 From a sample of 1,033 drug users starting a new drug treatment episode. 
131 They conducted two studies. The first was with 4,417 school pupils aged 11 to 16 years 
old. A second survey was conducted with 687 young people aged between 11 and 17 years 
of age who have been excluded from mainstream school. 
132 The study follows a single year group of approximately 4,300 young people who started 
secondary school in Edinburgh in 1998.  The researchers plan to interview them on their lives 
every year until they reach 30 years old. See: http://www.law.ed.ac.uk/cls/esytc/. 
133 This refers to those who had truanted in the previous school year. 
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8.2.4 Financial problems 
The Drugs Strategy Directorate (DSD 2004d) suggests that drug agencies should 
integrate money and debt work into their services so that clients are less reliant on 
begging.   
8.2.5 The effect of substance abuse on the family 
Research into the experiences of young people (aged 15 to 27 years old) affected by 
parental drug and/or alcohol use found that all of the 38 young people involved, 
despite the variety of their experiences, found ways to deal with their difficulties, 
showing resilience and the ability to adapt (Bancroft et al. 2004). 
 
Research on the impact on parents and siblings of drug users (Barnard 2005)134 
found that families reported stress, conflict and anxiety as a consequence of trying to 
protect the family member from drug-related harms, and to limit the damage arising 
from their behaviour towards the rest of the family. 
 
In Scotland, the Substance Misuse Research Team have commissioned a scoping 
study on parental drug use to examine the impact of parental drug use, families’ 
needs, how these needs are being met and details of best practice135.  
 
In addition, Mentor UK (2005) launched an intervention in January 2004 to support 
grandparents who are raising grandchildren seen to be at risk of drug use. They aim 
to identify the information and services that grandparents and their grandchildren 
need; and to develop a training pack, resource pack and support group. 
8.3 Drug related crime  
8.3.1 Drug offences  
Overall, the number of people found guilty, cautioned or dealt with by compounding 
for drug offences in England, Scotland and Wales increased by 14 per cent between 
2000 and 2003 (from 102,196 to 116,429) (Mwenda 2005).  So, for example, the 
number of individuals dealt with for unlawful production has increased by 41 per cent 
overall (from 2,028 to 2,865) and the number dealt with for unlawful possession has 
increased by 14 per cent (from 91,479 to 104,336) (see Figure 7 and Appendix 4).  
However, other offences have shown overall decreases, despite the figures 
fluctuating in the given period.  The number of individuals dealt with for permitting 
premises to be used unlawfully has decreased by 14 per cent (from 558 to 479) and 
the number for unlawful import or export of illegal drugs has decreased by nine per 
cent (from 1,292 to 1,173). 
                                                
134 The research took place in Greater Glasgow and involved qualitative interviews with 24 
problem drug users, 20 parents and 20 younger siblings. Where possible, these were 
members of the same family. Additionally, 10 interviews were carried out with practitioners 
whose area of work was directly or indirectly concerned with problem drug users and their 
families.  
135 For more information, please see http://194.83.73.129/research/cr/eoi-
substancemisusingparents.cfm.  
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Figure 7: Number of people found guilty, cautioned or dealt with by compounding for drug 
offences in England, Scotland and Wales from 2000 to 2003 by offence 
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In 2003, 87,706 people were found guilty, cautioned or dealt with by compounding for 
cannabis-related offences in England, Scotland and Wales (see Figure 8).  In 
comparison, only 90 were dealt with for LSD-related offences. 
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Figure 8: Number of people found guilty, cautioned or dealt with by compounding for drug 
offences in England, Scotland and Wales in 2003, by drug 
448 90
11,847
6,230 8,165 8,165
2,370
87,706
6,313
570
0
20,000
40,000
60,000
80,000
100,000
M
et
ha
do
ne
LS
D
H
er
oi
n
E
cs
ta
sy
-ty
pe
C
oc
ai
ne
C
oc
ai
ne
C
ra
ck
 
C
an
na
bi
s
Am
ph
et
am
in
es
An
ab
ol
ic
 s
te
ro
id
s
Illegal drug
Number of 
people found 
guilty, 
cautioned or 
dealt with by 
compounding 
for drug 
offences
  
Source: Mwenda (2005). 
 
The National Treatment Outcome Research Study (NTORS) highlighted that just 
over 1,000 drug users reported committing 27,000 acquisitive and 40,000 drug 
supply offences in the 90 days prior to starting treatment (Gossop 2005b).  However, 
not all of the individuals were involved in such acts (less than one third reported 
supplying drugs).  
 
The British Transport Police136 reported a 31 per cent increase in drug offences from 
2003/04 to 2004/05 (from 2,451 to 3,211).  
8.3.2 Other drug-related crime 
More than 63,000 drug tests for heroin, crack and cocaine were carried out amongst 
offenders charged with a trigger offence137 in 2004/05 (an average of 5,250 per 
                                                
136 The British Transport Police are the national police force for the railways in England, 
Scotland and Wales (including the London Underground and a number of local transport 
systems, as well as railway property such as car parks).  Please see http://www.btp.police.uk/ 
for more information. 
137 These are defined as: theft, attempted theft, robbery, attempted robbery, burglary; 
attempted burglary, aggravated burglary, deception, attempted deception, handling stolen 
goods, attempted handling stolen goods, taken without consent, aggravated taken without 
consent, going equipped, begging, persistent begging, production of specified Class A drugs, 
supply of specified Class A drugs, and possession of specified Class A drugs. 
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month) (Home Office 2005e).  From these tests, and as part of the Drug Interventions 
Programme (DIP; see Section 9.3.3), over 1.900 offenders entered treatment. 
Prostitution  
Sex and drug markets are seen as interconnected, so much so that when a Police 
operation focusing on the crack market arrested 118 prostitutes, many were referred 
to drug treatment services (Home Office 2004d).  Between 1985 and 2002, the 
number convicted for prostitution offences138 decreased by 73 per cent (from 10,193 
to 2,717) in England and Wales.  
Prescription offences 
The Medicines and Healthcare products Regulatory Agency (MHRA) prosecutes 
those cases brought forward under medicines legislation.  In 2004, four cases were 
successfully prosecuted with penalties given ranging from a fine to five years’ 
imprisonment139. 
Driving offences 
In 2003, approximately 105,700 people were dealt with by official Police action 
because of offences relating to ‘driving etc. after consuming alcohol or taking drugs’ 
in England and Wales (Fiti et al. 2003).  This represents an decrease of 2,700 
compared to 1996, but an increase of 3,600 compared to 2002. 
Violence under the influence  
In the British Crime Survey, Nicholas et al. (2005) asked those respondents who 
reported being the victims of violent crime in England and Wales in 2004/05140, if 
they perceived that the offender had been under the influence of drugs.  Those who 
reported being the victim of a violent crime were the most likely to report the 
perception that the offender had been under the influence of drugs (see Table 24). 
Table 24: Violent crime victims in the British Crime Survey 2004/05 and their perceptions of 
the offender involved 
Offence 
Participants who reported 
being the victim of a 
violent crime (%) 
Violent crime victims 
who perceived that their 
offender had been under 
the influence of drugs 
(%) 
Acquaintance violence 1.2 22 
Domestic violence 0.5 11 
Mugging 0.7 25 
Stranger violence 1.4 14 
Source: Nicholas et al. (2005). 
Drug Related Litter 
In the UK, littering is a crime and is subject to a maximum fine of €3,700 (£2,500) 
under the Environment Protection Act 1990.  It is also a nuisance and can be a public 
health issue (for example, if needles or syringes are abandoned).  Hauck (2004) has 
                                                
138 Procuring, soliciting and brothel-keeping. 
139 For more information, please see  
http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&useSecondary=true&ssDo
cName=CON009782.  
140 The British Crime Survey carried out 45,120 interviews with adults aged 16 years old and 
over.  Overall 3.6 per cent of the participants reported having been the victim of a violent 
crime (this includes domestic violence, mugging, stranger violence and acquaintance 
violence). 
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explored public attitudes towards drug-related litter.  Findings and recommendations 
include: 
• drug litter is seen as a symptom of more serious drug problems; 
• there is a lack of faith in the ability of the authorities to act and public services 
need to be seen to be taking action; 
• apathy can be a barrier and prevent the public from reporting drug litter; 
• safety concerns can motivate the public to report drug litter, particularly relating to 
abandoned needles or syringes; and 
• public information should be hard hitting to provoke action, with clear simple 
messages about what action to take. 
8.4 Drug use in prisons  
England and Wales 
Sixty-six per cent of respondents in a survey of prisoners reported drug use in the 
month before coming into prison (Singleton et al. 2005a)141.  Use of drugs while in 
custody was reported by 25 per cent of respondents.  Sixteen per cent reported drug 
use in the last week, an estimate which correlates with the results of the Mandatory 
Drug Tests (MDT).  In England and Wales in 2003/04, 11.6 per cent of these proved 
positive.  This is a reduction from the previous year (12.3%) (HM Prison Service 
2005).  (Please see Section 9.3.1 for more details on Mandatory and Voluntary Drug 
Tests.) 
 
Payne-James et al. (1994, 2005) compared populations in Police custody in London 
in 1992 and 2003.  They noted that patterns of drug use amongst this population 
have changed considerably with, for example in 2003, 87 per cent of the participants 
reporting crack cocaine use compared to 30 per cent in 1992 (see Table 25).  
Table 25: Drug use amongst Police custody populations in London in 1992 and 2003 
 1992 2003 
Crack cocaine use 30 87 
Heroin use 77 73 
Injecting drug use 72 56 
Use of a shared 
needle 41.6 25 
Sample size 150 115 
Source: Payne-James et al. (1994); Payne-James et al. (2005). 
Scotland  
In Scotland, 55 per cent reported having ever used an illegal drug whilst in prison 
(SPS 2004)142.  Cannabis is the drug that is most likely reported to have been used 
in the last month whilst in prison (see Table 26).  Five per cent reported injecting in 
the last month, and of these 69 per cent reported sharing injecting equipment in the 
last month143.  
                                                
141 Singleton et al. (2005) surveyed 2,270 prisoners across England and Wales aged 16 years 
old and over. 
142 6,189 prisoners were surveyed, 4,793 responded.   
143 These figures have not been verified by the Scottish Prison Service. 
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Table 26: Percentage prevalence of drug use in the last month whilst in prison in Scotland in 
2004 
Drug used  Percentage 
Amphetamines  6 
Ecstasy  12 
Benzodiazepines (e.g. valium, ativan)  36 
Cannabis  78 
Cocaine  14 
Methadone (not on prescription)  13 
Heroin  63 
Temazepam  12 
Other opiates (e.g. Temgesic, Dihydrocodeine)  26 
Source: Scottish Prison Service (SPS 2004)144. 
8.5 Social Costs 
York University has been contracted to update the cost model of Class A drugs 
published in 2002 (Godfrey et al. 2002).  This is expected to provide updated and 
improved estimates of drug use, as well as simulations of changes. An online report 
is due in autumn 2005. 
                                                
144 Data provided by the SPS has not yet been verified. 
 96
UNITED KINGDOM FOCAL POINT REPORT 2005 
9. Responses to Social Correlates and Consequences 
9.1 Overview 
9.1.2 Social Reintegration 
Social reintegration is a key element of the national Drug Strategy (DSD 2002a) and 
responsibility for responding to the social correlates and consequences discussed in 
Chapter 8 rests with a number of Government departments and agencies, for 
example: 
• Government departments are responsible for key areas of social reintegration, 
such as the Department for Education and Skills (DfES);   
• the Neighbourhood Renewal Unit is developing the overall National Strategy for 
Neighbourhood Renewal (Social Exclusion Unit 2001);  
• the National Treatment Agency for Substance Misuse (NTA) supports elements 
of social reintegration, for example through residential treatment and counselling; 
• the Homelessness Directorate, set up in 2002, coordinates policy nationally 
(DTLR 2002) and is working with the NTA to build treatment services that 
respond to the needs of the homeless (Randall and DrugScope 2002).  
Homelessness issues are also addressed in the UK Drug Strategy and the 
Strategy on Rough Sleepers; and  
• in Scotland, the Homelessness Task Force is aiming to improve interventions for 
drug users. 
 
Various projects have been established, such as: 
• progress2work (p2w), initiated in 2002, supports those who are drug free or 
stabilised, but whose history of drug use can be a significant factor in preventing 
them from getting or keeping a job.  Led by the Department of Work and 
Pensions (DWP), it is a cross Government initiative and has representatives from 
the Home Office, Her Majesty’s (HM) Prison Service, NTA, Welsh Assembly and 
Scottish Executive; 
• the Building Safer Communities Fund aims to build communities that are resistant 
to drugs; and 
• social inclusion programmes such as Positive Futures can bridge the gap 
between universal and targeted services (see Section 3.3.2). 
 
The Social Exclusion Unit (established in 1997) and the Drug (and Alcohol) Action 
Teams (D(A)AT)s are coordinating the responses. 
 
In Scotland, each D(A)AT reports annually in its Corporate Action Plan and plans to 
help recovering drug users enter education, skills training and employment. In 
Scotland, also, local D(A)ATs inform the multi-agency Homelessness Strategy of 
each Local Authority and the Homelessness and Health Action Plan of each Health 
Board concerning measures to include people with drug problems. 
9.1.2 Prevention of drug related crime 
The Drug Interventions Programme (DIP)145 was established in England and Wales 
in 2003 to reduce drug-related crime.  It is a major initiative designed not only to 
ensure offending problem drug users access treatment services, but also related 
services concerned with for example housing and employment etc. to assist 
reintegration.  Schemes based on similar principles have been established elsewhere 
in the UK.   
                                                
145 Previously known as the Criminal Justice Intervention Programme. 
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9.1.3 Drug use in prison 
Drug strategies have existed in prison services for a number of years (SPS 2000; 
NIPS 2003; HM Prison Service 2004c).  These seek to prevent drug use in custody 
and help drug users become drug free.   
 
The main focus of treatment in prison has been on abstinence.  The programmes 
available include: intensive drug treatment programmes (such as cognitive-
behavioural treatment, 12-Step and Therapeutic Communities or TCs); a high 
intensity Short Duration Drug Treatment Programme (SDP) for those imprisoned for 
a short time; and counselling, assessment, referral, advice and throughcare services 
(CARATS).  Maintenance treatment has been introduced in a few prisons and there 
are a number of harm reduction measures, including vaccination for hepatitis.  
However, needle and syringe exchange services are not available.  
9.1.4 Other responses to social correlates and consequences 
There is a range of public services (from street cleansing to needle exchange 
schemes) that tackle inappropriate disposal of drug paraphernalia.  A cross-
government working group is dealing with the impact of drug-related litter on 
communities and it feeds into the Cleaner Safer Greener Communities 
programme146. 
9.2 Social Reintegration 
Involving local communities  
Research by Shiner et al. (2004) aimed to identify community responses to drug-
related problems and to consider what influenced their success or failure147.  They 
concluded that the community element of the Drug Strategy should be reconsidered.  
Community is mostly limited to education or prevention, support for users and carers, 
and campaigning.  There is little evidence of involvement in strategic decision-
making.  Instead, community engagement should address, for example, housing 
allocation, employment and transport policies; the effects of poverty and relative 
disadvantage; and the influence of economic, social and geographic isolation. 
 
The Scottish Executive’s (2004c) Criminal Justice Plan emphasises the need to 
protect and support communities through, for example, community wardens, 
increased Police funding, the Anti-Social Behaviour etc. (Scotland) Act (2004)148 and 
Community Safety Partnerships. 
Change for Children 
The Children Act 2004 forms the legislative background on which Government aims 
to ensure that young people are better equipped to resist drugs.  Every Child Matters: 
Change for Children sets out the national framework for local change programmes to 
build services around needs of children and young people (HM Government 2004 – 
see Section 3.3.2).   
Targeted interventions with vulnerable young people 
See Section 3.3.2 for more details. 
                                                
146 For more information see http://www.cleanersafergreener.gov.uk.  
147 A survey was administered to 155 people from 34 Drug (and Alcohol) Action Team areas 
in England and Wales.  Most respondents had some kind of professional involvement in the 
drug and alcohol fields.  Case studies were also used. 
148 This is similar to the Anti-Social Behaviour Act introduced in 2003 (see UK Focal Point 
Report for 2004, Chapter 13 for details). 
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9.2.1 Housing 
The Office of the Deputy Prime Minister (OPDM 2005) has published a new strategy 
on homelessness.  It noted that in 2004/05, under the Supporting People Programme 
in England149, approximately €525.32 million (£353 million) was used to support 
17,000 families, 47,000 single people (who have experienced homelessness or are 
at risk of it), and 1,600 former rough sleepers.  A further €148.8 million (£100 million) 
is providing housing-related support to those who are at risk of homelessness (such 
as victims of domestic violence and people with drug or alcohol problems). 
 
In addition, the ODPM and Drugs Strategy Directorate (DSD) have published 
guidance for Supporting People Commissioners on meeting the housing needs of 
drug users (ODPM and DSD 2005).  It suggested that appropriate and sustainable 
housing is the first step for the successful rehabilitation of drug users, and is 
necessary to sustain employment, drug treatment, family support and finances.  This 
is particularly important for those leaving prison and residential rehabilitation.  
Specific guidance to meet the housing needs of DIP clients has also been published 
(DSD et al. 2004). 
 
In 2003/04, Supporting People in Scotland provided housing support for 3,500 people 
with drug or alcohol problems (Scottish Executive, internal communication).  In 
addition, 19,000 people who had been homeless or sleeping rough were also helped 
to lead more stable lives and maintain tenancies (Scottish Executive 2005g). 
Accommodation for young people with drug use problems  
In Wales, €4.5 million (£3 million) per annum has been allocated from 2004/05 
onwards to help provide accommodation for young people with drug use problems 
(Welsh Assembly Government, internal communication).  
Begging  
The Home Office has published guidance to support the development of services that 
successfully engage and sustain contact with drug users who beg (Davies and Waite 
2004). 
9.2.2 Education and training 
In 2004, the final year of Scottish Enterprise’s New Futures Fund150, €8.9 million (£6 
million) per annum supported 72 projects of which 23 were drug services engaging 
some 2,000 drug users in confidence building, education, training and employment 
(Scottish Executive, internal communication).   
 
For the period 2003-07, the Big Lottery, in partnership with local D(A)ATs, has 
invested €14.9 million (£10 million) to fund 60 specialist drug projects across 
Scotland with one of the key aims being to support recovering drug users access 
education, training and employment151. 
9.2.3 Employment 
The third and final phase of p2w was rolled out to all districts in England, Scotland 
and Wales in 2004.  The Jobcentre Plus service suggests that by March 2005, 
20,350 individuals had approached p2w.  In total, 4,022 individuals (20%) had 
                                                
149 Please see Chapter 9.2.1 of 2004’s UK Focal Point Report for more details. 
150 For more information please see  
http://www.scottish-enterprise.com/sedotcom_home/stp/extra-
support/newfuturesfund1.htm?siblingtoggle=0.  
151 Please see http://www.nof.org.uk/default.aspx?tc=57&tct=2&fc=250&fct=1 for further 
details. 
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obtained jobs and of these, 1,215 (30%) had remained in work (Jobcentre Plus, 
internal communication). 
 
In Scotland, the Scottish Centre for Healthy Working Lives152 has been established 
with a remit that extends to the implementation and development of drug policies 
across the Scottish business community (Scottish Executive 2005h). This will include 
co-ordinating and supporting activities that encourage employers to offer employment 
opportunities to reforming drug users. 
 
For further information regarding Scotland, please see Section 9.2.2. 
9.2.4. Basic social assistance  
Advocacy for drug users 
The Effective Interventions Unit (EIU 2004f) has published guidance to help D(A)ATs 
and local partners examine how advocacy could be included in the development of 
Integrated Care. 
9.3 Prevention of Drug-Related Crime 
9.3.1 Assistance to drug users in prison  
In England and Wales, the National Offender Management Service (NOMS) was 
created in 2004.  It aims to tackle the needs of problem drug users and reduce harm 
caused to themselves and others by integrating the work of the Prison Service and 
the Probation Service to enable end-to-end management of the offender (NOMS 
2005).  It will design interventions that aim to reduce re-offending.  
 
CARATs is expected to engage with 47,000 drug users in custody in England and 
Wales in 2004/05 (HM Prison Service and National Probation Service 2004), but had 
already engaged with 53,396 by February 2005, two months prior to the end of the 
financial year. 
 
Research Development and Statistics-National Offender Management Service (RDS-
NOMS) is monitoring the profile of prisoners accessing CARATS, and will provide 
information for the Prison Service and D(A)ATs.  Findings will be available in the 
autumn of 2005.  
Harm reduction 
Disinfecting tablets are being introduced in prisons in England and Wales to enable 
shared needles to be disinfected before use (NOMS 2005). 
Treatment  
To improve prisoners’ health services, the responsibility of these services in England 
is being transferred to local Primary Care Trusts (PCTs) (DH 2005c).  By April 2005, 
86 prisons had completed this transfer. In Wales, the prisons are developing their 
partnerships with the local health boards.   
 
In 2003/04, 7,119 drug users began treatment programmes in prison in England and 
Wales, 64.6 per cent were completed (4,600) (HM Prison Service 2005). 
 
Short duration drug treatment programme: SDP, a high intensity programme, has 
been introduced to cater for the drug needs of those offenders who are serving short 
                                                
152 For more information see http://www.healthscotland.com.  
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sentences (Joint Committee on Human Rights 2005).  In March 2005, 24 SDPs were 
running and the programme will be rolled out across England and Wales.  
 
Clinical Services: In 2004/05 in England and Wales, prison health care services 
expected to provide clinical services for 27,000 drug users, but actually provided 
services for 49,197.  The Prison Service in England and Wales aimed to provide 
6,500 rehabilitation places by the end of 2004/05, and had provided for 6,110 by 
February 2005. In total, 4,124 completed the programme. 
 
Various research projects have been published in 2004/05 or are ongoing, including: 
• Neale and Saville (2004) compared the effectiveness of community-based drug 
treatments with those based in prisons in Scotland, as part of DORIS153. They 
found that the clients attending the former showed increased levels of 
employment and decreased levels of drug use. 
• The Home Office RDS division is undertaking a pilot survey assessing prisoners' 
problems and needs on reception. The results of the main study are expected in 
late 2005. 
• In Wales, the Transitional Support Scheme (Mentoring Service) will support those 
prisoners who have been discharged after serving less than 12 months and who 
have an acknowledged problem with drugs or other substance154.  It is hoped that 
this will prevent drug-related deaths, and assist in finding employment and 
education. 
• A report on throughcare and aftercare approaches was published in 2005 (Fox et 
al. 2005). It highlighted that individuals need to be assessed as soon as possible 
after they enter custody or rehabilitation, that collaboration is needed between the 
different agencies involved, and that it is important to maintain contact with 
individuals after they are released. 
• In Scotland, the Interim Care Scheme is used to manage the transition between 
prison and the community155.  Its evaluation found that 28 per cent of ex-
prisoners had met with their Transitional Care worker at least once since their 
release (EIU 2004g). 
Prevention 
Supply reduction: In England and Wales, NOMS (2005) highlights the need for 
measures such as: CCTV surveillance of all visits areas; low-level fixed furniture in 
visit areas to obstruct drug smuggling; sanctions to tackle visitors who attempt to 
smuggle drugs (such as visit bans or Police arrest); Mandatory Drug Testing (MDT); 
close working with Police to block supply; and perimeter and physical security to 
prevent drugs coming in over the wall.  In Northern Ireland, passive drug dogs are 
being used, for example, to monitor drug smuggling when prisoners return from 
home leave (NIPS 2005).  
 
Mandatory drug testing: In 2003/04, HM Prison Service for England and Wales aimed 
to reduce the proportion of positive results from MDT to 10 per cent.  Although the 
proportion has continued to decrease (by 50 per cent in comparison to five years 
                                                
153 They surveyed 487 clients of community-based drug treatment agencies and 229 clients of 
prison-based drug treatment agencies. 
154 For more information, please see http://www.wales.gov.uk/subicsu/content/substance/sub-
misuse-team-e.htm.  
155 Transitional Care was introduced in 2001 to support those in prison for less than four years 
and remand prisoners with a drug use problem.  In total, 158 survey interviews and 37 in-
depth interviews were conducted with ex-prisoners around 4 months after their release.  In 
addition, 177 ex-prisoners who had been released seven months earlier completed 
questionnaires.  
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previously), the target has still not been met with 11.6 per cent of results being 
positive in 2004/05 (HM Prison Service 2005).  In comparison, the Scottish Prison 
Service (SPS 2005) reported 18 per cent of MDT tests were positive (against a target 
of 15%)156.  The SPS’s (2004) prison survey showed that over four in five prisoners 
(85%) who report using drugs in prison indicated a change in their drug use while in 
prison157.  Of these, 73 per cent reported a decrease in their drug use and 17 per 
cent reported an increase.  Research into the impact and effectiveness of MDT 
(Singleton et al. 2005)158 suggests that about 16 per cent of prisoners reported using 
drugs in the week before interview.  Cannabis and opiates (usually heroin) were the 
drugs most commonly used.  The research concluded that MDT results generally 
underestimate the level of drug use as reported by prisoners, but that the current 
numbers of random tests are sufficient to track annual changes in drug use in 
prisons. 
 
Voluntary drug testing: With a target of 28,000 Voluntary Drug Testing (VDT) 
compacts, 32,907 were made by February 2005 in England and Wales. VDT was 
introduced in 2004 in Northern Ireland.  From August 2004 to March 2005, 3,652 
tests were performed (NIPS 2005).  However, the results are not yet available. 
 
Two notable research projects that are ongoing are:  
• RDS-NOMS are undertaking research into the prison drugs supply/markets 
study.  Publication is expected in September 2005.  
• In Scotland, research is being conducted on the impact of offending 
behaviour programmes, methadone maintenance in prison, and drugs 
pathways and progression (SPS 2005). 
9.3.2 Alternatives to prison for drug users 
In the UK, if an offence is seen as warranting a custodial sentence, the offender will 
enter custody.  However, sanctions such as the Drug Treatment and Testing Orders 
can be used where appropriate (DTTOs) (see Section 9.3.3).   
9.3.3 Other interventions for prevention of drug related crime 
Drug Interventions Programme 
The DIP, which was discussed in last year’s report (see Section 12.2.1) now covers 
all of England and €245.5 million (£165 million) will be invested into it in 2005/06159.  
This is on top of the additional funding for treatment through the Pooled Treatment 
Budget and funding for additional measures, such as the increased target for 
commencing DTTOs (Home Office, internal communication).  In addition, work is 
underway to increase and develop the workforce to meet future demands.  
 
In February 2005 alone over 1,800 offenders from DIP intensive areas entered 
treatment.  Waiting times for treatment in the ‘intensive’ DIP areas have fallen 
significantly over the past year.  
 
The extension of trigger offences160 (to include handling stolen goods, attempted 
                                                
156 These figures have not been verified by the Scottish Prison Service. 
157 These figures have not been verified by the Scottish Prison Service. 
158 A survey of over 2,000 prisoners was carried out in 2001–2002 by the Office for National 
Statistics and other data were also analysed. 
159 Please see http://www.drugs.gov.uk/drug-interventions-programme/ for further details. 
160 These now are defined as: theft, attempted theft, robbery, attempted robbery, burglary; 
attempted burglary, aggravated burglary, deception, attempted deception, handling stolen 
goods, attempted handling stolen goods, taken without consent, aggravated taken without 
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acquisitive crime and begging) became operational in July 2004, expanding the 
scope of DIP. 
 
Interventions within the criminal justice system  
 
Drug testing on arrest: New measures in the Drugs Act 2005 will give Police the 
power to test for drugs on arrest rather than charge. This means that more people 
can be directed into treatment earlier. The Act will also require those testing positive 
for Class A drugs to have an assessment with a suitably qualified person, and that 
they attend a follow-up assessment if appropriate.   
 
Drug Testing on Charge: Drug Testing on Charge is now fully operational in 97 
“intensive” DIP Basic Command Units (BCUs) and in over 170 custody suites across 
22 Police forces (see Section 8.2).  
 
Restriction on bail: Restriction on bail (RoB) provision was originally implemented in 
May 2004 with pilots in Nottingham, Salford and Manchester (Hucklesby et al. 2005).  
It has given new powers to courts to order assessment and drug treatment as 
conditions of bail.  In April 2005, RoB was expanded to a further 33 D(A)AT (47 areas 
in total).  Since the start of the programme, 720 people have received RoB conditions 
in the three original sites.  In January alone, over 300 people received RoB 
conditions.  Ninety-one per cent of defendants were recommended some form of 
treatment at assessment and 76 per cent of defendants were attending assessment 
in March 2005.  Very few have been remanded in custody for breaching conditions.   
 
Conditional Cautioning: Conditional cautioning has begun in five out of six early 
implementation areas in England and Wales.  For the first time, this allows conditions 
to be attached to a caution given to adult offenders as part of the Criminal Justice Act 
2003, including a requirement to attend a drug rehabilitation programme (Home 
Office 2004e).  Failure to comply with conditions may result in the offender being 
charged with the original offence.  
 
Prolific and Priority Offenders: Prolific and other Priority Offenders (PPOs) schemes 
were launched in England and Wales in September 2004 (Home Office 2005e).  DIP 
plays a key role in addressing their drug-related treatment and support needs as in 
many areas up to 85 per cent of identified PPOs are problem drug users.  Guidance 
to support effective working partnerships between Criminal Justice Intervention 
Teams and PPO schemes has been issued161 and additional DIP funding (of just 
over €2.2 million or £1.5million) has been allocated across 12 D(A)AT areas to 
enable them to develop these partnerships intensively.  Their work will be evaluated 
and findings will inform future plans.  
 
Drug Treatment and Testing Orders: In total, 8,514 DTTO (DTTOs) were made in 
2003/04, against target of 9,000.  However, over 9,000 DTTOs were made between 
April 2004 and January 2005.  Research shows that offenders completing DTTOs 
have significantly lower levels of reconviction: 53 per cent of the 49 who had 
completed their DTTO were reconvicted within two years compared to those whose 
orders were revoked (91% of 108) (Hough et al. 2003).  
 
                                                                                                                                         
consent, going equipped, begging, persistent begging, production of specified Class A drugs, 
supply of specified Class A drugs, and possession of specified Class A drugs. 
161 See http://www.crimereduction.gov.uk/ppominisite05.htm for details of guidance that have 
been issued. 
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Drug Interventions Programme - throughcare and aftercare: Case management and 
aftercare services were made available across England and Wales during 2004/05.  
Phased implementation of throughcare and aftercare will continue in 2004/05 with 
€81.9 million (£55 million) being made available to D(A)ATs partnerships.  All 
D(A)ATs in England can make and receive referrals to and from all prisons.  
Nineteen out of 22 D(A)ATs are now involved in Phase II and 17 of the non-intensive 
D(A)ATs.  Twenty-four hour, 7 days a week client phone support is available in all 
Phase 1 areas except London.  
Scotland 
Following an evaluation of DTTOs in Scotland (Eley et al. 2002), they are now 
available nationally.  
 
Arrest referral schemes are now available in six areas of Scotland funded on a pilot 
basis by the Scottish Executive; the Scottish Executive views Arrest Referral as 
being potentially a crucial part of the overall strategy for tackling the drugs problem in 
Scotland162.   
Wales 
In Wales, the Turnabout Project aims to support young people, aged 14 to 19, who 
are engaged in significant drug use and who offend back into mainstream education 
and training.  Young people involved demonstrated a considerable increase in their 
ability to control their anger, deal with disappointment and express emotion on 
leaving the project compared to when they first joined.  On project completion, 80 per 
cent of the young people immediately entered work, full time education, training or 
work-experience.  The project will receive €1.8 million (£1.2 million) over three years.  
Research 
Key findings from recent research shows:  
• Household acquisitive crime as reported to the British Crime Survey decreased 
by 53 per cent between 1995 and 2003/04 (Nicholas et al. 2005). 
• Gossop (2005b) reviewed four national drug treatment outcome studies 
examining treatment and crime (see Section 5.2.6). 
 
The Home Office has also recently commissioned several studies including: 
• a linking study (between the National Treatment Outcome Research Study or 
NTORS and the Offenders Index) to examine whether the reductions in rates of 
crime reported by the NTORS cohort are reflected in reduced levels of conviction 
following treatment entry. 
• a systematic review of drugs-crime literature to examine the links between drug 
use and offending, and the effectiveness of interventions to break these links. 
• an analysis of data sources to develop drug-related crime trajectories and to 
produce sub-national estimates of drug-related crime.  
Other interventions for the prevention of drug related crime  
Young People  
Ten D(A)AT areas in England are piloting youth-centred models of Arrest Referral for 
those aged 10 to 17 years old163.  In addition, 22 custody suites based within these 
                                                
162 For more details, please see  
http://www.scotland.gov.uk/Topics/Justice/criminal/16928/7127.  
163 Further details can be accessed through http://www.drugs.gov.uk/drug-interventions-
programme/strategy/children-yp/.  
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D(A)ATs began piloting drug testing on charge for 14 to 17 year olds charged with 
those crimes that are most often linked to drugs.   
 
Matrix Research and Consultancy’s (2005) preliminary findings from its evaluation of 
DIP services for young people has highlighted several key issues as important for its 
ongoing development including: 
• being clear about objectives sought; 
• having the capacity to fulfil objectives; and  
• consideration of how to co-ordinate with other agencies. 
9.4 Other responses to social consequences 
Drug related litter 
Burgess (2004) notes that the Home Office is taking action on drug-related litter in 
the form of: 
• educating drug users about drug-related litter; 
• improving collection, cleaning and reporting; 
• helping needle exchanges to minimise drug-related litter; 
• educating the general public. 
 
Pilot projects in the south west of England have led to guidance being published 
(DEFRA 2005).   
Drug Misuse in the workplace  
The Home Office (2005f) has issued an updated Training Pack on Substance Misuse 
and the Workplace. 
Drug driving 
Following the changes in 2003 to the Road Traffic Act 1998 (which enabled the 
Police to perform three preliminary drug tests to establish whether a driver is under 
the influence of drugs), a new Code of Practice was introduced in 2004 detailing the 
tests that can be administered (DfT 2004).  Campaigns have also been run in 2005 to 
raise awareness of the effects of drugs on driving164 (DOE 2004). 
 
                                                
164 For more information, please see  
http://www.srsc.org.uk/publicity/drug_driving/drug_driving_2005.asp and 
http://www.dft.gov.uk/stellent/groups/dft_rdsafety/documents/page/dft_rdsafety_039950.hcsp.  
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10. Drug markets 
10.1 Overview 
10.1.1 Importation and distribution routes 
Information from the National Criminal Intelligence Service (NCIS 2005a) suggests 
that it remains difficult to provide reliable information about the availability and supply 
of drugs.  Quantities can only be inferred from the data available (for example on 
seizures, other law enforcement interventions or treatment figures) and so the exact 
relationship between supply and demand remains unclear.   
 
Widespread poly-drug use and the convergence of various drug trades in countries 
such as the Netherlands or Spain provides an incentive for traffickers to engage in 
multi-drug trafficking (NCIS 2005a).  However, the largest importers of heroin and 
cocaine tend to concentrate on a single commodity.  These drugs then enter the UK 
market through a variety of different routes (see Table 27).  
Table 27: Importation routes of some illegal drugs entering the United Kingdom 
Drug Origin Importation route Major regional hub Further details 
Cocaine Mainly Columbia, Peru and Bolivia. 
Shipped across the Atlantic to 
the Iberian Peninsula, the 
Netherlands or increasingly to 
Central and Eastern Europe.  
Shipments are concealed in 
heavy goods vehicles and routed 
overland to the Channel and 
North Sea ports.  It is also 
smuggled into the UK by air 
couriers and by post, direct from 
South and Central America, and 
from the Caribbean. 
London in 
particular but 
also 
Birmingham, 
Bristol and 
Merseyside 
Many of those 
involved also 
import and 
distribute other 
drugs, as well as 
cigarettes. 
Crack 
cocaine 
It was thought that 
it was produced in 
the UK in small 
street-level 
quantities but there 
is now intelligence 
that it is being 
imported from the 
West Indies. 
Evidence suggests the 
involvement of British 
Caucasians, West Africans and 
South Asians working both 
independently and 
collaboratively. 
In particular 
Birmingham, 
Liverpool, 
London and 
Wolverhampton 
but also Bristol, 
Nottingham and 
Leeds. 
Intelligence 
indicates that the 
UK crack trade is 
becoming 
complex and 
dynamic, and that 
crack is often 
sold with heroin.   
Ecstasy-
type 
substances 
Eighty per cent of 
MDMA distributed 
internationally is 
produced in the 
Netherlands and 
Belgium but some 
ecstasy and other 
synthetic drugs are 
produced in the 
UK. 
Ecstasy enters the UK market 
through the ferry ports, airports 
and the Channel Tunnel. 
Birmingham, 
Bristol, London, 
Manchester, 
and 
Merseyside. 
Ecstasy is 
exported to 
Australia, 
Malaysia, South 
Africa and 
locations popular 
with British 
clubbers e.g. 
Ibiza. 
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Drug Origin Importation route Major regional hub Further details 
Heroin 
Mainly Afghanistan 
and the ‘Golden 
Triangle’. 
Much arrives via Northern 
Cyprus and Turkey into the UK 
through ports in the South East 
of England, in freight and 
passenger vehicles.  The 
Channel Tunnel and air couriers 
are also used. 
East London in 
particular but 
also 
Birmingham, 
Bristol, 
Merseyside, 
Glasgow. 
Crack is often 
sold with heroin. 
Source: National Criminal Intelligence Service (NCIS 2003; 2005a). 
Cocaine 
British criminals are significantly involved both in the importation and distribution of 
cocaine (NCIS 2005a).   
Crack cocaine 
The crack trade involves West Indian groups, British Caucasians, West Africans, and 
South Asians who work both independently and collaboratively (NCIS 2005a).  West 
African groups, mainly based in the South East of England, appear to play an 
increasingly important role in the supply of both cocaine and crack.  There is 
evidence of crack being distributed at a wholesale level, although this is in small 
amounts.  
Ecstasy-type substances 
British Caucasian groups mainly control distribution in the UK.  Ecstasy-type 
substances are distributed to groups or individuals operating regionally or locally who 
also supply other drugs such as cocaine and cannabis resin.   
Heroin 
Turkish groups in the Netherlands, north Cyprus, and Turkey dominate the UK heroin 
trade with Turkish groups in the UK (although other groups are becoming more 
significant including British Caucasians and South Asians) (NCIS 2005a).  Albanians, 
Bulgarians, Macedonians, Kosovans, Romanians, Bosnians and Serbs are involved 
moving Turkish heroin through the Balkans but the extent of this involvement is not 
known.  The UK groups buy heroin in the UK on a large scale for distribution, and are 
increasingly involved in importing their own deliveries (sometimes with other drugs).   
 
Turkish groups based in London dominate distribution but other cities are also 
significant. For example, Merseyside is an important source for the North West of 
England, Scotland and Northern Ireland.  
10.1.2 Purity and price 
In general, the quantity of seizures have been rising in the UK. However seizures of 
LSD are falling165.  Overall, brown heroin has shown an increase in its mean purity 
whilst the mean purity of amphetamines, cocaine and brown heroin has fluctuated 
over the last few years166.  The mean price of ecstasy, heroin and cocaine have been 
falling since 1998 although prices of cannabis leaves and resin, amphetamines and 
crack have remained largely similar167. 
                                                
165 Information about seizures is provided by the Home Office Research and Statistics 
Directorate who collate figures provided by Customs and Excise, and the police.   
166 Information on the average purity at street level of certain drugs and the content of tablets 
is provided by the Forensic Science Service (FSS). 
167 Information on the average price of drugs is provided by the National Criminal Intelligence 
Service (NCIS). 
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10.1.3 Further details on the drug market 
The latest estimate of the value of the UK drug market is for 1998 (Bramley-Harker 
2001).  They suggested a total value of around €9.8 billion (£6.6 billion).  This 
estimate is being reconsidered in light of newly available data. 
 
Ease of access is often tied closely to patterns and levels of use, where the most 
commonly used drugs are usually also the most accessible (Condon and Smith 
2003). 
10.2 Availability of drugs (perceived availability/access in population, other 
indicators) 
The schools survey in England and Wales in 2004 asked pupils aged between 11 
and 15 years old whether they had been offered any drugs (NatCen/NFER 2005)168:  
It showed that: 
• thirty six per cent of pupils reported having been offered at least one drug during 
their lifetime (42% in 2003); 
• boys were more likely to have been offered drugs than girls (39% compared to 
34%); 
• cannabis was the most common drug that pupils reported having ever been 
offered (25%); and 
• in 2004, 14 per cent of pupils reported ever being offered volatile substances. 
 
In Scotland, pupils aged 13 and 15 were also asked about accessing drugs (Corbett 
et al. 2005).  Forty-six per cent of 13 year olds and 28 per cent of 15 year olds did not 
know where they could access drugs.  Of the remaining pupils 31 per cent of 13 year 
olds and 58 per cent of 15 year olds felt it would be easy or fairly easy. 
10.2.1 Production, sources of supply and trafficking patterns within countries as well 
as from and towards other countries 
Latest available information from the National Criminal Intelligence Service (NCIS 
2005a) suggests that Turkish groups in the Netherlands, North Cyprus and Turkey 
continue to dominate heroin importation.  With regards to crack cocaine, Colombian 
groups are becoming involved in production and wholesale supply.  
Disrupting local markets 
Operation Crackdown was launched in January 2005 and targeted local Class A drug 
markets (Home Office 2005b).  Thirty-two Police forces worked together to close 
drug dens, disrupt local drug markets, seize illegal firearms and convict drug 
suppliers.  At the end of the three month campaign, the Police forces had:  
• closed 170 crack houses;  
• seized over 100 kilograms of cocaine, 3 kilograms of crack cocaine, 100 
kilograms of heroin and over 86,000 ecstasy tablets;  
• charged 1,471 people with supplying class A drugs;  
• seized 483 firearms and 3,402 rounds of ammunition; and  
• seized €4.8 million (£3.2 million) in cash assets. 
Research  
The Home Office has commissioned several research studies examining the UK drug 
market: 
                                                
168 Just under 10,000 pupils in 313 schools across England completed questionnaires in the 
autumn term. 
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• an examination of rolling-quarterly estimates of the size of the markets for heroin, 
cocaine and crack using a consumption-based approach to be published in 
autumn 2005; 
• an examination of British South Asian drug trafficking groups aimed at 
understand drug dealing networks in these groups; and 
• a process, impact and economic evaluation of Merseyside Middle Market Drugs 
Unit (MMDU)169 is also being undertaken.  
10.3 Seizures 
Latest information on seizures in the UK is for England, Scotland and Wales for 2003 
(Home Office 2005d).  Data for Northern Ireland is unavailable (although it has 
accounted for a very small proportion of seizures in past years).  The available data 
show that in 2003, the total number of illegal drug seizures appears to have fallen 
overall since 2000 (by 13% from 136,150 to 117,962), although there were increases 
in 2001 and 2002.  The quantity of drugs seized has fluctuated since 2000, but 
overall has decreased (see Table 28).  
Table 28: Number of and quantities of illicit drugs seized by all law enforcement agencies in 
England, Scotland and Wales, 2000-2003 
2000 2001 2002 2003 
Drug Number Quantity (Kg) Number
Quantity 
(Kg) Number
Quantity 
(Kg) Number 
Quantity 
(Kg) 
Amphetamines 7,080 1,775 6,830 1,726 6,990 1,406 6,798 1,635 
Cannabis 93,750 73,861 96,460 85,747 102,390 79,188 78,520 99,773 
Cocaine 6,010 3,948 6,980 2,841 6,630 3,577 7,627 6,858 
Crack cocaine 2,770 26 3,690 56 4,260 58 4,810 252 
Ecstasy-type 
substances 9,790 
6,552,000 
(Kg 
tablets) 
10,410 
7,669,000 
(Kg 
tablets) 
8,300 
5,852,000 
(Kg 
tablets) 
7,246 
6,912,000 
(Kg 
tablets) 
Heroin 16,450 3,387 18,170 3,929 15,360 2,730 12,831 2,753 
LSD 300 25,000 doses 170 
36,000 
doses 50 
17,000 
doses 130 
29,000 
doses 
Source: Home Office (2005d). 
 
Data for individual drugs present a slightly different picture, as although most drugs 
follow a similar pattern to seizures overall (see Table 28), seizures for cocaine and 
crack cocaine having increased considerably (by 27% and 74% respectively since 
2000). 
10.4 Price/purity 
10.4.1 Price of drugs at street level 
Generally, in 2003, the average price of illegal drugs had decreased compared to 
2001, especially for cannabis resin, cocaine and LSD (see Table 29).  However, the 
levels shown are affected by the prevailing exchange rate. In Euros, it appears as 
                                                
169 Middle Market Dealers mainly operate above street dealers but below the level of 
importation into the UK, although some function at all three levels at different times.  They 
often supply more than one type of drug or often any other profitable illegal commodity 
(imported tobacco, human trafficking, firearms etc.).  
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though the price of heroin decreased between 2002 and 2003, but the price in 
Pounds showed that it in fact stayed the same at £61. However, the table shows that 
there were no increases in the price of any illegal drugs shown, whether in Euros or 
in Pounds. 
Table 29: The mean price of illegal drugs in euros in the United Kingdom, from 2001 to 2003 
2001 2002 2003 
Illegal drug 
Exchange rate: 
€1.57 = £1 
Exchange rate: 
€1.5 = £1 
Exchange rate: 
€1.42 = £1 
€14.13 €13.5 €12.78 Amphetamines £9 £9 £9 
€4.43 €4.39 €3.8 Cannabis herb £2.82 £2.93 £2.68 
€4.37 €4.13 €3.46 Cannabis resin £2.78 £2.75 £2.44 
€95.77 €87 €78.1 Cocaine £61 £58 £55 
€32.97 €31.5 €26.98 Crack (per rock) £21 £21 £19 
€10.99 €10.5 €7.1 Ecstasy-type 
substances (per 
tablet) £7 £7 £5 
€103.62 €91.5 €86.62 Heroin £66 £61 £61 
€6.25 €5.25 €4.26 LSD £3.98 £3.5 £3 
Source: National Crime Intelligence Service (NCIS 2005b). 
10.4.2 Mean purity of drugs at street level and composition of drugs/tablets 
Overall since 1998, the mean purity of illegal drugs (as shown in Table 30 and Figure 
9) has fallen.  However, for most, the mean purity has fluctuated considerably (for 
example, purity for cannabis resin has fluctuated between 2% and 18.1%), and for 
cannabis leaves and brown heroin, purity has increased. 
Table 30: Street level average percentage purity of illegal substances in England and Wales, 
1998 to 2004 
Illegal drug 1998 1999 2000 2001 2002 2003 2004 
Amphetamines 16.4 13.7 5 10.1 13.4 10.8 9 
Cannabis 
leaves 7.9 9.5 12 9.5 10.8 10.7 12.7 
Cannabis resin 7.3 2.6 18.1 7.4 2 9.8 3.4 
Cocaine 53.9 61.6 52.3 57.7 48.7 51.2 42.4 
Crack 81.7 80.2 65.9 72.8 70.3 69.6 63.8 
Heroin 37.3 43.3 46.9 49.2 40 32.7 39.9 
For cannabis products, the % THC content is shown; for other illicit drugs, the % of pure 
substance is shown. 
Source: Forensic Science Service (FSS 2005). 
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Figure 9: Street level average percentage purity of illegal substances in England and Wales, 
from 1998 to 2004 
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SUMMARY 
11. Gender differences 
Prevalence  
In the general population, men are more likely to use drugs than women, the 
differential increasing with age.  In 2003/04, lifetime use amongst adults was 3.4 per 
cent for males and 1.4 for females.  Males are also more likely to use drugs 
problematically, the ratio being approximately 3:1. 
Treatment  
The ratio of males to females in treatment services is approximately 3:1 and there 
are other differences including referral source, age at referral, drugs used and family 
circumstances. 
Infectious Diseases 
Prevalence of HIV and hepatitis C are similar, hepatitis B is lower among women.  
Crimes and arrests  
Female arrestees are significantly more likely to test positive for methadone and 
cocaine (including crack), amphetamines and benzodiazepines than males. 
Responses 
There are few gender specific responses; those which are tending to relate to gender 
specific issues such as sex work and pregnancy.  There are mother and baby units in 
a few drug services. 
12. European drug policies: extended beyond illicit drugs? 
Official endorsement by the National Drug Strategy  
Only in Wales does the strategy covers both drug and alcohol use. 
Genesis and rationale 
In Wales, the rational was that use of any substance results in similar physical, 
psychological and social problems, requiring similar responses.  
Responsibilities and competencies (Coordination) 
In Wales, responsibility lies with the Welsh Assembly Government and at the local 
level though local partnerships.  In the rest of the UK, Drug Action Teams 
increasingly tackle alcohol misuse as well as drugs.  In Northern Ireland there is a 
Drugs and Alcohol Co-ordinator responsible for both areas. 
 
In the rest of UK there are policies in to tackle alcohol and tobacco but they are 
outside the competency of the Drug Strategy Directorate. 
13. Developments in drug use within recreational settings 
New findings 
Routine population surveys indicate that people consume drugs in a number of 
recreational settings such as nightclubs, bars, pubs and music events.  Those who 
attend such events or venues are more likely to use drugs more frequently, in larger 
quantities, and to be poly-drug users.  However, levels and patterns of drug use can 
vary according to the venue, highest at established dance/gay clubs.  In addition, 
certain music styles are associated with the use of specific drugs.   
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New trends in available drugs 
There is evidence of increased use of 4-MTA (p-methylthioamphetamine or 4-
methylthioamphetamine), ketamine, magic mushrooms and methamphetamine.   
Responses, national policies and legal aspects  
Reponses to recreational drug use tend to follow a harm reduction or targeted 
prevention approach.  To address the safety of the venue as a physical environment 
(by tackling issues such as overcrowding and overheating), various guidelines have 
been produced for venue managers and promoters, Drug (and Alcohol) Action 
Teams, licensing officers and those providing outreach services.  The industry itself 
has also developed a Code of Practice for members of the Bar Entertainment and 
Dance Industry. 
 
All door supervisors at clubs, pubs and bars must have a Security Industry Authority 
Licence, under the Private Security Act 2001.  
National policies and legal developments to address drug use 
In 2003, GHB became a Class C controlled drug under the Misuse of Drugs Act 
1971. 
 
The Drugs Act 2005 clarified the legal position on magic mushrooms, making them a 
Class A drug, regardless of whether or not they have been prepared. 
 
The Advisory Council on the Misuse of Drugs Technical Committee has 
recommended that ketamine should be controlled as a Class C drug.  
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11. Gender differences 
11.1 Situation 
An analysis of gender differences should take account of issues such as societal 
construction of the terms man and woman; the different roles expected of them; and 
the different norms applied to them (Thom 2003).  However, much of the research 
and discussion in the United Kingdom tend to focus around the distinction of sex 
rather than gender. 
 
Notable differences exist between the situations of men compared to women 
regarding drugs.  More men use drugs, are problematic users, die from drug-related 
reasons, are arrested for drug-related offences, and more men enter treatment.  In 
comparison, female drug users are more likely to have: 
• a drug-using partner (Gilbert et al. 2000; Neale 2004a).  
• experienced domestic violence (Gilbert et al. 2000; Powis et al. 2000); 
• a history of abuse (Wallen and Berman 1992; Becker and Duffy 2002; Neale 
2004a); 
• low self esteem (Swift 1996); and 
• mental health needs (Becker and Duffy 2002). 
11.1.1 Prevalence amongst the general population and young people 
General prevalence 
Population prevalence surveys have highlighted that men report higher prevalence 
levels of drug use across all age groups and a variety of different drugs (see Figures 
10 and 11).  However, the percentage difference is variable.  For example, 54 per 
cent of male 25 to 34 year olds and 40.8 per cent of females reported using any 
illegal drug in their lifetime (13.2% difference).  This can be compared to 55 to 64 
year olds where 15.1 per cent of males and 10 per cent of females reported lifetime 
prevalence (5.1% difference).   
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Figure 10: Lifetime percentage prevalence of use of any illegal drug amongst 15 to 64 year 
olds in the United Kingdom by age 
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Data for England and Wales is for 16 to 59 year olds, 16 year olds and over for Scotland and 
15 to 64 year olds for Northern Ireland.  In England and Wales, data refer to 2003/04, in 
Northern Ireland the data are from 2002/03 and in Scotland, they are from 2003. 
Source: Chivite-Matthews et al. (2005); Hay (2005a); Home Office (2005d); National Advisory 
Committee on Drugs and Drugs and Alcohol Information Research Unit (NACD and DAIRU 
2005); Scottish Executive (2005a). 
 
Variations can also be seen when looking at drug type as, of those surveyed men 
report much higher lifetime use of magic mushrooms, cocaine (including crack) and 
LSD than women, but surveys show more similar levels between men and women for 
drugs such as sedatives and/ or tranquilisers (see Figure 11).  
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Figure 11: Lifetime percentage prevalence of use of any illegal drug amongst 16 to 64 year 
olds in the United Kingdom by drug 
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Data for England and Wales is for 16 to 59 year olds, 16 year olds and over for Scotland and 
15 to 64 year olds for Northern Ireland.  In England and Wales, data refer to 2003/04, in 
Northern Ireland the data are from 2002/03 and in Scotland, they are from 2003. 
Source: Chivite-Matthews et al. (2005); Hay (2005a); Home Office (2005d); National Advisory 
Committee on Drugs and Drugs and Alcohol Information Research Unit (NACD and DAIRU 
2005); Scottish Executive (2005a). 
 
Further studies have shown other gender differences of note: 
• Riley et al. (2001) noted that women used more drugs on average than men 
(female mean was 4.77, male mean was 3.72) in their study of 122 drug 
users at dance events in Scotland. 
• The Office for National Statistics (ONS 1999) surveyed prisoners in England 
and Wales and found that women’s use of and dependence on drugs was 
approximately level with that of men’s.  However, they were more likely to 
report opiate dependence, and reported less cannabis use. 
Prevalence among young people 
School surveys show that boys are only slightly more likely to report drug use than 
girls.  For example, 31 per cent of males aged 11 to 15 years old report illicit drug 
use during their lifetime compared to 30 per cent of females in England (Boreham 
and Blenkinsop 2004)170.  
 
Sweeting and West’s (2003) research in Glasgow171 shows that in 1987, young 
males were more likely to have tried an illicit drug (11%) than females (6.4%); 
however, by 1999, this gender difference had become less marked (42% males; 
38.5% females).  They partly attribute this to the constraints being lifted on young 
women’s lives enabling them to participate more fully in the public arena and in risk-
taking. 
                                                
170 This study had a sample size of approximately 10,000 pupils in England. 
171 They issued very similar questions to 1,009 15 year olds in Glasgow in 1987, and then in 
1999 to 2,196 15 year olds.  
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Prevalence of problematic drug use 
Hickman et al. (2004) used capture-recapture methods to estimate the prevalence of 
problematic drug use in three cities in England.  The ratio of male to female 
problematic drug use overall was approximately 2.7:1.  
 
In Scotland in 2003, 51,582 individuals were estimated to be misusing heroin and/or 
benzodiazepines.  Of these, 69 per cent are male and 31 per cent are female (Hay et 
al. 2004). 
11.1.2 Drug-related deaths 
Significantly more men have suffered drug-related deaths (DRDs) than women in the 
UK (see Figure 12)172.  The trends for male and female DRDs have followed a similar 
pattern since 1996, peaking in 2000 and decreasing since then. 
Figure 12 The number of drug-related deaths by gender in the United Kingdom using the 
European Drug Monitoring Centre for Drugs and Drug Addiction standard definition, 1996-
2003 
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Source: Health Statistics Quarterly, Numbers 5, 7, 9, 11, 13, 17, 21 & 25; ONS 2000, 2001, 
2002, 2003, 2004 & 2005. 
 
The mean age at death also shows gender differences: on average, men die from 
drug-related reasons at 34.2 years old, compared to 39.4 years for women.  Figure 
13 highlights that the differences are most pronounced for 20 to 49 year olds where 
male DRDs are substantially in the majority.  For those under 15 years, however, the 
figures are notably similar (33 males and 36 females), and for those over 65 years, 
more female DRDs occurred than male (17 males and 27 females).  However, 
caution is required when interpreting these data as numbers are relatively low and 
figures relating to the number of deaths as a percentage of all drug users are not 
available. 
                                                
172 This could be because men are more likely to use illicit drugs (see Chapter 11.1.1) and are 
more likely to be ‘at risk’ from associated harms (Thom 2003). 
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Figure 13 The number of drug-related deaths by age and gender, according to the European 
Monitoring Centre for Drugs and Drug Addiction standard definition in 2003 
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11.1.3 Treatment demand data 
The latest treatment data for the UK show that there are more men than women in 
treatment in the UK across different treatment settings (see Figure 14).  Men 
represented 70.3 per cent of all treatment episodes in the General Practitioner (GP) 
setting, 83.1 per cent in inpatient settings and 71.5 per cent in an outpatient setting in 
2003/04.  This ratio reflects the ratio of men to women estimated to be problem drug 
users (see Section 11.1.1).  The English data show that further gender differences 
are apparent in treatment modality (see Table 31).  Here, the ratio of men to women 
ranges from 2.3:1 for those in structured counselling to 2.7:1 for those in structured 
day care.  The lower proportions and numbers of women in inpatient settings, in 
residential rehabilitation and in structured counselling could be linked to the different 
situation that women experience.  For example, their family commitments (Stewart et 
al. 2002) could obstruct them from accessing treatment types that would require 
them to find substantial amounts of childcare (see Section 11.2.3).   
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Figure 14: Percentage and number of gendered treatment episodes in the United Kingdom by 
treatment setting in 2003/04 
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Data for General Practitioners and inpatient settings are for England and Scotland only. 
Source: National Drugs Evidence Centre, Information Services Division, Scotland; 
Department for Health Social Services and Public Safety Northern Ireland, Health Solutions 
Wales. 
 
Table 31 The number of drug users in treatment in England by treatment modality and gender 
in 2004/05 (provisional data) 
Treatment modality Number of male drug users 
Number of 
female drug 
users 
Ratio of men to 
women 
Inpatient detoxification 2,482 984 2.5:1 
Residential rehabilitation 3,000 1,148 2.6:1 
Special prescribing 42,725 17,567 2.4:1 
General Practitioner 
prescribing 14,882 5,804 2.6:1 
Structured counselling 27,557 11,971 2.3:1 
Structured day care 9,650 3,511 2.7:1 
Other interventions 16,525 6,359 2.6:1 
TOTAL  116,821 47,164 2.5:1 
Source: Best and Abdulrahim (2005). 
 
A number of other studies addressing gender in treatment have also been published: 
• Differences are apparent regarding referral source, with just under one third of all 
self-referrals, GP referrals and other referral sources being for women, whereas 
men make up almost three-quarters of all criminal justice referrals (Best and 
Abdulrahim 2005).  
• Women in treatment tend to be younger, have used drugs for a shorter length of 
time and have less delay in taking up treatment (Meier et al. 2000).  
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• Stewart et al. (2002) interviewed National Treatment Outcome Research Study 
(NTORS) clients (552 men and 201 women) and found that women reported 
greater health problems, were more likely to have a drug-using partner, and were 
more likely to be responsible for children. 
• Neale (2004a) surveyed 715 male and 318 female drug users accessing 
treatment in Scotland as part of Drug Outcome Research in Scotland (DORIS - 
see Section 5.2.6 for more details).  She sees the lives of this population as 
heterogeneous.  However, she did find some gender-specific results with men 
more likely to have illegal debts173, to have been in prison174 and to be less 
reliant on state benefits175. 
11.1.4 Infectious Diseases 
Because of differences in methodologies between the devolved administrations, it is 
not possible to provide UK estimates of prevalence.  Therefore, this section will focus 
on England and Wales, as this dataset is the largest.  
 
Prevalence levels of HIV176, hepatitis B and C177 are similar amongst men and 
women (see Figures 15 and 16).  However, there has been evidence of a lower level 
of prevalence of hepatitis B amongst women in recent years.  
Figure 15: Percentage of male and female injecting drug users diagnosed with HIV in a 
representative cross sectional survey in England and Wales, 1995-2004 
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Source: Health Protection Agency et al. (2005a). 
                                                
173 Males’ increased likelihood to have illegal debts equated to 25.3 per cent of the male 
sample compared to 17.4 per cent of females (p≤0.05). 
174 Males’ increased likelihood to have been in prison equated to 78.1 per cent of the male 
sample compared to 49.8 per cent of females (p≤0.001). 
175 As such, 87.1 per cent of the male sample had received income from state benefits in the 
last six months, compared to 94.0 per cent of the females (p≤0.001). 
176 In a representative cross-section survey in England and Wales of 2,585 injecting drug 
users, only 36 or 1.4 per cent tested positive for HIV/AIDS (Health Protection Agency 2005). 
177 Forty-two per cent of the 2,585 tested were diagnosed with hepatitis C in England and 
Wales, and 22 per cent were diagnosed with hepatitis B. 
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Figure 16: Percentage of male and female injecting drug users diagnosed with hepatitis B and 
C in England and Wales, 1998-2004 
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Source: Health Protection Agency (2005a).  
 
While women can have similar or even lower prevalence levels than men, female 
injecting drug users (IDUs) may have a higher risk of blood borne viral infections than 
male IDUs because they may engage in more risky behaviour.  Historical data show 
that they are more likely to share injecting equipment: data from the Regional Drug 
Misuse Database show that women in England have a higher incidence of sharing 
injecting equipment in the last month (25% compared to 19% - out of a total of 
31,815 drug users entering treatment; DH 2000).  Other studies support this (Durante 
et al. 1995; Gossop 1996; Bennett et al. 2000) and it is thought to be because 
women may be more reluctant to access syringe exchange services for various 
reasons such as: 
• injecting drug use is more stigmatised for women (McKeganey 1998; Derricott et 
al. 1999; McElrath and Jordan 2005), which may increase their reluctance to 
attend services (Hunter and Judd 1998; McKeganey 1998). 
• perceptions that agencies target men, and that male injectors are intimidating 
(Derricott et al. 1999). 
• non-child friendly agencies (Derricott et al. 1999). 
 
Female IDUs may also be more likely to acquire infections such as septicaemia 
because they are more likely to inject into a muscle or subcutaneous tissue due to 
poor venous access (NHS Greater Glasgow 2001). 
 
Whilst there is little primary research regarding Anabolic Steroid (AS) use, evidence 
indicates that the vast majority of AS users are male (Korkia and Stimson 1993) and 
that most (81%) inject at least some drugs (Lenehan et al. 1996).  There is a risk of 
blood borne virus transmission amongst AS injectors (Henrion et al. 1992); however, 
the UK Unlinked Anonymous HIV Prevalence Monitoring Survey found that only two 
per cent of a sample of 149 AS injectors had hepatitis B core antibodies and none 
had HIV antibodies suggesting the risk of blood borne virus transmission amongst 
these injectors is low (Crampin et al. 1998).  However, despite this, the risk of 
contracting injection-related diseases or any adverse effects is still present (Yesalis 
2000). 
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11.1.5 Crimes and arrests 
Significantly more men commit crimes than women.  In 2003 in England and Wales, 
just over two million defendants were proceeded against by a magistrates’ court 
(Home Office 2004f).  Of these, 82.4 per cent were male (1,648,822), 16.9 per cent 
were female (337,988) and 0.7 per cent were identified as “other” (14,012).  This 
gender difference holds true when assessing the different types of indictable offence 
(see Figure 17) and is also apparent elsewhere in the UK.  For example, in Northern 
Ireland, 90 per cent of those prosecuted are male (NIO Statistics and Research 
Branch 2002).  In addition, for those proceeded against, the male:female ratio was 
highest for violent crimes and lowest for acquisitive crimes. 
Figure 17 Defendants proceeded against by a magistrate’s court for an indictable offence in 
England and Wales in 2003 by type of offence and gender as a percentage 
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Source: Home Office (2004f). 
 
The NEW-ADAM research178 found that, among the relatively few females who were 
tested for drugs, there was a higher rate of positive opiate tests in comparison to 
male arrestees179 (Bennett and Holloway 2004).  Female arrestees were also 
significantly more likely to test positive for methadone and cocaine (including crack), 
amphetamines and benzodiazepines.  However, this may say as much about male 
and female offending patterns as it does about differences in drug use. 
                                                
178 The New English and Welsh Arrestee Drug Abuse Monitoring (NEW-ADAM) research 
programme interviews and examines voluntary urine tests to establish the prevalence of drug 
use among arrestees. It was suspended in 2002 – for further details please see  
http://www.homeoffice.gov.uk/rds/drugs_new_adam.html. 
179 Forty-two per cent of the 407 females tested, had positive results for opiates compared to 
69 per cent of the 2,684 males (Bennett and Holloway 2004).  
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Goulden and Sondhi’s (2001) research with a small group of young offenders (aged 
12 to 30 years old) suggested that male serious offenders were four times more likely 
to have used a Class A drug in the last month than female serious offenders.  
Prisons 
The prison population is overwhelmingly male (see Table 32).  However, overall the 
percentage of females in prison because of drug offences is higher than for males.  
Table 32: Number and percentage of prisoners under immediate custodial sentence who 
were convicted because of drug offences in the United Kingdom by gender and country in 
2004 
Females in prison Males in prison 
Country 
Number 
imprisoned 
because of 
drug 
offences 
Total 
number 
of female 
prisoners 
Percentage 
imprisoned 
because of 
drug 
offences 
Number 
imprisoned 
because of 
drug 
offences 
Total 
number 
of male 
prisoners 
Percentage 
imprisoned 
because of 
drug 
offences 
England and 
Wales 1,235 3,449 35.8% 9,252 54,475 17.0% 
Northern 
Ireland 1 12 8.3% 58 782 7.4% 
Scotland 73 258 28.3% 772 5,408 14.3% 
UNITED 
KINGDOM 1,309 3,719 35.2% 10,082 60,665 16.6% 
Scottish data present details for 2004/05.  In England and Wales, these data are based on 
monthly figures for June 2004.  In Northern Ireland and Scotland, the data are based on the 
average daily prison population for the specified time period.  
Source: Home Office (2004g); O’Loan and Amelin (2005); Scottish Executive (2005i). 
 
Home Office (2003b) interviews of 301 female prisoners highlighted that: 
• nearly half were dependent on at least one drug; 
• over a quarter said they were using heroin in prison; 
• as noted in Section 11.1, an association with abuse, low self-esteem and 
mental health problems was apparent, emphasising the importance of 
psychological and pharmacological support.  However Black/ mixed race 
women were less likely to seek help for emotional problems; 
• the prevalence and frequency of pre-prison drug use by female prisoners 
matched or even exceeded that of male prisoners. 
11.2 Responses 
11.2.1 Gender specific responses on children and young people - prevention 
Universal prevention 
Much universal prevention for children and young people in the UK focuses on the 
school setting and campaigns such as FRANK, Know the Score and the National 
Drugs Helpline (see Chapter 3).  These often lack a gender-specific approach.  
However, boys can have particular needs in drug education.  This is seen as being 
due to a lack of advice in their magazines on issues such as drugs, and because 
boys and girls learn differently (Gurian 2001).  Universal prevention strategies are 
employed in gendered environments in the UK, for example, through single sex 
schools, but as yet there has been no evaluation on their efficacy (White et al. 2004). 
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Selective prevention in recreational settings 
Please see Section 11.2.2 for details of outreach work in the night time environment 
concerning the reduction of sexually transmitted infections.  Such work is often 
holistic, targeting issues such as sexual health and drug use. 
Selective prevention among socially vulnerable groups 
The 2003 Crime and Justice Survey indicates that young people180 identified as 
belonging to a vulnerable group181 account for over half of young Class A drug users 
despite accounting for less than a third of the sampled population (Becker and Roe 
2005).  However, there are no direct comparisons of the effectiveness of specific 
curriculum content or teaching styles on different genders within the vulnerable 
groups (White et al. 2004).  Such research would be beneficial by discovering the 
role of demography and background in prevention, and to investigate how effects can 
be sustained (White et al. 2004). 
Young people involved in sex work 
Studies suggest that more young women become involved in sex work than young 
men, at a ratio of 4:1 (Barrett 1998).  Far less has been documented about sex work 
among young men but evidence suggests that boys tend to enter and exit sex work 
at a younger age (Palmer 2001).  This population may also be less visible because of 
the additional perceived stigma of homosexuality (Palmer 2001).  
 
Various interventions and organisations support young people involved in sex work 
such as specialist foster carers, structured day care programmes, Children and 
Adolescent Mental Health Services (CAMHS) and projects such as the Coalition for 
the Removal of Pimping (Home Office 2004d).  However, few of these are gender 
specific and there has been little research examining them (Edmonds et al. 2005).  
Teenage pregnancy 
Strategies have been launched to help tackle teenage pregnancy in the UK, but 
these are not drug specific (Social Exclusion Unit 1999; DHSSPSNI 2002a; Scottish 
Executive 2003c). 
Early criminality 
Although the majority of young offenders are male (Home Office 2003c; O’Loan and 
Amelin 2005; Scottish Executive 2005i), the established responses in the UK (such 
as Youth Offending Teams) are not gender specific. 
 
Edmonds et al. (2005) highlighted that more research is needed on whether a young 
offender’s gender affects their experiences and behaviours.  
11.2.2 Problem drug use and harm reduction: provision of gender specific responses  
Reduction of injecting 
Injecting drug use is normally associated with heroin use but there has been a 
significant rise in the number of AS using men accessing syringe exchange services 
(McVeigh et al. 2003).  Harm reduction in this context is complex as they do not 
associate themselves with heroin injectors because of not injecting for psychoactive 
                                                
180 They surveyed 4,574 individuals aged 10 to 24 years old. 
181 Vulnerable groups are defined as those who have ever been homeless, truants, school 
excludees, and young offenders.  These groups are not exclusive, and many young people 
will be part of multiple groups or transfer between them.  Inclusion in one or more of these 
groups is not seen as a pre-cursor to problematic drug use.  There may also be vulnerable 
sub-sets within these classifications. 
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reasons182.  So basic harm reduction messages that are established in other injector 
groups, such as encouraging non-injecting drug administration, are not clear-cut 
(McVeigh et al. 2005). 
 
Attempts to reduce injecting amongst women can also be problematic.  Syringe 
exchange services rarely see women as clients (McVeigh et al. 2003).  To encourage 
their attendance, Derricott et al. (1999) suggest that services should provide: 
• women only sessions; 
• female-specific services (such as smear tests, contraceptive advice); 
• services, which are appropriate to carers of children; 
• staff with awareness of female-specific injecting issues (such as greater 
difficulty in accessing superficial veins). 
Reduction of risk of sexual transmission of infectious diseases 
Because women and gay men both suffer disproportionately high levels of sexual ill 
health (Lacey et al. 1997; Hughes et al. 2000; DH 2003a), these groups are 
recognised as needing to be targeted with information and interventions (DH 2001b).   
 
In the night-time environment, sexual health promotion activity often focuses on 
outreach work targeting gay cruising areas (seeking out gay men in places such as 
Blackpool and Manchester), and prostitutes (targeting women in places such as 
Edinburgh183 and Liverpool) (Hughes and Bellis 2003).  It has also been 
recommended that advice and screening for chlamydia184 are targeted at males, who 
are more difficult to reach, outside traditional health settings and in places such as 
nightclubs (DH 2003a; House of Commons Health Committee 2003).  
 
All pregnant women are offered tests for Sexually Transmitted Infections (such as 
hepatitis B, HIV and syphilis) as part of routine antenatal screening (NICE 2003). 
Male and female sex workers’ health 
The National Strategy for Sexual Health and HIV specifically identifies those involved 
in prostitution as a target group for health promotion (DH 2001b).  So, local projects 
offer services to help sex workers, and many follow a gendered approach.  The 
Capital Care Project was established in 1999 in London to ensure that a Needs 
Assessment Worker is available for any woman arrested for street sex work.  May et 
al.’s (2001) assessment of it noted several recommendations: 
• Making sure the sex workers report incidents of violence to the Police. 
• Referring clients to appropriate services. 
• Giving more priority to reducing drug use. 
• Relying on settings other than custody suites to access this population. 
 
Services such as BASE 75 in Glasgow and Streetreach in Doncaster offer women a 
holistic programme, providing access to accommodation, education, training and help 
with benefits (Home Office 2004d).  Other services, such as the Magdalene Group in 
Norwich, offer outreach work and a school prevention programme (Home Office 
2004d).  It is important that these projects provide flexible access, as crack and/or 
heroin use can influence their ability to keep appointments (Home Office 2004d).  
This is exacerbated by housing problems, working hours, fear of their pimp and/or 
partner’s response to treatment, and a lack of confidence in services. 
                                                
182 Instead they inject for a variety of reasons including to enhance their sporting 
performance, to improve their ability to do their job (where size or strength are beneficial), or 
to enhance their physical appearance (by far the most common reason; Lenehan et al. 1996). 
183 See www.scot-pep.org.uk for more details. 
184 Chlamydia is highlighted because of its high prevalence amongst young people. 
 126
UNITED KINGDOM FOCAL POINT REPORT 2005 
 
Although the vast majority of the 80,000 people thought to be working in some form 
of prostitution in the UK are female (whether as adults or young girls), there is also a 
substantial sex market involving men and young boys (Home Office 2004d).  SW5185 
provides a sexual health service in London for men and transgendered people who 
are, have been or are thinking about becoming involved in sex work.  Many use 
drugs (including alcohol).  SW5 offers somewhere to speak freely, advice, support, 
help with housing, information on education and training, and drug information.  It 
also operates an outreach service. 
Pregnant problem drug users 
Pregnancy can be a significant point when the individual seeks to address their drug-
using behaviour (DH 2002a), as drug use can impact on both the unborn baby (see 
Section 6.1, UK Focal Point on Drugs 2004) and the mother (see Sparey and 
Walkinshaw 1999 for further details; DH 2002a).  
 
The Scottish Executive (2001a) has established principles to underpin good practice 
in maternity care for drug using parents: 
• Maternity care should focus on the woman, who must be able to make 
informed decisions. Siney (1999) notes that women must be encouraged to 
admit drug use so that they are able to make these decisions. 
• Staff should support partners throughout pregnancy and childbirth. 
• Maternity services should be easily accessible. 
• Women should help plan maternity services. 
• A multi-disciplinary approach is essential. 
 
Some further points are that: 
• pregnant drug users should be able to access the same services as other 
women (Scottish Executive 2001b). 
• care should be holistic, addressing social and financial needs too, as many 
obstetric problems are associated with alcohol, tobacco, social deprivation, 
poor health and nutrition (Siney 1999). 
 
The Effective Interventions Unit (EIU 2005b) has issued guidance for those working 
with pregnant drug users (including alcohol and tobacco).  This emphasises: 
• the importance of focusing on the needs of the mother and baby; 
• engaging the fathers in the care process; 
• accounting for the parents’ fears and hopes. 
• multi-agency working, engaging for example paediatricians, midwives and 
drug services to provide a framework that is adaptable to local needs. 
 
In 2004, DH (2004h) dedicated €2.4 million (£1.6 million) to tackling teenage 
pregnancy and drug abuse in England.  Through the Young People’s Development 
Programme, 27 pilot schemes will offer integrated training and education in areas 
such as journalism, environmental activity, arts and sport, mentoring, life skills and 
health-related training.  It will run for three years.  
 
See Section 11.2.3 for details on treatment services for pregnant drug users. 
                                                
185 See http://www.drugs.gov.uk/WorkPages/Diversity/CaseStudies/1074262168 for more 
information. 
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Parents with small children 
The Advisory Council for the Misuse of Drugs (ACMD 2003) estimated that 43 per 
cent (95,000) of those accessing treatment in England and Wales had a dependent 
child over a five-year period186 187.  Of these, 69 per cent were fathers.  Drug-using 
parents are more likely to live in poverty, have poor health and have a low socio-
economic status188 (Kettinger et al. 2000; Nair et al. 2003).  However, not all find it 
difficult to care for their children (Barnard and McKeganey 2004).  
 
Children can motivate their parents into addressing their drug use (Taylor 1993; 
Powis 2000); however, fear of having their children taken into care can affect this 
(DH 2002a; EIU 2002).  So, programmes such as Sure Start189 are used to 
encourage attendance at drug services.  These do not follow a gendered approach.  
In addition, much of the literature and guidance concerning parents with small 
children does not address the mother and the father separately (Murray and Hogarth 
2003), unless they are discussing pregnancy (for example, NHS Borders 2004).  
Prevention of drug-related mortality and morbidity 
Mortality 
The National Treatment Agency for Substance Misuse (NTA 2002), when discussing 
DRDs, advises that all drug services should meet the needs of and attract vulnerable 
groups, which covers gender-specific issues. 
Mental health 
DH (2003b) recommends providing women-only community day services for those 
experiencing mental health problems. 
11.2.3 Treatment data 
Availability of gender specific treatment 
In the UK, the majority of treatment services cater for both genders, adapting their 
services to the needs of the individuals190.  NTORS shows how services can help 
both genders, even though they have different situations.  Stewart et al. (2002) 
interviewed 753 NTORS clients (552 men and 201 women) and found that despite 
the gender differences of those presenting to services (see Section 11.1.3), there 
was no gender difference in treatment response, and both men and women made 
significant progress in reducing drug use191, health problems and criminal 
behaviour192 after a year.  However, differences were found for alcohol consumption: 
a fifth of participants began treatment drinking above recommended limits, but this 
was only reduced for men.  
                                                
186 In the Border regions, Murray and Hogarth (2003) estimate that between 10 and 50 per 
cent of clients accessing drug and alcohol services, are the parents of dependent children. 
187 These estimates are based on those attending drug treatment services, and so are likely 
to be conservative. 
188 Although Kettinger et al. (2000) argue that it is difficult to attribute drug use as the main 
cause of negative outcomes as a number of environmental factors may also be responsible. 
189 The Department for Education and Skill’s Sure Start programme aims to give children in 
deprived areas the best possible start in life through a multi-agency approach involving 
health, childcare, early learning and family services  - see http://www.surestart.gov.uk/ for 
more details. 
190 An example of this is the Northern Ireland Community Addiction services, see 
www.patient.co.uk for further information. 
191 For example, frequency of heroin and benzodiazepine use were approximately halved at 
one year. 
192 Although the reduction here was less marked for women. 
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However, it is thought that universal drug services may not be able to meet the 
specific needs of individual groups, such as women (DH 2002a).  As such, some 
female-specific services do exist193 194.  These are mainly aimed at particular groups 
of women: 
1. Pregnant users (the Women’s Reproductive Health Service in Glasgow; 
Special Needs in Pregnancy Service available in parts of Scotland). 
2. Victims of domestic abuse (through the low threshold and referral service 
Survive, in South Gloucestershire, England). 
3. Sex workers (Base 75 – see EIU 2002). 
 
The Drugs Strategy Directorate (DSD 2003) suggests that such gender-specific 
services can help to ensure that agencies are more informed about women’s 
concerns.  In addition, Osorio et al. (2002) evaluated a women-only service (30 
service users participated).  Overall, they found that the participants were satisfied, 
and that their health and social status had improved during contact with the service.  
However, because it relied on referrals, it did not reach those women who do not 
access services. 
Approaches relating to female role behaviour in treatment 
Because of the substantially fewer number of women compared to men in contact 
with treatment services, (see Section 11.1.3) it has been suggested that women are 
under-represented in these services (DH 2002a; EIU 2002).  The EIU (2002) 
suggests that more women need to be encouraged to come forward, through 
addressing factors such as women’s roles as mothers, their fear that their children 
might be taken into care, fear of judgement particularly if they are pregnant, and fear 
of the authorities if they are involved in criminal activities such as prostitution195.  
(See Section 11.1.1 for data regarding problematic drug users). 
 
However, other researchers suggest that women may not be under-represented 
(Meier et al. 2000; Beynon et al. 2004; Best and Abdulrahim 2005).  For example, 
Beynon et al. calculated that for Liverpool residents, there was a higher male to 
female ratio observed in the estimated total number of problem drug users, 
compared to that for individuals who had been recorded as accessing structured drug 
treatment.  This suggested a higher service penetration by female drug users.  The 
authors propose that men’s reluctance to access treatment could explain their higher 
numbers with regards to DRDs (see Section 11.1.2).  However, it is still important for 
drug services to address women’s needs (Best and Abdulrahim 2005).  It is 
suggested that they should co-operate with others to address issues such as 
physical and sexual abuse, eating disorders, self-mutilation and parenting (DH 
2002a).  This can mean working with mental health services, social services, 
women’s refuges, antenatal care, childcare provision and welfare benefits advice.  As 
such, DH (2002a) has recommended: 
• services for children (for example, childcare, parental monitoring); 
• healthcare (for example, antenatal, family planning, HIV prevention); 
• appropriate staffing (female staff who are culturally and racially sensitive on 
telephone lines or as counsellors); 
• shared care treatment programmes, for example for pregnant drug users. 
• advocacy (for example, contact with welfare agencies); 
                                                
193 Information on the services available in Scotland can be accessed through 
www.sdf.org.uk.  An example of a female service in Scotland is Brenda’s House in Edinburgh. 
194 Information on the services available in England can be found through www.drugs.gov.uk.  
An example of a female service in England is the Longreach Women’s Treatment Centre. 
195 It should be noted that some of these issues can also be relevant for male drug users. 
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• access to education, training, housing, co-morbid services and aftercare; 
• treatment incorporating factors connected to their drug use (for example, 
eating disorders); 
• group/therapy counselling as Hodgins et al. (1997) suggest treatment 
outcomes are better for those women who have access to such services, 
especially when they are single sex groups; 
• extended treatment; women are thought not to benefit as much from brief 
interventions (Thom and Green 1996); 
• outpatient behavioural programmes; and 
• accurate needs assessment for the female service users and their families. 
 
Becker and Duffy (2002) propose that treatment services should be made more 
women-friendly by (Becker and Duffy 2002): 
1. providing women-only spaces; 
2. taking women directly to appointments or meeting travel expenses; 
3. providing childcare; 
4. employing staff from a range of different ethnic backgrounds; 
5. performing outreach work; 
6. providing a fast response or immediate access to services; 
7. varying the opening times; 
8. making stronger links, for example with midwives and social workers. 
Approaches relating to masculine role behaviour in treatment 
Whilst it is important to attract female drug users into treatment services, it is also 
important to attract male drug users.  This is because men are more likely to use 
drugs, and because more men die from drug-related causes (see Section 11.1; 
Beynon et al. 2004).  As such, for AS users, Derricott et al. (1999) recommended 
peer outreach in gyms, information in gyms and specific sessions at syringe 
exchange services.  (Interventions and services for AS users going beyond syringe 
exchange and basic harm reduction measures are rare in the UK.) 
11.2.4 Gender specific responses in social (re)integration 
As we have seen throughout this chapter, many interventions in the UK are holistic, 
and aim to provide both drug services and re-integration techniques.  So, the gender-
specific services such as SW5 and BASE 75 (see Section 11.2.2) not only provide 
access to treatment and information, but also provide training or help with housing. 
Family and social relationships 
Drug treatment services give advice and support, where needed, on issues such as 
family and social relationships (DSD 2003).  Mother and Baby units have been 
established by local agencies (DSD 2004e).  Services such as Corekids are more 
specialist (Drink and Drugs News 2005).  It treats the drug-using parents and children 
alongside each other to enable children (who may have been looking after their 
parents) to renegotiate their position in the family.  However, there is no structured 
gender dynamic to this service. 
Work and employment 
Progress2work (p2w) is the main intervention in the UK, which helps get drug users 
in treatment back into employment, but it does not use a gendered approach. 
Education and training 
Positive Futures is a national initiative in England and provides an intervention based 
on relationship-building to re-integrate vulnerable young people (including drug 
users) into education or training.  It does not follow a gendered approach (aiming to 
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reach all those living in deprived areas) but it largely involves young men (28% of the 
35,263 who had been involved up to October 2004 are female; DSD 2005b).  
However, some local projects cater in particular for vulnerable women (Home Office 
2004d): 
1. The Reclaim Life Project develops Information Technology and basic skills for 
excluded women in North and West Yorkshire. 
2. Street Girls provides pre-employment courses for prison leavers in 
Lancashire on subjects such as gym instruction and literacy. 
Debt counselling 
DSD (2004d) suggests that drug agencies should integrate financial work into their 
services so that clients are less reliant on begging but this is not a gendered 
approach.  This lack of a gendered-structure is because the drug user, whatever 
gender, finances their own drug habit (Taylor 1993), and so both men and women 
are likely to have financial issues that need addressing. 
Housing 
The Office of the Deputy Prime Minister (OPDM) and the Home Office (2005) have 
issued guidance on housing for those working with drug users.  It identifies women 
as a group with specific needs because they often have access to fewer bed-spaces 
than men, and that those providing housing-related support to women must ensure 
that local services have clear policies on childcare and confidentiality. 
11.2.5 The criminal justice system 
Responses to petty crime 
The Home Office is investing €14.1 million (£9.15 million) into reducing women’s 
offending (DSD 2005c).  Initiatives will be set up in two areas in England to tackle 
issues such as drug use, housing, childcare, domestic violence, and mental health 
problems.   
 
Other responses to petty crime include Community Orders.  The majority of those 
issued with an Order are male.  For example, in 2002 in England and Wales, 82 per 
cent of those issued with a Drug Treatment and Testing Order (DTTO) were male 
(NAO 2004).  The National Audit Office (NAO) suggest that women may be less likely 
to commit the types of crime that would lead to a DTTO (such as burglary). 
Prison responses, differences in culture of practices in men’s and women’s prisons 
There are a number of important differences when discussing women’s offending and 
women’s prisons that must be considered in comparison to men196 and it has been 
acknowledged that the imprisonment of women is in need of revision (HM 
Inspectorate of Prisons 2001; Scottish Executive 2002a).  There are calls for 
expansion into services in the community, and alternatives to custody.  Yet the 
female prison population continues to rise (see Figure 6). 
 
Most prison responses to drug use in UK prisons (such as CARATs, DIP – see 
Section 9.3.3) do not have a gendered approach.  However, Ash (2003) has 
published guidance for prisons on working with female prisoners, which covers 
issues such as procedures for Mandatory Drug Tests and healthcare arrangements. 
 
 
                                                
196 More information can be found at  
http://www.hmprisonservice.gov.uk/adviceandsupport/prison_life/femaleprisoners/.  
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12. European drug policies: extended beyond illicit 
drugs? 
12.1 Official endorsement by the National Drug Strategy  
The formal UK Drug Strategy documents do not generally include other addictive 
behaviours (UKADCU 1998; DSD 2002a); though with devolution Northern Ireland, 
Scotland and Wales have developed their own strategies, based upon UK strategy, 
but reflecting local need.  In Wales, the strategy, is concerned with both drug and 
alcohol use (National Assembly for Wales 2000).  In Northern Ireland, while there are 
separate strategies for drugs (NIO 1999) and alcohol (DHSSPNI 2000), there is a 
Drugs and Alcohol Co-ordinator responsible for policy in both areas.  The Scottish 
approach focuses mainly on the use of illicit drugs, but recognises that the problem is 
multi-faceted.  Scotland’s Drug Strategy identified that there are inextricable links 
between illegal drug use, smoking and alcohol misuse stating that ‘Tobacco and 
alcohol use often provide a gateway into illicit drug use’ (Scottish Office 1999). 
 
Links between addictive behaviours are, however, well recognised, notably the link 
between drugs and alcohol and are addressed through various initiatives at local and 
national level. 
12.1.1 Northern Ireland Drug Strategy 
The Northern Ireland Drugs Strategy (NIO 1999) identifies the main drug problem as 
use of recreational drugs in Northern Ireland.  While the original strategy did not 
address alcohol, tobacco, solvents or doping, it did identify young people as a key 
target group for drug prevention work, as did the UK Drug Strategies (UKADCU 
1998; DSD 2002a).  As a result of this, education and prevention programmes are a 
prime focus of action.  Such programmes, focusing on school children and young 
adults, include medicines, alcohol, tobacco and solvents.  The Drug Strategy will be 
updated in the near future following a comprehensive review.. 
12.1.2 Welsh Assembly Government 
The Welsh strategy not only covers illicit drugs but also alcohol, prescription-only 
medicines (for example, anabolic steroids and benzodiazepines), over the counter 
medicines (for example, those containing codeine or ephedrine), and volatile 
substances (National Assembly for Wales 2000).  The strategy recognises that drug 
use is multi-faceted, adding that the problem is complex, dynamic and far-reaching.  
12.2 Genesis and Rational 
12.2.1 Northern Ireland  
The Northern Ireland Drug Strategy originally did not incorporate alcohol misuse (NIO 
1999).  However, the separate alcohol strategy by the Department for Health, Social 
Services and Public Safety, Northern Ireland (DHSSPSNI 2000) has been cross-
referenced with the Drug Strategy through the Northern Ireland Drugs and Alcohol 
Campaign (DHSSPSNI 2001).  This campaign enabled regional and local action 
plans to be developed, and to empower groups and individuals to progress initiatives.  
While meeting local needs, the model remained part of the overall purpose of the 
national strategy.  In addition, a Regional Drug and Alcohol Strategy Coordinator was 
appointed in 2003, and tasked to take forward the implementation and delivery of the 
combined Drug and Alcohol Strategies (DHSSPSNI 2003). 
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12.2.2 Wales  
The Welsh strategy has built upon the work of the previous strategy for Wales of 
1996 (Welsh Office 1996), and following a review it developed a strategy aimed to 
increase prevention activity with a view to reduce the acceptability of taking drugs 
and of excessive or inappropriate drinking (Welsh Office 1996).  It prioritised work on 
young people and emphasised the needs of children.   The 2000 strategy expands 
on this and now encompasses non-illicit substances (National Assembly for Wales 
2000).  The rational for this was that there are overlaps in responses required to deal 
with problems rising from drug use, and that use of different substances often result 
in similar physical, psychological and social problems.   
12.3 Responsibilities and competencies (Coordination) 
While it is only in Wales that there is formal endorsement of extending the Drug 
Strategy beyond illicit drugs, in England and Scotland, Drug Action Teams now 
commonly co-ordinate local action on alcohol and, accordingly, are frequently 
designated as Drug (and Alcohol) Action Teams (D(A)ATs). 
12.3.1 Volatile substance abuse 
Further, the responsibility for a strategic response to addictions in other areas can lie 
within the competence of government departments who lead on drugs.  Thus, the 
Substance Misuse Team at the Department of Health in England are responsible for 
developing a framework to tackle volatile substance abuse (VSA), working in 
partnership with Home Office and supported by the Department of Trade and 
Industry (DH 2005b).  The principal aim is to ensure the number of deaths arising 
from VSA continue to fall.  
 
Scotland does not have a specific strategy on VSA but they launched a campaign to 
raise awareness in March 2005 (see Section 3.2.3; Scottish Executive 2005a).  This 
campaign follows the Lord Advocate's decision in February 2005 to revise 
prosecution policy (Scottish Executive 2005a).  
12.3.2 Alcohol 
The Substance Misuse Team with the Department of Health also worked with the 
Home Office (responsible for UK Drug Strategy) to develop an Alcohol Harm 
Reduction Strategy for England (Prime Minister’s Strategy Unit 2004).  The Home 
Office and the Department of Health share responsibilities for delivery, but work 
closely with departments such as the Department for Culture, Media and Sport, the 
Office of the Deputy Prime Minster, and the Department for Education and Skills.  
The Public Health White Paper Choosing Health: Making healthier choices easier 
seeks to build on the commitments within the Alcohol Strategy through guidance and 
training, piloting approaches to targeted screening and brief intervention, and 
improving alcohol treatment services (DH 2004a). 
 
The Scottish Executive published its Plan for action on alcohol problems in 2002 
(Scottish Executive 2002b).  This identifies binge drinkers and the need to reduce 
harmful drinking by children and young people as key priorities.  It sets out the action 
required in relation to culture change, prevention and education, provision of services 
and protection and controls.  The Executive will publish an updated Plan by the end 
of 2005, which will review progress to date and set out forward actions for the 
Executive and partner agencies for the next three years. 
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12.3.3 Doping 
The use of performance enhancing drugs, while not incorporated in national 
strategies, may be addressed at local D(A)AT level.  The UK Government supports 
the National Anti-Doping Policy (UK Sport 2005).  UK Sport is the country's National 
Anti-Doping Organisation (NADO) and it receives Government funding to combat 
drugs in sport197.  The Scottish Executive and sportscotland198 are supporting the UK 
Government and UK Sport fully on this (Scottish Executive 2002c). 
12.3.4 Tobacco 
Tobacco is not within the competence of the UK Drug Strategy (UKADCU 1998; DSD 
2002a).  In England, the Department of Health has lead responsibility for the most 
recent Government White Paper on public health issues Choosing Health: Making 
healthier choices easier (DH 2004a).  This aims to tackle tobacco health issues and 
reduce the number of smoking-related deaths.  Government is to bring forward 
policies set out to regulate smoking in public places and workplaces, to tighten 
regulation of underage tobacco sales and to take action on tobacco smuggling. In 
addition it will continue maintaining a high level of tax on cigarettes.   
 
Northern Ireland has a corresponding strategy (DHSSPSNI 2002b).  It outlines 
Northern Ireland’s approach to improve health, well-being and reducing health 
inequalities, and identifies the need to tackle smoking as a priority.   
 
In Scotland, A breath of fresh air for Scotland: tobacco control action plan sets out a 
programme of action covering prevention and education, protection and controls and 
the expansion of cessation services (Scottish Executive 2004d).  It also addresses 
the issue of second hand smoke and proposed consultations which led to the 
Smoking, Health and Social Care (Scotland) Act 2005 being passed.  As a result by 
26 March 2006, the Scottish Executive (internal communication) suggests that 
Scotland will have one of the most comprehensive sets of restrictions on smoking in 
public places anywhere in the world.  
12.3.5 Gambling 
The Department for Media, Culture and Sport (DCMS 2004) believes that the UK has 
relatively low levels of problem gambling. Nevertheless, the Foresight project (see 
Section 7.3.1 for more details on Foresight) on Brain Science, Addiction and Drugs 
looked at the potential problems of behavioural addiction and reported that gambling 
is the ‘best-known non-chemical addiction’ (Orford 2005).  
 
A new Gambling Bill became an Act of Parliament in April 2005.  It introduces new 
regulations for commercial gambling and is intended to afford greater protection for 
those who have problems with gambling as all gambling operators will be required to 
act responsibly (DCMS 2004).  Following the bill, the gambling industry established 
the Responsibility in Gambling Trust (RIGT)199.  This will fund prevention, treatment 
and research into the causes of problem gambling and effective treatment.   
 
                                                
197 Please see http://www.culture.gov.uk/sport/drug_free_sport.htm and  
http://www.uksport.gov.uk/ for more information. 
198 Sportscotland is the national agency for sport in Scotland.  They aim to develop sport and 
physical recreation in Scotland. See http://www.sportscotland.org.uk for more details. 
199 For more information, please see http://www.rigt.org.uk/about.asp.  
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13. Developments in drug use within recreational 
settings 
Much of the research and information available in the United Kingdom concerning 
recreational settings revolves around nightclubs.  However, general population data 
indicate that people consume drugs in other recreational settings such as bars or 
pubs (Ramsey et al. 2001; Chivite-Matthews et al. 2005), parties, gigs, festivals etc. 
(Sumnall, in preparation). 
13.1 New findings about trends in drug use, patterns of consumption and 
availability within recreational settings 
13.1.1 Research 
An estimated 14.8 million people visited at least one nightclub in the UK in 2004 
(Mintel 2004).  Those who attend such events or venues are more likely to use drugs 
more frequently, in larger quantities (O’Hagan 1999; Measham et al. 2001; see 
Figure 18) and are more likely to be poly-drug users (Riley et al. 2001).  Drug use 
prevalence among club goers is also likely to be higher amongst younger age groups 
(see Figure 18). 
Figure 18 Percentage of individuals reporting to have used any illegal drug in the last year by 
frequency of visits to nightclubs or discos in the last month in England and Wales 
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Source: Chivite-Matthews et al. (2005). 
 
Higher drug use prevalence is also associated with the frequency of attending pubs 
or wine bars in England and Wales, particularly amongst those in the younger age 
groups (see Figure 19), with similar patterns evident in Scotland (Riley et al. 2001). 
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Figure 19 Percentage of individuals reporting use of an illegal drug in the last year by 
frequency of visits to a pub or wine bar in the evening in the last month in England and Wales 
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Source: Chivite-Matthews (2005). 
 
Deehan and Saville (2003) interviewed 760 clubbers in the South East of England.  
Several key points emerged: 
• Seventy nine per cent had used drugs during their lifetime compared to 46.6 
per cent of 16 to 24 year olds in the British Crime Survey (Chivite-Matthews et 
al. 2005). 
• Ecstasy was the most common drug used, followed by cannabis and cocaine. 
• A third were using both alcohol and drugs when surveyed. 
• The clubbers bought their drugs from trusted dealers200 to bring to the venue 
to minimise health risks and legal consequences.  So, effective searching at 
the door could tackle drug use inside the venue. 
13.1.2 Types of recreational settings where drug use is most prevalent 
Music types 
Certain music styles are thought to be associated with the use of specific drugs.  
Webster et al. (2002) state that ecstasy, amphetamines and ketamine are associated 
with ‘techno’ music whilst alcohol, cocaine and ecstasy are associated with ‘garage’ 
music.  However, they do not provide a reference for this, and as music and fashion 
trends are transient, it must be viewed cautiously. 
Venue and clientele 
Levels and patterns of drug use can vary according to the venue.  Deehan and 
Saville (2003) found that drug use201 ranged from nine per cent at a leisure park to 
70 per cent at an established dance/gay club (see Figure 20).  Measham et al. (2001) 
also found that venue could affect drug use, as the type of venue attended was 
associated with the drug used. 
                                                
200 Riley et al. (2001) support this, stating that in their study drugs were more likely to be 
accessed through friends rather than from any other source. 
201 The interviewees either already had used or were intending to use an illegal drug on the 
evening of the interview. 
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Figure 20 Percentage of drug use prevalence on the night of interview among clubbers by 
venue in the South East of England 
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Source: Deehan and Saville (2003). 
Lifestyle 
Those employed in casual labour abroad can show higher levels of drug use.  
Hughes et al. (2004) interviewed 92 young people from the UK working in Ibiza for 
the summer and found that they were more likely to use illegal drugs than 
holidaymakers202.  For example, 43.5 per cent of workers had used amphetamines 
compared to 7.4 per cent of holidaymakers (P<0.01).  
13.1.3 Changes in drug use and attitudes since 2000 
McCambridge et al.’s (2005) survey of Mixmag203 readers shows that, since 1999, 
although most drugs have experienced increases and decreases in current use 
among dance venue attendees, overall levels of current use have remained broadly 
similar (see Figure 21).  However, there are marked decreases in use for 4-MTA, 
amphetamines and base amphetamine.  They found a similar pattern for lifetime 
prevalence.  
                                                
202 Who have an elevated level of drug use compared to levels of drug use in the UK – see 
Chapter 13.1.4. 
203 A UK magazine whose target audience is those interested in the dance scene. 
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Figure 21 Percentage prevalence of current use of specific illegal drugs in the United 
Kingdom among Mixmag readers, 1999-2003 
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(1999, n = 1,151; 2000, n = 795; 2001, n = 787; 2002, n= 335; 2003, n = 805.) 
Source: McCambridge et al. (2005).   
Those holidaying abroad 
Bellis et al. (2003) examined the patterns of substance use amongst those 
holidaying204 in Ibiza in 1999 and in 2002.  The percentage of individuals who had 
ever used any illegal drugs did not change significantly over the time period either at 
home205 or abroad206.  However, cocaine, ecstasy and GHB use in both settings had 
risen notably by 2002, whilst tobacco, amphetamine and LSD use had reduced (see 
Figure 22).   
                                                
204 They surveyed 846 people returning to the UK from Ibiza in 1999 and 868 in 2002.  
205 In 1999, 56.6 per cent had ever tried an illegal drug in the UK, and in 2002, it was 57.4 per 
cent (x2=0.10, P=0.75). 
206 In 1999, 47.7 per cent had ever tried an illegal drug whilst in Ibiza, and in 2002, it was 51.3 
per cent (x2=2.28, P=0.13). 
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Figure 22 Levels of drug use amongst those holidaying in Ibiza in 1999 and 2002 whilst they 
are in the United Kingdom and in Ibiza 
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Source: Bellis et al. (2003). 
New trends in available drugs 
4-MTA207
Winstock et al. (2002) surveyed 1,151 Mixmag readers on their awareness and use 
of 4-MTA or ‘Flatliners’.  Just over 75 per cent were aware of the drug and 10 per 
cent had used it. 
Ketamine 
Ketamine use has been increasing in the UK since the 1990s when it became linked 
to the dance scene (ACMD Technical Committee 2004).  However, it appears that 
levels of use in clubs in some areas have stabilised208.  
Magic mushrooms 
The British Crime Survey (BCS) shows a significant increase in magic mushroom use 
(see Section 2.1.2).  The number of shops who were selling magic mushrooms, prior 
                                                
207 p-methylthioamphetamine, 4-methylthioamphetamine. 
208 See http://www.lifeline.org.uk/research/radar4.html for more information. 
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to the change in legislation (see Section 13.2.2), had increased from a handful to 
over four hundred in the last two years209. 
Methamphetamine 
Reports suggest the use of crystal methamphetamine at private parties, with higher 
levels of usage amongst clubbers (McCambridge et al. 2005) although it is still 
unclear as to how widespread or available it is210.   
13.1.4 Geographical area where specified drugs/patterns of use are most prevalent 
Levels of drug use are variable across the United Kingdom administrations and 
regions (see Chapter 2). The BCS highlights that high population areas are 
associated with higher levels of drug use prevalence (Chivite-Matthews et al. 2005). 
However, these findings are not related to drug use in recreational settings. 
Holidays 
Evidence suggests that young people holidaying abroad behave differently than 
when at home (Smeaton et al. 1998; Bellis et al. 2000; Bellis et al. 2003).  This is 
thought to be due to time away from normal constraints, creating an atmosphere for 
experimentation (Sellers 1998).  Bellis et al.’s (2003) survey found that individuals, 
who had never used illegal drugs in the UK, started using whilst they were on holiday 
in Ibiza211.  For those who were already using in the UK, frequency of use was 
significantly higher during their stay (6.7% using ecstasy for five nights or more whilst 
in the UK and 36.9% in Ibiza).  Participants were also more likely to use drugs if they 
had been on holiday in Ibiza previously. 
13.1.5 Correlates and consequences of specified drug/patterns of use causing 
concern 
Use of ambulance and hospital services 
Luke et al. (2002: 543) studied 777 ‘nightclub cases’ attending an Accident and 
Emergency (A&E) department, highlighting that: 
• Most of those attending had lacerations (39%) or soft tissue injuries (26%). 
• Assault victims were recorded as having consumed a considerable amount of 
alcohol on 24 per cent of such occasions. 
• Eleven per cent presented solely because of alcohol or drug consumption.  
The most common illegal drug causing presentation was ecstasy.   
 
Williams et al. (1998) noted an association between problematic ecstasy use and 
weekend presentations at a large London A&E department, with young adults 
presenting with sympathetic overactivity, disturbed behaviour and increased 
temperature. 
Overdose 
From 1997 to 2000, there were 81 ecstasy-related deaths212 in England and Wales 
(Schifano et al. 2003).  Most of these occurred at the weekends, during the summer 
or at New Year (‘party times’). 
                                                
209 For more information, please see  
http://www.drugs.gov.uk/NationalStrategy/DrugsAct2005/MagicMushroomFAQ#1116427021.  
210 See http://www.lifeline.org.uk/research/radar4.html for more information. 
211 Approximately 250,000 people under the age of 30 years old travel to Ibiza annually from 
the UK (Centre d’Investigatció i de Tecnologies Turístiques de les Illes Balears 2002). 
212 Defined as a coroner’s report including the words ecstasy, XTC, MDMA or MDA. 
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Other physical risks 
Drug effects 
Drug effects vary depending on a range of different factors including the dose 
consumed, the route of administration, the setting, and the users’ expectations and 
experiences (Jaffe 1985). 
 
Effects of drugs such as ecstasy can be exacerbated in the night time environment 
by (Webster et al. 2002): 
1. continuous dancing, raising body temperature; 
2. poor ventilation, over-heated venues and over-crowding resulting in increased 
body temperature; and 
3. insufficient water intake, preventing the body from cooling itself.  Although 
excessive water intake can also be problematic213. 
Drink spiking 
Establishing the incidence drug-facilitated sexual assault (DFSA) in recreational 
settings214 is problematic.  The most comprehensive UK study reported that only 21 
of the 1,014 of alleged DFSAs (2%) were attributed to involuntary drug ingestion 
(Scott-Ham and Burton 2005).  This included three cases where the drug was 
ecstasy, which may have been given to reduce inhibition rather than to induce 
sedation.  No samples tested positive for flunitrazepam (or Rohypnol), a drug often 
thought to be associated with such incidences.  Nevertheless, such instances can 
happen and professionals such as door supervisors can be trained to minimise the 
risks (Beynon et al. 2005).  Whilst drug detector kits are publicly available, Beynon et 
al.’s (in preparation) research suggests that their effectiveness and utility in the night-
time environment has not yet been proven. 
Driving 
Neale et al. (2000) interviewed 61 dance venue attendees215 in Scotland and found 
that 52 (85.2%) had ever driven whilst under the influence of an illegal drug.  Ingram 
et al.’s (2000) study surveyed 1,008 drivers aged 18 to 39 years in Scotland, and 
found that nine per cent had ever driven under the influence of an illegal drug.  The 
most common drug implicated was cannabis but ecstasy, amphetamines, cocaine 
and LSD were also involved (Neale et al. 2000).  
Environmental factors 
The following key risks in the night-time environment have been identified: 
1. overcrowding and lack of ventilation (Bellis et al. 2002; Webster et al. 2002); 
although the license changes (see Section 13.2.2) may help to address this; 
2. problems can arise when lighting and sound systems are used in premises 
that were not purpose-built (Bellis et al. 2002); 
3. design of venues and the outside environment can contribute to alcohol and 
drug-related violence (Bellis et al. 2002). 
                                                
213 See http://www.brookes.ac.uk/health/libra/ecstasy.html or http://www.homehealth-
uk.com/index.html?f=body|fr=http://www.homehealth-uk.com/medical/ecstasy.htm|r for more 
details. 
214Settings such as parties, nightclubs and pubs have been associated with the risk of drink 
spiking (Beynon et al. 2005). 
215 These individuals had all used illegal drugs and had all driven a vehicle. 
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Noise 
Regular over-exposure to loud noises can damage hearing: noise levels in clubs or 
concerts can reach 110 decibels, 25 decibels higher than the level at which workers 
must be offered hearing protection216 (RNID 2004) However, there is no legislation 
protecting nightclub customers.  Employees are also affected, and Smeatham (2002) 
recommends that guidance should be produced to help Local Authority Inspectors 
enforce the existing regulations.  
Risky behaviour 
Much of the literature and interventions surrounding violence in the night-time 
economy focus on alcohol use (Marsh and Fox-Kibby 1992; Budd 2003; Finney 
2004) as there is little empirical evidence on the link with illegal drugs (Bellis et al. 
2004). However, drugs can be involved: 
• Nearly one in five violent incidents in England and Wales are drug-related 
(Nicholas et al. 2005). 
• Like alcohol, drugs can hamper co-ordination and self-control, increasing the 
prevalence of violence and risk-taking behaviour (such as unsafe sex). 
• High levels of drug use among young people in this setting (see Section 
13.1.1) suggest that use of drugs are involved in night time violence. 
• Like alcohol, drugs affect behaviour and can influence levels of aggression 
and depression (Bellis et al. 2002).  
 
Violence is also associated with drug dealers.  Door supervisors may be involved in 
drug dealing or be the victim of drug dealing-related violence (Hobbs et al. 2003). 
The new Security Industry Authority Licence will help to combat this (see Section 
13.2.2). 
 
Unsafe sexual behaviour can also be a risk in this environment (Riley et al. 2001).  
Calafat et al. (2003) found that those consuming substances are more likely to have 
more sexual partners, and are more likely to practice safe sex less frequently.   
Other psychological risks 
A growing body of evidence suggests that ecstasy users may be exposing 
themselves to psychological risks regarding memory, cognitive abilities (Morgan 
1999; Wareing et al. 2000; Croft et al. 2001) and mood regulation (Parrott et al. 1998; 
Dughiero et al. 2001).  Long-term effects are still being investigated, although studies 
have shown that users who have not used the drug for at least 6 months continue to 
experience problems in short-term memory (Morgan et al. 2002) verbal working 
memory (Wareing et al. 2004), and in visuo-spatial memory (Wareing et al. 2005). 
Public nuisance 
The BCS asked respondents about the level of disorder in their area217, and 
compared this against drug use prevalence (Chivite-Matthews et al. 2005). The 
survey showed that there was no significant difference in levels of drug use 
prevalence across the area classifications (12.3% had used any illegal drug in the 
last year in low disorder areas compared to 13.6% in high disorder areas). However, 
these findings were not related to recreational settings. 
                                                
216 According to the Noise at Work Regulations 1989. 
217 This is in terms of the level of litter, the level of vandalism and the condition of the houses 
in their area. 
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13.2 An overview of developments in responses, national policies and legal 
aspects 
13.2.1 Responses and prevention 
There are various responses across the UK.  They tend to follow a harm reduction or 
targeted prevention approach because club goers are already likely to be drug users 
(see Section 13.1.1), and so Webster et al. (2002) believe this type of message to be 
more effective.  
Guidance for those involved in dance/club events 
The proportion of clubbers who experience harm is small, but there are often specific 
clubs involved (Luke et al. 2002).  These clubs typically offer cheap drinks, their staff 
serve intoxicated customers and ignore overcrowding.  As such, guidelines exist for 
venue managers and promoters, Drug (and Alcohol) Action Teams (D(A)ATs), 
licensing officers and those providing outreach services, for example.  Many of these 
address the safety of the venue as a physical environment through: 
1. preventing overcrowding in the venue in specific areas and overall (SDF 
1995; Bellis et al. 2002; Webster et al. 2002; BEDA 2005); 
2. providing air conditioning and ventilation (SDF 1995; Webster et al. 2002; 
BEDA 2005); 
3. providing drinking water (SDF 1995; Webster et al. 2002; BEDA 2005), 
although over-consumption can be problematic; and 
4. encouraging clubbers to take a break from dancing by providing ‘chill out’ 
areas or incorporating calm time into the record mix (SDF 1995; Webster et 
al. 2002). 
 
Such guidance also encourages staff training and first aid provision (SDF 1995; 
Webster et al. 2002; BEDA 2005). 
 
The industry itself has also developed a Code of Practice, which members of the Bar 
Entertainment and Dance Association (BEDA 2005) adhere to: 
1. venue managers will co-operate with the Police fully on drug-related matters; 
2. every customer must submit to a search, if asked.  Non-compliance will mean 
non-admission; 
3. once inside, customers may still be required to submit to a search if there is a 
suspicion that they are carrying drugs; 
4. if any customer possesses drugs or they are reasonably suspected, the 
Police will be informed; 
5. any customer possessing drugs will be barred. 
 
BEDA also emphasises the need for venues to work in partnership with for example, 
local authorities, the Police, and D(A)ATs.  Lastly, the British Beer and Pub 
Association (BBPA 2005) has banned “happy hour” drink promotions in its 32,000 
member pubs across the UK, and has strongly advised that the remaining 27,000 do 
the same to discourage binge drinking and anti-social behaviour. 
Advice for clubbers 
Although clubbers’ safety is the responsibility of everyone involved in dance club 
industry218, some drugs are illegal and clubbers must take responsibility for their 
                                                
218 Such as club owners and promoters, those responsible for licensing and policing events, 
Drug (and Alcohol) Action Teams and those providing drug education or services at events. 
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health and safety219 (Webster et al. 2002).  As such, media campaigns aim to inform 
clubbers about the risks involved regarding drug use (including alcohol) and night-
time risks.  Leaflets (Enhance RDP and SDF 1996), press releases (Health 
Promotion Agency 2001, 2003; RNID 2004; Safer Swansea 2004), websites220 221 222 
and advertising (Health Promotion Agency 2001, 2003; Safer Swansea 2003; RNID 
2004) detail first aid methods, the law, getting home safely and general safety tips.  
In addition, outreach services target clubbers and drug users at club venues.  For 
example, D3 provides services such as: 
• Free literature on safer drug using. 
• Information on legal rights. 
• Advice on accessing drug services. 
• Information about drug quality and purity. 
 
However, it is unlikely that information-based approaches are effective, particularly if 
they are used in isolation (Neale et al. 2000; Canning et al. 2004).  
13.2.2 National policies and legal developments to address drug use 
The Northern Ireland Drug Strategy (NIO 1999: 17) explicitly notes that prevention 
should include targeted information on issues such as “safer dancing”.  The Drug 
Strategy for England addresses this population but under the wider term, vulnerable 
groups (DSD 2002a). 
Amendments to the Misuse of Drugs Act 1971 
In 2003, GHB223 became a Class C controlled drug under the Misuse of Drugs Act 
1971. 
Licensing Act 2003 
The Licensing Act 2003 modernises licensing laws by providing more flexibility to the 
leisure industry224 and more power to the criminal justice system to manage the 
night-time economy. 
The Drugs Act 2005 
The Drugs Act 2005 has classified those fungi containing psilocin or psilocybin as 
Class A drugs (see Section 1.2.1).   
Security Industry Authority Licence 
Door supervisors at bars and clubs have been linked to an involvement in the 
problems of the night-time economy such as drug dealing and violence (Morris 1998; 
Luke et al. 2002; Hobbs et al. 2003).  Because of this, as of April 2005, all door 
supervisors must have a Security Industry Authority (SIA) Licence225, under the 
Private Security Act 2001.  To qualify, they must undergo a criminal background 
                                                
219 This ties into the recent White Paper Choosing Health, which seeks to provide people with 
the appropriate information, services and opportunities so that they can effectively take 
responsibility for their own health (DH 2004a). 
220 The Royal National Institute for Deaf People have launched a website at 
http://www.dontlosethemusic.com to give advice to clubbers on how to protect their ears. 
221 The Police Service of Northern Ireland have launched the Get Home Safe campaign, 
which is publicised through press releases and online at  
http://www.psni.police.uk/index/advice_centre/get_home_safe.htm.  
222 The Drugs Strategy Directorate has launched Talk to FRANK, which offers advice on 
drugs at http://www.talktofrank.com.  
223 Gamma hydroxybutyrate. 
224 In terms of opening hours and new licensing formats. 
225 For more information, please see http://www.the-sia.org.uk.  
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check and gain specific qualifications.  They must pass a course, which covers drug 
awareness. 
Future policy 
Because of the dangers associated with recreational ketamine use, the Advisory 
Council on the Misuse of Drugs Technical Committee (ACMD Technical Committee 
2004) has recommended that ketamine should be controlled under the Misuse of 
Drugs Act 1971 as a Class C drug.  
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Health and Safety Executive 
www.hse.gov.uk  
 
Health Promotion Agency 
www.healthpromotionagency.org.uk
 
Health Protection Agency 
www.hpa.org.uk
 
Health Protection Scotland 
http://www.hps.scot.nhs.uk/  
 
Health Scotland 
http://www.healthscotland.com  
 
Health Solutions Wales 
www.hsw.wales.nhs.uk
 
Healthcare Commission 
www.healthcarecommission.org.uk  
 
Her Majesty’s Inspectorate of Education in 
Scotland 
www.hmie.gov.uk  
 
Her Majesty’s Prison Service for England and 
Wales 
www.hmprison.gov.uk
 
Her Majesty’s Treasury 
www.hm-treasury.gov.uk
 
Home Office 
www.homeoffice.gov.uk
 
Information Services Division, Scotland 
www.isdscotland.org  
 
Investing for Health 
www.investingforhealthni.gov.uk
 
Joseph Rowntree Foundation 
www.jrf.org.uk  
 
Know the Score 
www.knowthescore.info
 
Learning and Teaching Scotland 
www.ltscotland.org.uk  
 
Lifeline 
www.lifeline.org.uk
 
Management Standards Consultancy 
www.themsc.org
 
Market and Opinion Research International 
www.mori.com  
 
Matrix Research and Consultancy 
www.matrixcl.co.uk  
 
Mentor UK 
www.mentorfoundation.org  
 
Metropolitan Police Authority 
www.mpa.gov.uk  
 
Middlesex University 
www.mdx.ac.uk  
 
Mintel 
www.mintel.com  
 
National Audit Office 
www.nao.org.uk  
 
National Centre for Social Research 
www.natcen.ac.uk  
 
National Children’s Bureau 
www.ncb.org.uk
 
National Collaborating Centre for Drug 
Prevention 
www.cph.org.uk/nccdp
 
National Criminal Intelligence Service 
www.ncis.co.uk
 
National Drug Evidence Centre, University of 
Manchester 
http://www.medicine.manchester.ac.uk/ndec/  
 
National Foundation for Educational 
Research 
www.nfer.ac.uk  
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National Health Service 
www.nhs.uk
 
National Health Service hepatitis C 
awareness website 
www.hepc.nhs.uk
 
National Institute for Health and Clinical 
Excellence 
www.nice.org.uk  
 
National Treatment Agency for Substance 
Misuse 
www.nta.nhs.uk
 
New Opportunities Fund 
www.nof.org.uk  
 
North West Public Health Observatory 
www.nwpho.org.uk  
 
Northern Ireland Office 
www.nio.gov.uk
 
Northern Ireland Prison Service 
www.nips.gov.uk  
 
Office of Public Sector Information 
www.opsi.gov.uk  
 
Office of the Deputy Prime Minister 
www.odpm.gov.uk  
 
Office for National Statistics 
www.statistics.gov.uk  
 
Office for Standards in Education 
www.ofsted.gov.uk  
 
Patient UK 
www.patient.co.uk
 
Pharmaceutical Services Negotiating 
Committee 
www.psnc.org.uk
 
Police Service Northern Ireland 
www.psni.police.uk
 
Pricing Prescription Authority 
www.ppa.org.uk
 
Prime Minister’s Strategy Unit 
www.strategy.gov.uk  
 
Research and Statistics Division, Home 
Office 
www.homeoffice.gov.uk/rds
 
Responsibility in Gambling Trust 
www.rigt.org.uk
 
Royal College of General Practitioners 
www.rcgp.org.uk
 
Safer Swansea 
www.saferswansea.org.uk  
 
School of Law, University of Edinburgh 
www.law.ed.ac.uk
 
Scotland Against Drugs 
www.sad.org.uk
 
Scottish Drugs Forum 
www.sdf.org.uk
 
Scottish Enterprise 
www.scottish-enterprise.com  
 
Scottish Executive 
www.scotland.gov.uk
 
Scottish Prison Service 
www.sps.gov.uk  
 
Scottish Prostitutes Education Project 
www.scot-pep.org.uk
 
Scottish Road Safety Campaign 
www.srsc.org.uk  
 
Security Industry Authority 
www.the-sia.org.uk
 
Spiked 
www.spiked-online.com  
 
Sportscotland 
www.sportscotland.org.uk
 
St George’s Hospital Medical School 
www.sgul.ac.uk  
 
Standards Site 
www.standards.dfes.gov.uk  
 
Student 
www.studentnewspaper.org  
 
Substance Misuse Management in General 
Practice 
www.smmgp.demon.co.uk
 
Tackling Anti-Social Behaviour 
www.together.gov.uk
 
Teachernet 
www.teachernet.gov.uk  
 
Think 
www.drugdrive.co.uk
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Think Road Safety United Kingdom Focal Point on Drugs 
www.thinkroadsafety.gov.uk www.ukfocalpoint.org.uk  
  
United Kingdom Parliament Times 
www.timesonline.co.uk  www.parliament.uk
  
Turning Point United Kingdom Sport 
www.turning-point.co.uk  www.uksport.gpv.uk  
  
University of Dundee Welsh Assembly Government 
www.dundee.ac.uk www.wales.gov.uk  
  
Wired for Health University of Glasgow 
www.gla.ac.uk www.wiredforhealth.gov.uk
  
University of Manchester Youth Justice Board 
www.manchester.ac.uk  www.youth-justice-board.gov.uk  
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Appendix 1: Percentage prevalence of illegal drugs in the United Kingdom by drug and 
country amongst 15 to 64 year olds 
British 
Crime 
Survey 
2003/04 
Northern 
Ireland 
Crime 
Survey 
2003/04 
All Ireland 
Drug 
Prevalence 
Survey 
2002/03 
Scottish 
Crime 
Survey 
2003* 
United 
Kingdom 
estimate* Illicit 
16 to 59 
year olds 
16 to 59 
year olds 
15 to 64 
year olds 
16 to 64 
year olds  
15 to 64 
year olds 
Lifetime prevalence 
Any illicit drug  35.6 27.4 20.0 23.4 34.1 
Amphetamine 12.2 8.5 4.0 8.9 11.7 
Cannabis  30.8 19.9 16.8 21.0 29.6 
Cocaine (including 
crack) 6.8 3.3** 1.6 4.6 6.5 
Ecstasy  6.9 7.0 5.8 5.5 6.7 
LSD 6.1 4.7 4.5 4.3 5.9 
Magic mushrooms 7.1 4.4 4.3 4.3 6.8 
Last year prevalence 
Any illicit drug 12.3 9.7 6.4 8.5 11.8 
Amphetamine 1.5 0.9 0.8 1.3 1.5 
Cannabis  10.8 6.4 5.4 7.4 10.3 
Cocaine (including 
crack) 2.5 1.1** 0.5 1.4 2.3 
Ecstasy 2.0 1.9 1.6 1.5 1.9 
LSD 0.2 0.0 0.1 0.1 0.2 
Magic mushrooms 0.8 0.2 0.2 0.2 0.8 
Last month prevalence 
Any illicit drug 7.5 6.2 3.4 4.7 7.1 
Amphetamine 0.6 0.2 0.2 0.3 0.5 
Cannabis 6.5 4.0 2.9 4.2 6.2 
Cocaine (including 
crack) 1.1 0.6** 0.1 0.4 1.0 
Ecstasy  0.9 1.1 0.5 0.6 0.9 
LSD 0.1 0.0 <0.05 <0.05 0.1 
Magic mushrooms 0.3 0.1 <0.05 <0.05 0.2 
Total sample size 24,422 3,104 3,516 4,665 35,707 
* The United Kingdom estimate is achieved by combining the data from the British Crime 
Survey, the Northern Ireland Drug Prevalence Survey and the Scottish Crime Survey.   
** These figures for the Northern Ireland Crime Survey are for cocaine only (and do not 
include data for crack). 
Source: Chivite Mathews et al. (2005); Hay (2005a); McMullan and Ruddy (2005); National 
Advisory Committee on Drugs and Drugs and Alcohol Information Research Unit (NACD and 
DAIRU 2005); Northern Ireland Office (NIO 2005); Scottish Executive (2005a). 
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Appendix 2: Number of deaths in the United Kingdom using the European Monitoring Centre 
for Drugs and Drug Addiction’s drug-related deaths definition from 1996 to 2003, by country 
Country 1996 1997 1998 1990 2000 2001 2002 2003 
Northern Ireland  9 15 17 22 21 9 12 4 
Scotland  208 188 230 272 318 376 417 343 
England and 
Wales 1153 1225 1393 1486 1606 1443 1385 1069 
Total  1370 1428 1640 1780 1945 1828 1814 1416 
Source: Corkery 2005. 
 
 
Appendix 3: The number of drug-related deaths in the United Kingdom from 1996 to 2003 
according to the definition 
Definition 1996 1997 1998 1999 2000 2001 2002 2003 
ONS 'Standard' 3221 3344 3411 3485 3517 3473 3297 2964 
EMCDDA DRD 1370 1428 1640 1780 1945 1827 1815 1416 
UK Drug 
Strategy 1531 1566 1748 1912 2011 1983 1972 1718 
Source: Corkery (2005). 
 
 
Appendix 4: Number of people found guilty, cautioned or dealt with by compounding for drug 
offences in England, Scotland and Wales from 2000 to 2003 by offence 
Offence 2000 2001 2002 2003 
Unlawful production 2,028 1,730 2,063 2,865 
Unlawful supply 5,347 5,416 4,825 4,975 
Possession with intent 6,545 6,479 5,980 6,442 
Unlawful possession  91,479 96,360 101,791 104,336 
Permitting premises to be used
unlawfully 558 413 440 479 
Unlawful import or export 1,292 1,797 1,743 1,173 
Other offences involving drugs 362 441 426 673 
All drug offences 102,196 108,047 113,054 116,429 
Source: Mwenda (2005). 
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Appendix 5: Percentage of male and female injecting drug users diagnosed with hepatitis B in 
England and Wales, 1998-2004 
Gender  1998 1999 2000 2001 2002 2003 2004 
Number 
tested 2,518 2,875 2,554 2,201 2,011 1,890 1,795 Men  Number 
positive 551 597 556 489 475 458 424 
Number 
tested 763 824 832 729 725 726 757 Women  Number 
positive 177 135 156 135 137 133 133 
Source: Health Protection Agency (2005a).  
 
Appendix 6: Percentage of male and female injecting drug users diagnosed with hepatitis C in 
England and Wales, 1998-2004 
Gender  1998 1999 2000 2001 2002 2003 2004 
Number 
tested 2520 2875 2556 2201 2021 1894 1795 Men  Number 
positive 1016 1007 898 779 812 823 756 
Number 
tested 764 825 832 729 729 726 757 Women  Number 
positive 318 286 300 272 276 300 308 
Source: Health Protection Agency (2005a).  
 
 
Appendix 7: Percentage of male and female injecting drug users diagnosed with HIV in 
England and Wales, 1996-2004 
Gender  1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Number 
tested 2,128 2,436 2,011 2,520 2,875 2,556 2,126 1,990 1,894 1,795Men  Number 
positive 34 12 22 22 24 18 21 20 24 25 
Number 
tested 675 937 620 764 825 832 698 715 727 757 Women Number 
positive 6 9 4 4 7 7 5 5 8 11 
Source: Health Protection Agency (2005a).  
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Appendix 8: Number of defendants proceeded against by a magistrate’s court for an 
indictable offence in England and Wales in 2003 by type of offence and gender 
Indictable offences Male Female Total 
Violence against the person 71,174 8,438 79,612 
Sexual offences 8,999 122 9,121 
Burglary offences 38,572 2,709 41,281 
Robbery offences 12,255 1,477 13,732 
Theft and handling stolen 
goods 119,845 31,880 151,725 
Fraud and forgery 17,998 6,741 24,745 
Criminal damage 16,712 1,877 18,589 
Drug offences 52,295 6,205 58,503 
Source: Home Office (2004f). 
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